Fidelity & Guaranty Life 10-K 21 Nov 16 2016 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Sep. 30, 2016	Nov. 16, 2016	Mar. 31, 2016
Document and Entity Information [Abstract]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Sep. 30, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	FY
Trading Symbol	FGL
Entity Registrant Name	Fidelity & Guaranty Life
Entity Central Index Key	1,585,064
Current Fiscal Year End Date	--09-30
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		58,954,049
Entity Well-known Seasoned Issuer	No
Entity Current Reporting Status	Yes
Entity Voluntary Filer	No
Entity Public Float			$ 293,482,828

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Sep. 30, 2016	Sep. 30, 2015
Investments:
Fixed maturity securities, available-for-sale, at fair value (amortized cost: September 30, 2016 - $18,521; September 30, 2015 - $17,622)	$ 19,411	$ 17,746
Equity securities, available-for-sale, at fair value (amortized cost: September 30, 2016 - $640; September 30, 2015 - $597)	683	620
Derivative investments	276	82
Commercial mortgage loans	595	491
Other invested assets	60	155
Total investments	21,025	19,094
Related party loans	71	78
Cash and cash equivalents	864	502
Accrued investment income	214	191
Reinsurance recoverable	3,464	3,579
Intangibles, net	1,026	988
Deferred tax assets	0	228
Other assets	371	265
Total assets	27,035	24,925
LIABILITIES AND SHAREHOLDERS' EQUITY
Contractholder funds	19,251	17,770
Future policy benefits	3,467	3,468
Funds withheld for reinsurance liabilities	1,172	1,267
Liability for policy and contract claims	55	55
Debt	300	300
Revolving credit facility	100	0
Deferred tax liability	10	0
Other liabilities	746	563
Total liabilities	25,101	23,423
Commitments and contingencies (Note 12)
Shareholders' equity:
Preferred stock ($.01 par value, 50,000,000 shares authorized, no shares issued at September 30, 2016 and September 30, 2015)	0	0
Common stock ($.01 par value, 500,000,000 shares authorized, 58,956,127 issued and outstanding at September 30, 2016; 58,870,823 shares issued and outstanding at September 30, 2015)	1	1
Additional paid-in capital	714	714
Retained earnings	792	710
Accumulated other comprehensive income	439	88
Treasury stock, at cost (537,613 shares at September 30, 2016; 512,391 shares at September 30, 2015)	(12)	(11)
Total shareholders' equity	1,934	1,502
Total liabilities and shareholders' equity	$ 27,035	$ 24,925

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2016	Sep. 30, 2015
Statement of Financial Position [Abstract]
Fixed maturity securities, available-for-sale, at fair value (amortized cost)	$ 18,521	$ 17,622
Equity securities, available-for-sale, at fair value (amortized cost)	$ 640	$ 597
Preferred Stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred Stock, shares authorized (in shares)	50,000,000	50,000,000
Preferred Stock, shares issued (in shares)	0	0
Preferred Stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	58,956,127	58,870,823
Common stock, shares outstanding (in shares)	58,956,127	58,870,823
Treasury Stock, shares (in shares)	537,613	512,391

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Revenues:
Premiums	$ 70	$ 58	$ 56
Net investment income	923	851	760
Net investment gains (losses)	19	(37)	307
Insurance and investment product fees and other	127	89	68
Total revenues	1,139	961	1,191
Benefits and expenses:
Benefits and other changes in policy reserves	791	578	788
Acquisition and operating expenses, net of deferrals	119	113	102
Amortization of intangibles	54	64	89
Total benefits and expenses	964	755	979
Operating income	175	206	212
Interest expense	(22)	(24)	(23)
Income before income taxes	153	182	189
Income tax expense	56	64	26
Net income	$ 97	$ 118	$ 163
Net income per common share - adjusted to reflect stock split:
Basic (in USD per share)	$ 1.67	$ 2.03	$ 2.91
Diluted (in USD per share)	$ 1.66	$ 2.02	$ 2.90
Weighted average common shares used in computing net income per common share:
Basic (in shares)	58,275,013	58,117,884	55,969,912
Diluted (in shares)	58,578,163	58,360,841	56,011,436
Cash dividend per common share (in dollars per share)	$ 0.260	$ 0.260	$ 1.110
Total other-than-temporary impairments	$ (45)	$ (82)	$ (1)
Portion of other-than-temporary impairments included in other comprehensive income	(1)	0	0
Net other-than-temporary impairments	(44)	(82)	(1)
Gains (losses) on derivatives and embedded derivatives	33	(8)	206
Other investment gains	30	53	102
Net investment gains (losses)	$ 19	$ (37)	$ 307

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Statement of Comprehensive Income [Abstract]
Net income	$ 97	$ 118	$ 163
Unrealized investment gains (losses):
Change in unrealized investment gains (losses) before reclassification adjustment	788	(650)	622
Net reclassification adjustment for losses (gains) included in net income	9	29	(101)
Changes in unrealized investment gains (losses) after reclassification adjustment	797	(621)	521
Adjustments to intangible assets	(258)	220	(157)
Changes in deferred income tax asset/liability	(187)	140	(128)
Net unrealized gains (losses) on investments	352	(261)	236
Non-credit related other-than-temporary impairment:
Changes in non-credit related other-than-temporary impairment	(1)	0	0
Net non-credit related other than-temporary impairment	(1)	0	0
Net changes to derive comprehensive income (loss) for the period	351	(261)	236
Comprehensive income (loss), net of tax	$ 448	$ (143)	$ 399

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Millions	Total	Preferred Stock	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Beginning Balance at Sep. 30, 2013	$ 1,139	$ 0	$ 0	$ 527	$ 499	$ 113	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends	(55)				(55)
Stock split	0		1	(1)
Proceeds from issuance of common stock, net of transaction fees	173			173
Net income	163				163
Unrealized investment gains, net	236					236
Stock-based compensation	3			3
Ending Balance at Sep. 30, 2014	1,659	0	1	702	607	349	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury shares purchased	(11)						(11)
Dividends	(15)				(15)
Net income	118				118
Unrealized investment gains, net	(261)					(261)
Common stock issued under employee plans	2			2
Stock-based compensation	10			10
Ending Balance at Sep. 30, 2015	1,502	0	1	714	710	88	(11)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury shares purchased	(1)						(1)
Dividends	(15)				(15)
Net income	97				97
Unrealized investment gains, net	351					351
Common stock issued under employee plans	2			2
Stock-based compensation	(2)			(2)
Ending Balance at Sep. 30, 2016	$ 1,934	$ 0	$ 1	$ 714	$ 792	$ 439	$ (12)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net income	$ 97	$ 118	$ 163
Adjustments to reconcile net income to net cash provided by operating activities:
Stock based compensation	8	7	8
Amortization	(40)	(60)	(35)
Deferred income taxes	51	50	(25)
Interest credited/index credits to contractholder account balances	632	420	659
Net recognized (gains) losses on investments and derivatives	(19)	37	(307)
Charges assessed to contractholders for mortality and administration	(103)	(68)	(45)
Deferred policy acquisition costs, net of related amortization	(296)	(253)	(149)
Changes in operating assets and liabilities:
Reinsurance recoverable	(2)	46	(16)
Future policy benefits	(1)	(36)	(53)
Funds withheld from reinsurers	(89)	(62)	(101)
Collateral posted (returned)	111	(128)	64
Other assets and other liabilities	16	(36)	11
Net cash provided by operating activities	365	35	174
Cash flows from investing activities:
Proceeds from commercial mortgage loans	35	139	17
Costs of commercial mortgage loans	(99)	(535)	(133)
Related party loans	1	35	6
Capital expenditures	(8)	(7)	(9)
Net cash (used in) investing activities	(1,186)	(1,024)	(1,659)
Cash flows from financing activities:
Treasury stock	(1)	(11)	0
Proceeds from issuance of common stock, net of transaction fees	0	0	176
Common stock issued under employee plans	2	2	0
Debt issuance costs	0	0	(4)
Draw on revolving credit facility	100	0	0
Dividends paid	(15)	(15)	(55)
Contractholder account deposits	2,780	2,503	2,365
Contractholder account withdrawals	(1,683)	(1,564)	(1,625)
Net cash provided by financing activities	1,183	915	857
Change in cash & cash equivalents	362	(74)	(628)
Cash & cash equivalents, beginning of period	502	576	1,204
Cash & cash equivalents, end of period	864	502	576
Supplemental disclosures of cash flow information:
Interest paid	19	19	19
Income taxes paid	7	38	34
Deferred sales inducements	27	26	7
Available-for-sale Securities
Cash flows from investing activities:
Proceeds from available-for-sale investments, sold, matured or repaid:	2,264	4,947	5,084
Cost of available-for-sale investments:	(3,359)	(5,746)	(6,775)
Derivative and other
Cash flows from investing activities:
Proceeds from available-for-sale investments, sold, matured or repaid:	246	439	518
Cost of available-for-sale investments:	$ (266)	$ (296)	$ (367)

Basis of Presentation and Natur

Basis of Presentation and Nature of Business	12 Months Ended
	Sep. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Nature of Business	Basis of Presentation and Nature of Business Fidelity & Guaranty Life (formerly, Harbinger F&G, LLC (“HFG”)) (“FGL” and, collectively with its subsidiaries, the “Company”) is a subsidiary of HRG Group Inc. (formerly, Harbinger Group Inc. (“HRG”)). HRG is a diversified holding company focused on obtaining controlling equity stakes in companies that operate across a diversified set of industries. FGL and HRG’s shares of common stock trade on the New York Stock Exchange (“NYSE”) under the symbols “FGL” and “HRG,” respectively. In January of 2014, HRG transferred HRG’s ownership interest in FGL common shares to FS Holdco II, Ltd. ("FS Holdco") which is a direct wholly-owned subsidiary of HRG. HRG indirectly holds 47,000 thousand shares of FGL's outstanding common stock, representing an approximate 80% interest at September 30, 2016 . Dollar amounts in the accompanying footnotes are presented in millions, unless otherwise noted. On November 8, 2015, FGL entered into an Agreement and Plan of Merger ( as amended the “Merger Agreement” and the merger contemplated thereby, the “Merger”), by and among FGL, Anbang Insurance Group Co., Ltd., a joint-stock insurance company established in the People’s Republic of China (“Anbang”), AB Infinity Holding, Inc., a Delaware corporation and a wholly-owned subsidiary of Anbang (“AB Infinity”), and AB Merger Sub, Inc., a Delaware corporation and a newly formed, wholly-owned subsidiary of AB Infinity (“Merger Sub”), which was amended on November 3, 2016, to extend the outside termination date for the completion of the Merger from November 7, 2016 to February 8, 2017. Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of FGL common stock will be canceled and converted automatically into the right to receive $26.80 in cash, without interest, other than any shares of common stock owned by FGL as treasury stock or otherwise or owned by Anbang, AB Infinity or Merger Sub (which will be canceled and no payment will be made with respect thereto), shares of common stock granted pursuant to FGL’s employee equity award plan and those shares of common stock with respect to which appraisal rights under Delaware law are properly exercised and not withdrawn. At the effective time of the Merger, each, vested and unvested, FGL option to purchase shares of common stock and restricted shares of common stock will become fully vested and automatically converted into the right to receive a cash payment in an amount pursuant to the Merger Agreement. In addition, at such time, each, vested and unvested, stock option and restricted stock unit relating to shares of Fidelity & Guaranty Life Holdings, Inc., a subsidiary of FGL (“FGLH”) will become fully vested and automatically converted into the right to receive a cash payment in an amount pursuant to the Merger Agreement, and each dividend equivalent right held in respect of a share of FGLH stock (a “DER”), whether vested or unvested, will become fully vested and automatically converted into the right to receive a cash payment equal to the amount accrued with respect to such DER. The Merger is subject to closing conditions, including the receipt of regulatory approvals from the Iowa Insurance Division, New York Department of Financial Services, Vermont Department of Financial Regulation, China Insurance Regulatory Commission, and the Committee on Foreign Investment in the United States ("CFIUS"). On November 8, 2015, FS Holdco II Ltd., a wholly-owned subsidiary of HRG Group, Inc. and direct holder of 47,000 thousand shares of FGL’s common stock representing approximately 81% of the outstanding shares of FGL’s common stock, delivered a written consent adopting, authorizing, accepting and approving in all respects the Merger Agreement and the transactions contemplated thereby, including the Merger. On November 25, 2015, FGL obtained the requisite approval for the Merger from the Vermont Department of Financial Regulation. On March 14, 2016, FGL received notification from CFIUS that it had concluded all action under Section 721 of the Defense Production Act of 1950, as amended, and determined that there are no unresolved national security concerns with respect to the merger. The parties are not required to file a notification of the Merger under the Hart-Scott Rodino Antitrust Improvements Act of 1976, as amended, due to an available exemption. The adoption of the Merger Agreement by FGL’s shareholders required the affirmative vote or written consent of holders of at least a majority of the outstanding shares of FGL’s common stock. The Company and Anbang are committed to securing the remaining regulatory approvals and seek to close the Merger as expeditiously as possible, however, the closing of the Merger and the timing thereof is subject to the regulatory review and approval process, none of which can be assured. In the event that the Merger Agreement is terminated, FGL may be required to pay a termination fee to Anbang and its subsidiaries of $51 . FGL’s primary business is the sale of individual life insurance products and annuities through independent agents, managing general agents, and specialty brokerage firms and in selected institutional markets. FGL’s principal products are deferred annuities (including fixed indexed annuity (“FIA”) contracts), immediate annuities and life insurance products. FGL markets products through its wholly-owned insurance subsidiaries, Fidelity & Guaranty Life Insurance Company (“FGL Insurance”) and Fidelity & Guaranty Life Insurance Company of New York (“FGL NY Insurance”), which together are licensed in all fifty states and the District of Columbia. Our reporting segments reflect the manner by which our chief operating decision makers view and manage the business. We currently distribute and service primarily fixed rate annuities, including FIAs. Therefore, we have only one reporting segment that our chief operating decision makers use to manage our business. Premiums and annuity deposits (net of coinsurance), which are not included as revenues (except for traditional premiums) in the accompanying Consolidated Statements of Operations, collected during the years ended September 30, 2016 , 2015 and 2014 , by product type were as follows: Year ended September 30, Product Type 2016 2015 2014 Fixed indexed annuities $ 1,861 $ 2,185 $ 1,451 Fixed rate annuities 539 211 708 Single premium immediate annuities 28 16 10 Life insurance (a) 181 163 143 Total $ 2,609 $ 2,575 $ 2,312 (a) Life insurance includes Universal Life (“UL”) and traditional life insurance products. The accompanying financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”).

Significant Accounting Policies

Significant Accounting Policies and Practices	12 Months Ended
	Sep. 30, 2016
Accounting Policies [Abstract]
Significant Accounting Policies and Practices	Significant Accounting Policies and Practices Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and all other entities in which FGL has a controlling financial interest. All intercompany accounts and transactions have been eliminated in consolidation. We are involved in certain entities that are considered variable interest entities ("VIEs") as defined under GAAP. Our involvement with VIEs is primarily to invest in assets that allow us to gain exposure to a broadly diversified portfolio of asset classes. A VIE is an entity that does not have sufficient equity to finance its own activities without additional financial support or where investors lack certain characteristics of a controlling financial interest. We assess our relationships to determine if we have the ability to direct the activities, or otherwise exert control to evaluate if we are the primary beneficiary of the VIE. See "Note 4. Investments" to the Company’s Consolidated Financial Statements for additional information on the Company’s investments in unconsolidated VIEs. Revenue Recognition Insurance Premiums The Company’s insurance premiums for traditional life insurance products are recognized as revenue when due from the contractholder. The Company’s traditional life insurance products include those products with fixed and guaranteed premiums and benefits and consist primarily of term life insurance and certain annuities with life contingencies. Premium collections for fixed indexed and fixed rate annuities, indexed universal life (“IUL”) policies and immediate annuities without life contingency are reported as deposit liabilities (i.e., contractholder funds) instead of as revenues. Similarly, cash payments to policyholders are reported as decreases in the liability for contractholder funds and not as expenses. Sources of revenues for products accounted for as deposit liabilities are net investment income, surrender and other charges deducted from contractholder funds, and net realized gains (losses) on investments. Net Investment Income Dividends and interest income, recorded in “Net investment income”, are recognized when earned. Income or losses upon call or prepayment of available-for-sale fixed maturity securities is recognized in net investment income. Amortization of premiums and accretion of discounts on investments in fixed maturity securities are reflected in “Net investment income” over the contractual terms of the investments in a manner that produces a constant effective yield. For mortgage-backed and asset-backed securities, included in the fixed maturity available-for-sale (“AFS”) securities portfolios, the Company recognizes income using a constant effective yield based on anticipated prepayments and the estimated economic life of the securities. When actual prepayments differ significantly from originally anticipated prepayments, the effective yield is recalculated prospectively to reflect actual payments to date plus anticipated future payments. Any adjustments resulting from changes in effective yield are reflected in “Net investment income’’. Net Investment Gains (Losses) Net investment gains (losses) include realized gains and losses from the sale of investments, write-downs for other-than-temporary impairments ("OTTI") of AFS investments, other invested assets, commercial mortgage loans and related party loans, and gains and losses on derivatives. Realized gains and losses on the sale of investments are determined using the specific identification method. Product Fees Product fee revenue from IUL products and deferred annuities is comprised of policy and contract fees charged for the cost of insurance, and policy administration and rider fees. Fees are assessed on a monthly basis and recognized as revenue when assessed and earned. Product fee revenue also includes surrender charges which are collected and recognized as revenue when the policy is surrendered. Benefits and Other Changes in Policy Reserves Benefit expenses for deferred annuity, FIA and IUL policies include index credits and interest credited to contractholder account balances and benefit claims incurred during the period in excess of contract account balances. Interest crediting rates associated with funds invested in the general account of our insurance subsidiaries during 2014 through 2016 ranged from 0.0% to 6.0% for deferred annuities and FIA's, combined, and 0.0% to 4.5% for IUL's. Other changes in policy reserves include the change in the fair value of the FIA embedded derivative and the change in the reserve for secondary guarantee benefit payments. Other changes in policy reserves also include the change in reserves for life insurance products. For traditional life and immediate annuities, policy benefit claims are charged to expense in the period that the claims are incurred. Stock-Based Compensation In general, we expense the fair value of stock awards included in our incentive compensation plans. As of the date our stock awards are approved and communicated to the recipients, the fair value of stock options is determined using a Black-Scholes options valuation methodology, and the fair value of other stock awards is based upon the market value of the stock. The fair value of the awards is expensed over the performance or service period, which generally corresponds to the vesting period, and is recognized as an increase to “Additional paid-in capital” in “Shareholders’ equity”. We classify certain stock awards as liabilities. For these awards, the fair value is classified as a liability on our Consolidated Balance Sheets, and the liability is marked-to-market through net income at the end of each reporting period. Stock-based compensation expense is reflected in “Acquisition and operating expenses, net of deferrals” on our Consolidated Statements of Operations. If we modify an award or change our intent to settle an award in equity or cash, we recognize additional compensation expense for the increase in the fair value of the award between the grant date and the date of modification for change in intent and any periods subsequent to the modification, if applicable. As described under "Recent Accounting Pronouncements" in Note 2, the Company early adopted ASU 2016-09 effective October 1, 2015. The adoption of ASU 2016-09 did not have a material effect on the Company's financial statements and related disclosures. Interest Expense Interest expense on our debt is recognized as due and any associated premiums, discounts, and costs are amortized (accreted) over the term of the related borrowing utilizing the straight line method. Interest expense also includes non-use fees on the revolving credit facility entered into in August 2014. Earnings Per Share Basic earnings per share (“EPS”) is computed by dividing earnings available to common shareholders by the average common shares outstanding. Diluted EPS is computed assuming the conversion or exercise of nonvested stock, stock options, and performance share units outstanding during the year. Stock options are excluded from the computation of diluted EPS, based on the application of the treasury stock method, if they are anti-dilutive. Cash and Cash Equivalents The Company considers all highly liquid debt instruments purchased with original maturities of three months or less to be cash equivalents. As of September 30, 2016 , the company held cash equivalents of $465 . As of September 30, 2015 there were no cash equivalents. Investments Investment Securities The Company’s investments in fixed maturity and equity securities have been designated as AFS and are carried at fair value with unrealized gains and losses included in “Accumulated other comprehensive income” (“AOCI”), net of associated intangibles “shadow adjustments” (discussed in "Note 7. Intangibles" to the Company’s Consolidated Financial Statements ) and deferred income taxes. Available-for-Sale Securities Other-Than-Temporary Impairments The Company regularly reviews AFS securities for declines in fair value that it determines to be other-than-temporary. For an equity security, if the Company does not have the ability and intent to hold the security for a sufficient and reasonable period of time to allow for a recovery in value, it concludes that an OTTI has occurred and the cost of the equity security is written down to the current fair value, with a corresponding charge to “Net investment gains (losses)” in the accompanying Consolidated Statements of Operations. When assessing its ability and intent to hold an equity security to recovery, the Company considers, among other things, the severity and duration of the decline in fair value of the equity security as well as the cause of the decline, a fundamental analysis of the liquidity, business prospects and the overall financial condition of the issuer. For its available-for-sale securities, the Company generally considers the following in determining whether its unrealized losses are other-than-temporary: • The estimated range and period until recovery; • Current delinquencies and nonperforming assets of underlying collateral; • Expected future default rates; • Collateral value by vintage, geographic region, industry concentration or property type; • Subordination levels or other credit enhancements as of the balance sheet date as compared to origination; and • Contractual and regulatory cash obligations and the issuer's plans to meet such obligations. The Company recognizes OTTI on debt (including redeemable and perpetual preferred stocks) securities in an unrealized loss position when one of the following circumstances exists: • The Company does not expect full recovery of its amortized cost based on the estimate of cash flows expected to be collected; • The Company intends to sell a security; or • It is more likely than not that the Company will be required to sell a security prior to recovery. If the Company intends to sell a fixed maturity available-for-sale security or it is more likely than not the Company will be required to sell the security before recovery of its amortized cost basis and the fair value of the security is below amortized cost, the Company will conclude that an OTTI has occurred and the amortized cost is written down to current fair value, with a corresponding charge to “Net investment gains (losses)” in the accompanying Consolidated Statements of Operations. If the Company does not intend to sell a fixed maturity security or it is more likely than not the Company will not be required to sell a fixed maturity security before recovery of its amortized cost basis and the present value of the cash flows expected to be collected is less than the amortized cost of the security (referred to as the credit loss), an OTTI has occurred and the amortized cost is written down to the estimated recovery value with a corresponding charge to “Net investment gains (losses)” in the accompanying Consolidated Statements of Operations, as this amount is deemed the credit loss portion of the OTTI. The remainder of the decline to fair value is recorded in AOCI as unrealized OTTI on available-for-sale securities, as this amount is considered a non-credit (i.e., recoverable) impairment. When assessing the Company’s intent to sell a fixed maturity security or if it is more likely than not the Company will be required to sell a fixed maturity security before recovery of its cost basis, the Company evaluates facts and circumstances such as, but not limited to, decisions to reposition the Company’s security portfolio, sale of securities to meet cash flow needs and sales of securities to capitalize on favorable pricing and tax planning strategies. In order to determine the amount of the credit loss for a security, the Company calculates the recovery value by performing a discounted cash flow analysis based on the current cash flows and future cash flows the Company expects to recover. The discount rate is the effective interest rate implicit in the underlying security. The effective interest rate is the original purchased yield or the yield at the date the fixed maturity security was previously impaired. When evaluating redeemable preferred stocks for OTTI the Company applies the accounting policy described above for fixed maturity securities. Additionally, the SEC’s staff in the Office of the Chief Accountant issued a letter (SEC OTTI Release) to the Financial Accounting Standards Board (“FASB”) on October 14, 2008, providing clarifying guidance on how to assess impairments of perpetual preferred securities (“PPS”), including perpetual preferred stock. After consultation with and concurrence of the FASB staff, the SEC staff has concluded that it will not object to an issuer treating a PPS similar to a fixed maturity security in an OTTI evaluation (including an anticipated recovery period), provided there has been no evidence of a deterioration in credit of the issuer. Consequently, when such criteria is met we apply the OTTI guidance of fixed maturity securities to perpetual preferred stock. When evaluating mortgage-backed securities and asset-backed securities, the Company considers a number of pool-specific factors as well as market level factors when determining whether or not the impairment on the security is temporary or other-than-temporary. The most important factor is the performance of the underlying collateral in the security and the trends of that performance. The Company uses this information about the collateral to forecast the timing and rate of mortgage loan defaults, including making projections for loans that are already delinquent and for those loans that are currently performing but may become delinquent in the future. Other factors used in this analysis include type of underlying collateral (e.g., prime, Alternative A-paper (“Alt-A”), or subprime), geographic distribution of underlying loans and timing of liquidations by state. Once default rates and timing assumptions are determined, the Company then makes assumptions regarding the severity of a default if it were to occur. Factors that impact the severity assumption include expectations for future home price appreciation or depreciation, loan size, first lien versus second lien, existence of loan level private mortgage insurance, type of occupancy and geographic distribution of loans. Once default and severity assumptions are determined for the security in question, cash flows for the underlying collateral are projected, including expected defaults and prepayments. These cash flows on the collateral are then translated to cash flows on the Company’s tranche based on the cash flow waterfall of the entire capital security structure. If this analysis indicates the entire principal on a particular security will not be returned, the security is reviewed for OTTI by comparing the present value of expected cash flows to amortized cost. To the extent that the security has already been impaired or was purchased at a discount, such that the amortized cost of the security is less than or equal to the present value of cash flows expected to be collected, no impairment is required. The Company also considers the ability of monoline insurers to meet their contractual guarantees on wrapped mortgage-backed securities. Otherwise, if the amortized cost of the security is greater than the present value of the cash flows expected to be collected, then an OTTI is recognized. The Company includes on the face of the Consolidated Statements of Operations the total OTTI recognized in "Net investment gains (losses)", with an offset for the amount of non-credit impairments recognized in AOCI. The Company discloses the amount of OTTI recognized in AOCI and other disclosures related to OTTI in "Note 4. Investments" to the Company’s Consolidated Financial Statements and the Consolidated Statements of Comprehensive Income (Loss). Mortgage Loans on Real Estate The Company’s mortgage loans on real estate are all commercial mortgage loans, which are reported at amortized cost, less impairment write-downs and allowance for losses. If a mortgage loan is determined to be impaired (i.e., when it is probable that the Company will be unable to collect all amounts due according to the contractual terms of the loan agreement or the loan is modified in a troubled debt restructuring), the carrying value of the mortgage loan is reduced to the lower of either the present value of expected cash flows from the loan, discounted at the loan’s original purchase yield, or fair value of the collateral. For those mortgages that are determined to require foreclosure, the carrying value is reduced to the fair value of the underlying collateral, net of estimated costs to obtain and sell at the point of foreclosure. The carrying value of the impaired loans is reduced by establishing an allowance with the offset recorded in "Net investment gains (losses)" in the Consolidated Statements of Operations. Mortgage loans are evaluated by the Company’s investment professionals, including an appraisal of loan-specific credit quality, property characteristics and market trends. Loan performance is continuously monitored on a loan-specific basis throughout the year. The Company’s review includes submitted appraisals, operating statements, rent revenues and annual inspection reports, among other items. This review evaluates whether the properties are performing at a consistent and acceptable level to secure the debt. Mortgages are rated for the purpose of quantifying the level of risk. Those loans with higher risk are placed on a watch list and are closely monitored for collateral deficiency or other credit events that may lead to a potential loss of principal or interest. The Company defines delinquent mortgage loans consistent with industry practice as 30 days past due. Interest on loans is recognized on an accrual basis at the applicable interest rate on the principal amount outstanding. Loan origination fees and direct costs, as well as premiums and discounts, are amortized as level yield adjustments over the respective loan terms. Unamortized net fees or costs are recognized upon early repayment of the loans. Loan commitment fees are deferred and amortized on an effective yield basis over the term of the loan. We establish mortgage loan valuation allowances both on a loan specific basis for those loans considered impaired where a property specific or market specific risk has been identified that could likely result in a future loss, as well as for pools of loans with similar risk characteristics where a property specific or market specific risk has not been identified, but for which we expect to incur a loss. Accordingly, a valuation allowance is provided to absorb these estimated probable credit losses. As of September 30, 2016 and 2015, the Company did not identify any specific loans that were impaired. The determination of the amount of valuation allowances is based upon our periodic evaluation and assessment of inherent risks associated with our loan portfolios. Such evaluations and assessments are based upon several factors, including our experience for loan losses, defaults and loss severity, and loss expectations for loans with similar risk characteristics. We evaluate and monitor loan-to-value ("LTV") ratios and debt service coverage ("DSC") ratios of our loans as indicators of potential risk of default in establishing our valuation allowance. Derivative Financial Instruments The Company hedges certain portions of its exposure to product related equity market risk by entering into derivative transactions. All of such derivative instruments are recognized as either assets or liabilities in the accompanying Consolidated Balance Sheets at fair value. The change in fair value is recognized within “Net investment gains (losses)” in the accompanying Consolidated Statements of Operations . The Company purchases financial instruments and issues products that may contain embedded derivative instruments. If it is determined that the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is bifurcated from the host contract for measurement purposes. The embedded derivative is carried at fair value with changes in fair value reported in the accompanying Consolidated Statements of Operations . Reinsurance Related Embedded Derivatives FGL Insurance has a modified coinsurance arrangement with FSRCI, meaning that funds are withheld by FGL Insurance. This arrangement creates an obligation for FGL Insurance to pay FSRCI at a later date, which results in an embedded derivative. This embedded derivative is considered a total return swap with contractual returns that are attributable to the assets and liabilities associated with this reinsurance arrangement. The fair value of the total return swap is based on the change in fair value of the underlying assets held in the funds withheld portfolio. Investment results for the assets that support the coinsurance with funds withheld reinsurance arrangement, including gains and losses from sales, are passed directly to the reinsurer pursuant to contractual terms of the reinsurance arrangement. The reinsurance related embedded derivative is reported in “Other assets”, if in a net gain position, or "Other liabilities", if in a net loss position, on the Consolidated Balance Sheets and the related gains or losses are reported in “Net investment gains” on the Consolidated Statements of Operations. Limited Partnership Investment Our investment in a limited partnership is included in Other invested assets on our Consolidated Balance Sheets. We account for our investments in the limited partnership using the equity method to determine the carrying value. Income from the limited partnership is included in Net investment income in the accompanying Consolidated Statements of Operations. Recognition of income is delayed due to the availability of the related financial statements, which are obtained from the partnership’s general partner generally on a three-month delay. Management also meets quarterly with the general partner to determine whether any credit or other market events have occurred since prior quarter financial statements to ensure any material events are properly included in current quarter valuation and investment income. In addition, the impact of audit adjustments related to completion of calendar-year financial statement audits of the limited partnership are typically received during the third quarter of each fiscal year. Accordingly, our investment income from the limited partnership investment for any fiscal-year period may not include the complete impact of the change in the underlying net assets for the partnership for that fiscal-year period. Intangible Assets The Company’s intangible assets include value of business acquired (“VOBA”), deferred acquisition cost (“DAC”) and deferred sales inducements (“DSI”). VOBA is an intangible asset that reflects the estimated fair value of in-force contracts in a life insurance company acquisition less the amount recorded as insurance contract liabilities. It represents the portion of the purchase price that is allocated to the value of the rights to receive future cash flows from the business in force at the acquisition date. DAC represents costs that are related directly to the successful sale of new or renewal insurance contracts, which may be deferred to the extent recoverable. These costs include incremental direct costs of successful contract acquisition, primarily commissions, as well as certain costs related directly to underwriting, policy issuance and processing. DSI represents up front bonus credits and vesting bonuses to policyholder account values, which are accounted for similarly to DAC and are recorded within the DAC asset balance. The methodology for determining the amortization of DAC and VOBA varies by product type. For all insurance contracts accounted for under long-duration contract deposit accounting, amortization is based on assumptions consistent with those used in the development of the underlying contract adjusted for emerging experience and expected trends. DAC and VOBA amortization are reported within “Amortization of intangibles” in the accompanying Consolidated Statements of Operations. DAC and VOBA for investment-type products and DAC for IUL products are generally amortized over the lives of the policies in relation to the incidence of estimated gross profits (“EGPs”) from investment income, surrender charges and other product fees, policy benefits, maintenance expenses, mortality net of reinsurance ceded and expense margins, and recognized gains (losses) on investments and changes in fair value of the coinsurance embedded derivative. Changes in assumptions can have a significant impact on DAC and VOBA balances and amortization rates. Due to the relative size and sensitivity to minor changes in underlying assumptions of DAC and VOBA balances, the Company performs quarterly and annual analyses of DAC and VOBA for the annuity and IUL businesses. The DAC and VOBA balances are also periodically evaluated for recoverability to ensure that the unamortized portion does not exceed the expected recoverable amounts. At each evaluation date, actual historical gross profits are reflected, and estimated future gross profits and related assumptions are evaluated for continued reasonableness. Any adjustment in estimated future gross profits requires that the amortization rate be revised (“unlocking”) retroactively to the date of the policy or contract issuance. The cumulative unlocking adjustment is recognized as a component of current period amortization. The carrying amounts of DAC and VOBA are adjusted for the effects of realized and unrealized gains and losses on fixed maturity securities classified as available-for-sale and certain derivatives and embedded derivatives. For investment-type products, the DAC and VOBA assets are adjusted for the impact of unrealized gains (losses) on investments as if these gains (losses) had been realized, with corresponding credits or charges included in AOCI. Amortization expense of DAC and VOBA reflects an assumption for an expected level of credit-related investment losses. When actual credit-related investment losses are realized, the Company performs a retrospective unlocking of DAC and VOBA amortization as actual margins vary from expected margins. This unlocking is reflected in the accompanying Consolidated Statements of Operations. Reinsurance The Company’s insurance subsidiaries enter into reinsurance agreements with other companies in the normal course of business. The assets, liabilities, premiums and benefits of certain reinsurance contracts are presented on a net basis in the accompanying Consolidated Balance Sheets and Consolidated Statements of Operations , respectively, when there is a right of offset explicit in the reinsurance agreements. All other reinsurance agreements are reported on a gross basis in the Company’s Consolidated Balance Sheets as an asset for amounts recoverable from reinsurers or as a component of other liabilities for amounts, such as premiums, owed to the reinsurers, with the exception of amounts for which the right of offset also exists. Premiums and benefits are reported net of insurance ceded. Front Street Re (Cayman) Ltd (“FSRCI”) Effective December 31, 2012, FGL Insurance entered into a reinsurance treaty with FSRCI, an indirect wholly-owned subsidiary of HRG, FGL’s parent, whereby FGL Insurance ceded 10% of its June 30, 2012 in-force annuity block business not already reinsured on a funds withheld basis. Effective September 17, 2014, FGL Insurance entered into a second reinsurance treaty with FSRCI whereby FGL Insurance ceded 30% of any new business of its multi-year guaranteed annuity block of business ("MYGA") issued effective September 17, 2014 and later on a funds withheld basis. Under the terms of the agreement, no initial ceding commission was paid as all of the underlying business is new business. The September 17, 2014 treaty was subsequently terminated as to new business effective April 30, 2015, but will remain in effect for policies ceded to FSRCI with an effective date between September 17, 2014 and April 30, 2015. Accordingly, policies issued with an effective date of May 1, 2015 and later will not be ceded to FSRCI. Income Taxes FGL and certain of its non-life insurance subsidiaries are included in the consolidated U.S. Federal income tax return of HRG. The Company’s life insurance subsidiaries file a consolidated life insurance income tax return. Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company assesses the recoverability of its deferred tax assets in each reporting period under the guidance outlined within Accounting Standards Codification (“ASC”) Topic 740, “Income Taxes”. The guidance requires an assessment of both positive and negative evidence in determining the realizability of deferred tax assets. A valuation allowance is required to reduce the Company’s deferred tax asset to an amount that is more likely than not to be realized. In determining the net deferred tax asset and valuation allowance, management is required to make judgments and estimates related to projections of future profitability. These judgments include the following: the timing and extent of the utilization of net operating loss carry-forwards, the reversals of temporary differences, and tax planning strategies. Because of the change in facts and circumstances described in "Note 11. Income Taxes" to the Company’s Consolidated Financial Statements , during the year ended September 30, 2014 the Company determined that a portion of its existing deferred tax assets that had previously had a valuation allowance placed against them, were now more likely than not recoverable. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company has the ability and intent to recover in a tax-free manner assets (or liabilities) with book/tax basis differences for which no deferred taxes have been provided, in accordance with ASC Topic 740 "Income Taxes". The Company applies the accounting guidance for uncertain tax positions which prescribes a minimum recognition threshold a tax position is required to meet before being recognized in the financial statements. The guidance also provides information on de-recognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. Accrued interest expense and penalties related to uncertain tax positions are recorded in “Income tax expense (benefit)” in the Company’s Consolidated Statements of Operations . The Company had no unrecognized tax benefits related to uncertain tax positions as of September 30, 2016 and 2015 . Contractholder Funds The liabilities for contractholder funds for deferred annuities, IUL and UL policies consist of contract account balances that accrue to the benefit of the contractholders. The liabilities for FIAs consist of the value of the host contract plus the value of the embedded derivative. The embedded derivative is carried at fair value in “Contractholder funds” in the accompanying Consolidated Balance Sheets with changes in fair value reported in the accompanying Consolidated Statements of Operations. Liabilities for immediate annuities without life contingencies are recorded at the present value of future benefits. Liabilities for the secondary guarantees on UL-type products or Investment-type contracts are calculated by multiplying

Significant Risks and Uncertain

Significant Risks and Uncertainties	12 Months Ended
	Sep. 30, 2016
Risks and Uncertainties [Abstract]
Significant Risks and Uncertainties	Significant Risks and Uncertainties Federal Regulation In April 2016, the Department of Labor (“DOL”) released its final “fiduciary” rule which could have a material impact on the Company, its products, distribution, and business model. The final rule treats persons who provide investment advice for a fee or other compensation with respect to assets of an employer plan or individual retirement account ("IRA") as fiduciaries of that plan or IRA. Significantly, the rule expands the definition of fiduciary to apply to persons, including insurance agents, who advise and sell products to IRA owners. As a practical matter, this means commissioned insurance agents selling the Company’s IRA products must qualify for a prohibited transaction exemption which requires the agent and financial institution to meet various conditions including that an annuity sale be in the “best interest” of the client without regard for the agent’s, financial institution’s or other party’s financial or other interests, and that any compensation paid to the agent and financial institution be reasonable. The final rule was effective June 2016 and generally applicable in April 2017. The rule has generated considerable controversy and is the subject of industry efforts to block implementation both in Congress and through court actions. The success or failure of these efforts cannot be predicted. Assuming the rule is not blocked, the precise impact of the rule on the financial services industry more generally, and the impact on the Company and its business in particular, is difficult to assess because the rule is new and still being studied. While we continue to analyze the regulation, we believe it could have an adverse effect on sales of annuity products to IRA owners particularly in the independent agent distribution channel. A significant portion of our annuity sales are to IRAs. Compliance with the prohibited transaction exemptions would likely require additional supervision of agents, cause changes to compensation practices and product offerings, and increase litigation risk, all of which could adversely impact our business, results of operations and/or financial condition. Use of Estimates and Assumptions The preparation of the Company's Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and assumptions used. The Company’s significant estimates which are susceptible to change in the near term relate to (1) recognition of deferred tax assets and related valuation allowances, (2) fair value of certain invested assets and derivatives including embedded derivatives (see "Note 4. Investments", "Note 5. Derivative Financial Instruments" and "Note 6. Fair Value of Financial Instruments" to the Company’s Consolidated Financial Statements ), (3) OTTI of available-for-sale investments (see "Note 4. Investments" to the Company’s Consolidated Financial Statements ), (4) amortization of intangibles (see "Note 7. Intangible Assets" to the Company’s Consolidated Financial Statements ), (5) estimates of reserves for loss contingencies, including litigation and regulatory reserves (see "Note 12. Commitments and Contingencies" to the Company’s Consolidated Financial Statements ), (6) reserves for future policy benefits and product guarantees and (7) recognition of stock-based compensation expense (see "Note 10. Stock Compensation" to the Company’s Consolidated Financial Statements ). The Company periodically, and at least annually, reviews the assumptions associated with reserves for policy benefits and products guarantees and amortization of intangibles. As part of the assumption review process that occurred in September 2016 , changes were made to the surrender rates and earned rates to bring assumptions in line with current and expected future experience. As part of the assumption review process in September 2015 , changes were made to the earned rates and the guaranteed option costs, and as part of the September 2014 review, changes were made to the surrender rates, earned rates and future index credits. The change in assumptions as of September 30, 2016 resulted in a net increase in future expected margins and a corresponding decrease in “unlocking” and amortization expense and increase intangible assets of $20 . These assumptions are also used in the reserve calculation and resulted in an increase in reserves of $22 for the year ended September 30, 2016 . The change in assumptions as of September 30, 2015 resulted in a net increase in future expected margins and a corresponding decrease in “unlocking” and amortization expense and increase to intangible assets of $55 . These assumptions are also used in the reserve calculation and resulted in an increase in reserves of $18 in the year ended September 30, 2015 . The change in assumptions as of September 30, 2014 resulted in a net decrease in future expected margins and a corresponding increase in “unlocking” and amortization expense and decrease in intangible assets of $2 . These assumptions are also used in the reserve calculation and resulted in a decrease in reserves of $4 during the year ended September 30, 2014, net of related intangible amortization. Concentrations of Financial Instruments As of September 30, 2016 and 2015 , the Company’s most significant investment in one industry, excluding United States ("U.S.") Government securities, was its investment securities in the banking industry with a fair value of $2,448 or 12% and $1,979 or 10% , respectively, of the invested assets portfolio and an amortized cost of $2,352 and $1,962 , respectively. As of September 30, 2016 , the Company’s holdings in this industry include investments in 97 different issuers with the top ten investments accounting for 34% of the total holdings in this industry. As of September 30, 2016 , the Company had no investments in a single issuer that exceeded 10% of shareholders' equity. The Company's largest concentration in any single issuer as of September 30, 2016 was Wells Fargo & Company , with a total fair value of $171 or 1% of the invested assets portfolio. As of September 30, 2015 , the Company had investments in 1 issuer, Wells Fargo & Company , that exceeded 10% of stockholders equity with a total fair value of $170 or 1% of the invested assets portfolio. The Company’s largest concentration in any single issuer as of September 30, 2015 was in Wells Fargo & Company which had a total fair value of $170 or 1% of the invested assets portfolio. Concentrations of Financial and Capital Markets Risk The Company is exposed to financial and capital markets risk, including changes in interest rates and credit spreads which can have an adverse effect on the Company’s results of operations, financial condition and liquidity. The Company expects to continue to face challenges and uncertainties that could adversely affect its results of operations and financial condition. The Company attempts to mitigate the risk, including changes in interest rates by investing in less rate-sensitive investments, including senior tranches of collateralized loan obligations, non-agency residential mortgage-backed securities, and various types of asset backed securities. The Company’s exposure to such financial and capital markets risk relates primarily to the market price and cash flow variability associated with changes in interest rates. A rise in interest rates, in the absence of other countervailing changes, will decrease the net unrealized gain position of the Company’s investment portfolio and, if long-term interest rates rise dramatically within a six to twelve month time period, certain of the Company’s products may be exposed to disintermediation risk. Disintermediation risk refers to the risk that policyholders may surrender their contracts in a rising interest rate environment, requiring the Company to liquidate assets in an unrealized loss position. Management believes this risk is mitigated to some extent by surrender charge protection provided by the Company’s products. Concentration of Reinsurance Risk The Company has a significant concentration of reinsurance with Wilton Reassurance Company (“Wilton Re”) and Front Street Re (Cayman) Ltd. ("FSRCI"), an affiliate that could have a material impact on the Company’s financial position in the event that Wilton Re or FSRCI fail to perform their obligations under the various reinsurance treaties. Wilton Re is a wholly owned subsidiary of Canada Pension Plan Investment Board ("CPPIB"). CPPIB has an AAA issuer credit rating from Standard & Poor's Ratings Services ("S&P") as of September 30, 2016 . As of September 30, 2016 , the net amount recoverable from Wilton Re was $1,523 and the net amount recoverable from FSRCI was $1,120 . The coinsurance agreement with FSRCI is on a funds withheld basis. The Company monitors both the financial condition of individual reinsurers and risk concentration arising from similar geographic regions, activities and economic characteristics of reinsurers to attempt to reduce the risk of default by such reinsurers.

Investments

Investments	12 Months Ended
	Sep. 30, 2016
Investments, Debt and Equity Securities [Abstract]
Investments	1.25 1.00 - 1.25 N/A(a) September 30, 2016 LTV Ratios: Less than 50% $ 158 $ 18 $ 1 $ 177 29 % $ 181 29 % 50% to 60% 189 — — 189 32 % 194 32 % 60% to 75% 230 — — 230 39 % 239 39 % Commercial mortgage loans $ 577 $ 18 $ 1 $ 596 100 % $ 614 100 % September 30, 2015 LTV Ratios: Less than 50% $ 115 $ — $ 11 $ 126 25 % $ 125 25 % 50% to 60% 161 20 — 181 37 % 180 37 % 60% to 75% 185 — — 185 38 % 185 38 % Commercial mortgage loans $ 461 $ 20 $ 11 $ 492 100 % $ 490 100 % (a) N/A - Current DSC ratio not available. We establish a general mortgage loan allowance based upon the underlying risk and quality of the mortgage loan portfolio using DSC ratio and LTV ratio. A higher LTV ratio will result in a higher allowance. A higher DSC ratio will result in a lower allowance. We believe that the DSC ratio is an indicator of default risk on loans. We believe that the LTV ratio is an indicator of the principal recovery risk for loans that default. September 30, 2016 September 30, 2015 Gross balance commercial mortgage loans $ 596 $ 492 Allowance for loan loss (1 ) (1 ) Net balance commercial mortgage loans $ 595 $ 491 The Company recognizes a mortgage loan as delinquent when payments on the loan are greater than 30 days past due. At September 30, 2016 and 2015, we had no CMLs that were delinquent in principal or interest payments. The following provides the current and past due composition of our CMLs: September 30, 2016 September 30, 2015 Current to 30 days $ 596 $ 492 Past due — — Total carrying value $ 596 $ 492 A Troubled Debt Restructuring ("TDR") is a situation where we have granted a concession to a borrower for economic or legal reasons related to the borrower's financial difficulties that we would not otherwise consider. A mortgage loan that has been granted new terms, including workout terms as described previously, would be considered a TDR if it meets conditions that would indicate a borrower is experiencing financial difficulty and the new terms constitute a concession on our part. We analyze all loans where we have agreed to workout terms and all loans that we have refinanced to determine if they meet the definition of a TDR. We consider the following factors in determining whether or not a borrower is experiencing financial difficulty: • borrower is in default, • borrower has declared bankruptcy, • there is growing concern about the borrower's ability to continue as a going concern, • borrower has insufficient cash flows to service debt, • borrower's inability to obtain funds from other sources, and • there is a breach of financial covenants by the borrower. If the borrower is determined to be in financial difficulty, we consider the following conditions to determine if the borrower will be granted a concession: • assets used to satisfy debt are less than our recorded investment, • interest rate is modified, • maturity date extension at an interest rate less than market rate, • capitalization of interest, • delaying principal and/or interest for a period of three months or more, and • partial forgiveness of the balance or charge-off. Mortgage loan workouts, refinances or restructures that are classified as TDRs are individually evaluated and measured for impairment. As of September 30, 2016 and 2015, our CML portfolio had no impairments, modifications or troubled debt restructuring. Net Investment Income The major sources of “Net investment income” on the accompanying Consolidated Statements of Operations were as follows: Year ended September 30, 2016 2015 2014 Fixed maturity securities, available-for-sale $ 869 $ 799 $ 723 Equity securities, available-for-sale 32 33 23 Commercial mortgage loans 24 11 3 Related party loans 4 6 7 Invested cash and short-term investments 3 2 — Other investments 9 20 20 Gross investment income 941 871 776 Investment expense (18 ) (20 ) (16 ) Net investment income $ 923 $ 851 $ 760 During the fiscal quarter ended June 30, 2015, the Company received notice that we are entitled to receive a settlement as a result of our ownership of certain RMBS that were issued by Countrywide Financial Corp ("Countrywide"), an entity which was later acquired by Bank of America Corporation. An $18 cash settlement was received in the fiscal quarter ended June 30, 2016 for a majority of the Countrywide securities, and another $2 is expected to be paid in the second fiscal quarter of 2017. In compliance with the Company's accounting policy described in "Note 2. Significant Accounting Policies and Practices", the Company updated its cash flow projections for its best estimate of the recovery as of May 31, 2016 and determined the new effective yield with the resulting immaterial impact recognized in "Net investment income". Net Investment Gains (Losses) Details underlying “Net investment gains (losses)” reported on the accompanying Consolidated Statements of Operations were as follows: Year ended September 30, 2016 2015 2014 Net realized gains on fixed maturity available-for-sale securities $ 11 $ 11 $ 104 Realized gains (losses) on equity securities 1 — (1 ) Change in fair value of other derivatives and embedded derivatives — 7 2 Realized losses on other invested assets (26 ) (40 ) (2 ) Net realized (losses) gains on available-for-sale securities (14 ) (22 ) 103 Realized (losses) gains on certain derivative instruments (84 ) 108 209 Unrealized gains (losses) on certain derivative instruments 166 (215 ) 37 Change in fair value of reinsurance related embedded derivative (49 ) 92 (42 ) Realized gains (losses) on hedging derivatives and reinsurance-related embedded derivatives 33 (15 ) 204 Net investment gains (losses) $ 19 $ (37 ) $ 307 For the year ended September 30, 2016 , proceeds from the sale of fixed maturity available-for-sale securities totaled $1,318 , gross gains on such sales totaled $40 and gross losses totaled $23 , respectively. For the year ended September 30, 2015 , proceeds from the sale of fixed maturity available-for-sale securities, totaled $3,200 , gross gains on such sales totaled $104 and gross losses totaled $44 , respectively. For the year ended September 30, 2014 , proceeds from the sale of fixed maturity available-for-sale securities, totaled $2,775 , gross gains on such sales totaled $113 and gross losses totaled $13 , respectively. Unconsolidated Variable Interest Entities The Company owns investments in VIEs that are not consolidated within the Company’s financial statements. VIEs do not have sufficient equity to finance their own activities without additional financial support and certain of its investors lack certain characteristics of a controlling financial interest. These VIEs are not consolidated in the Company’s financial statements for the following reasons: 1) FGL Insurance does not have any voting rights or notice rights; 2) the Company does not have any rights to remove the investment manager; and 3) the Company was not involved in the design of the investment. These characteristics indicate that FGL Insurance lacks the ability to direct the activities, or otherwise exert control, of the VIEs and is not considered the primary beneficiary of them. FGL Insurance participates in loans to third parties originated by Salus. Salus is an affiliated, limited liability company indirectly owned by HRG that originates senior secured asset-based loans to unaffiliated third-party borrowers. FGL Insurance also participates in CLOs managed by Salus and owns preferred equity in Salus within the funds withheld portfolio of the FSRCI treaty. The Company’s maximum exposure to loss as a result of its investments in or with Salus is limited to the carrying value of its investments in Salus which totaled $22 and $251 as of September 30, 2016 and 2015 , respectively. FGL’s investments in or with Salus are detailed in “Note 14. Related Party Transactions” to the Company’s Consolidated Financial Statements. During the fiscal quarter ended June 30, 2015, FGL invested in Boardwalk, an unaffiliated limited partnership fund that will invest in consumer whole loans, asset-backed investments, high yield, private investments, bank portfolio liquidations, bridge financing and other investments. The initial funding occurred March 20, 2015 with the remaining commitment expected to fund over the course of the next 3 years . FGL has funded $12 of a $35 commitment as of September 30, 2016 . FGL also executed a commitment of $75 to purchase common shares in an unaffiliated private business development company ("BDC"). The BDC invests in secured and unsecured fixed maturity and equity securities of middle market companies in the United States. Due to the voting structure of the transaction, FGL does not have voting power. The initial capital call occurred June 30, 2015, with the remaining commitment expected to fund through 2017. FGL has funded $42 as of September 30, 2016 ." id="sjs-B4">Investments The Company’s fixed maturity and equity securities investments have been designated as available-for-sale and are carried at fair value with unrealized gains and losses included in accumulated other comprehensive income (loss) ("AOCI") net of associated adjustments for deferred acquisition costs ("DAC"), value of business acquired ("VOBA"), and deferred income taxes. The Company’s consolidated investments at September 30, 2016 and 2015 are summarized as follows: September 30, 2016 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Carrying Value Available-for sale securities Asset-backed securities $ 2,528 $ 16 $ (45 ) $ 2,499 $ 2,499 Commercial mortgage-backed securities 850 23 (9 ) 864 864 Corporates 10,712 760 (132 ) 11,340 11,340 Equities 640 47 (4 ) 683 683 Hybrids 1,356 77 (47 ) 1,386 1,386 Municipals 1,515 206 (4 ) 1,717 1,717 Residential mortgage-backed securities 1,327 63 (28 ) 1,362 1,362 U.S. Government 233 10 — 243 243 Total available-for-sale securities 19,161 1,202 (269 ) 20,094 20,094 Derivative investments 221 78 (23 ) 276 276 Commercial mortgage loans 595 — — 614 595 Other invested assets 60 — — 58 60 Total investments $ 20,037 $ 1,280 $ (292 ) $ 21,042 $ 21,025 September 30, 2015 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Carrying Value Available-for-sale securities Asset-backed securities $ 2,148 $ 5 $ (47 ) $ 2,106 $ 2,106 Commercial mortgage-backed securities 878 14 (10 ) 882 882 Corporates 9,533 351 (354 ) 9,530 9,530 Equities 597 27 (4 ) 620 620 Hybrids 1,211 45 (42 ) 1,214 1,214 Municipals 1,520 103 (15 ) 1,608 1,608 Residential mortgage-backed securities 2,099 89 (26 ) 2,162 2,162 U.S. Government 233 11 — 244 244 Total available-for-sale securities 18,219 645 (498 ) 18,366 18,366 Derivatives investments 218 13 (149 ) 82 82 Commercial mortgage loans 491 — — 490 491 Other invested assets 164 — (9 ) 153 155 Total investments $ 19,092 $ 658 $ (656 ) $ 19,091 $ 19,094 Included in AOCI were cumulative gross unrealized gains of $1 and gross unrealized losses of $3 related to the non-credit portion of other-than-temporary impairments ("OTTI") on non-agency residential mortgage-backed securities ("RMBS") at September 30, 2016 and gross unrealized gains of $1 and gross unrealized losses of $2 related to the non-credit portion of OTTI on RMBS at September 30, 2015 , respectively. Securities held on deposit with various state regulatory authorities had a fair value of $18,075 and $16,012 at September 30, 2016 and 2015 , respectively. Under Iowa regulations, insurance companies are required to hold securities on deposit in an amount no less than the Company's legal reserve as prescribed by Iowa regulations. At September 30, 2016 and 2015 , the Company held investments that were non-income producing for a period greater than twelve months with fair values of $2 and $0 , respectively. In accordance with the Company's Federal Home Loan Bank of Atlanta ("FHLB") agreements, the investments supporting the funding agreement liabilities are pledged as collateral to secure the FHLB funding agreement liabilities. The collateral investments had a fair value of $649 and $524 at September 30, 2016 and 2015 , respectively. The amortized cost and fair value of fixed maturity available-for-sale securities by contractual maturities, as applicable, are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call or pre-pay obligations. September 30, 2016 Amortized Cost Fair Value Corporates, Non-structured Hybrids, Municipal and U.S. Government securities: Due in one year or less $ 261 $ 263 Due after one year through five years 1,863 1,919 Due after five years through ten years 3,233 3,407 Due after ten years 7,710 8,346 Subtotal 13,067 13,935 Other securities which provide for periodic payments: Asset-backed securities 2,528 2,499 Commercial mortgage-backed securities 850 864 Structured hybrids 749 751 Residential mortgage-backed securities 1,327 1,362 Subtotal 5,454 5,476 Total fixed maturity available-for-sale securities $ 18,521 $ 19,411 The Company's available-for-sale securities with unrealized losses are reviewed for potential OTTI. In evaluating whether a decline in value is other-than-temporary, the Company considers several factors including, but not limited to the following: (1) the extent and the duration of the decline; (2) the reasons for the decline in value (credit event, currency or interest-rate related, including general credit spread widening); and (3) the financial condition of and near-term prospects of the issuer. The Company also considers the ability and intent to hold the investment for a period of time to allow for a recovery of value. The Company analyzes its ability to recover the amortized cost by comparing the net present value of cash flows expected to be collected with the amortized cost of the security. For mortgage-backed and asset-backed securities, cash flow estimates consider the payment terms of the underlying assets backing a particular security, including interest rate and prepayment assumptions, based on data from widely accepted third-party data sources or internal estimates. In addition to interest rate and prepayment assumptions, cash flow estimates also include other assumptions regarding the underlying collateral including default rates and recoveries, which vary based on the asset type and geographic location, as well as the vintage year of the security. For structured securities, the payment priority within the tranche structure is also considered. For all other fixed maturity securities, cash flow estimates are driven by assumptions regarding probability of default and estimates regarding timing and amount of recoveries associated with a default. If the net present value is less than the amortized cost of the investment, an OTTI is recognized. Based on the results of our process for evaluating available-for-sale securities in unrealized loss positions for OTTI discussed above, the Company determined that the unrealized losses as of September 30, 2016 were improved due to credit spread narrowing. While recovery in the commodity and energy markets improved the overall portfolio, certain securities held in these sectors still reflect the sharp declines in energy prices experienced in 2015 . Similarly, the high yield market, which affects prices of leveraged loans typically used to secure collateralized loan obligations ("CLO"), improved during the quarter but certain components of the leveraged finance market continue to demonstrate price weakness based on lingering effects of the commodity correction. Nevertheless, the overall average rating of the Company’s holdings in these sectors remains investment grade. Based on an assessment of all securities in the portfolio in unrealized loss positions, the Company determined that the unrealized losses on the securities presented in the table below were not other-than-temporarily impaired as of September 30, 2016 . The fair value and gross unrealized losses of available-for-sale securities, aggregated by investment category and duration of fair value below amortized cost, were as follows: September 30, 2016 Less than 12 months 12 months or longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Available-for-sale securities Asset-backed securities $ 352 $ (4 ) $ 1,368 $ (41 ) $ 1,720 $ (45 ) Commercial mortgage-backed securities 44 (1 ) 182 (8 ) 226 (9 ) Corporates 413 (9 ) 1,031 (123 ) 1,444 (132 ) Equities 51 (1 ) 75 (3 ) 126 (4 ) Hybrids 41 (2 ) 412 (45 ) 453 (47 ) Municipals 69 (2 ) 38 (2 ) 107 (4 ) Residential mortgage-backed securities 70 (1 ) 544 (27 ) 614 (28 ) Total available-for-sale securities $ 1,040 $ (20 ) $ 3,650 $ (249 ) $ 4,690 $ (269 ) Total number of available-for-sale securities in an unrealized loss position less than twelve months 193 Total number of available-for-sale securities in an unrealized loss position twelve months or longer 543 Total number of available-for-sale securities in an unrealized loss position 736 September 30, 2015 Less than 12 months 12 months or longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Available-for-sale securities Asset-backed securities $ 816 $ (14 ) $ 833 $ (33 ) $ 1,649 $ (47 ) Commercial mortgage-backed securities 262 (8 ) 133 (2 ) 395 (10 ) Corporates 2,342 (201 ) 1,328 (153 ) 3,670 (354 ) Equities 37 — 106 (4 ) 143 (4 ) Hybrids 88 (4 ) 542 (38 ) 630 (42 ) Municipals 220 (6 ) 192 (9 ) 412 (15 ) Residential mortgage-backed securities 423 (10 ) 294 (16 ) 717 (26 ) Total available-for-sale securities $ 4,188 $ (243 ) $ 3,428 $ (255 ) $ 7,616 $ (498 ) Total number of available-for-sale securities in an unrealized loss position less than twelve months 712 Total number of available-for-sale securities in an unrealized loss position twelve months or longer 396 Total number of available-for-sale securities in an unrealized loss position 1,108 At September 30, 2016 and 2015 , securities in an unrealized loss position were primarily concentrated in investment grade, corporate debt, asset-backed, and hybrid instruments. At September 30, 2016 and 2015 , securities with a fair value of $183 and $302 , respectively, had an unrealized loss greater than 20% of amortized cost (excluding U.S. Government and U.S. Government sponsored agency securities), which represented less than 1% and less than 2% , respectively, of the carrying value of all investments. The following table provides a reconciliation of the beginning and ending balances of the credit loss portion of OTTI on fixed maturity available-for-sale securities held by the Company for the years ended September 30, 2016 and 2015 , for which a portion of the OTTI was recognized in AOCI: Year ended September 30, 2016 2015 Beginning balance $ 3 $ 3 Increases attributable to credit losses on securities: OTTI was previously recognized — — OTTI was not previously recognized — — Ending balance $ 3 $ 3 For the year ended September 30, 2016 , the Company recognized $40 of credit impairment losses in operations and $4 of change-of-intent losses in operations, related to fixed maturity securities and other invested assets with an amortized cost of $418 and a fair value of $374 at September 30, 2016 . The Company recognized $1 non-credit losses in other comprehensive income for investments which experienced OTTI. For the year ended September 30, 2015 , the Company recognized $74 of credit impairment losses in operations and $8 of change-of-intent losses, related to fixed maturity securities and other invested assets securities with an amortized cost of $488 and a fair value of $406 at September 30, 2015 . For the year ended September 30, 2014 , the Company recognized $1 of credit impairment losses in operations and $0 of change-of-intent losses, related to fixed maturity securities and low income housing tax credit securities with an amortized cost of $2 and a fair value of $1 at September 30, 2014 . Details underlying write-downs taken as a result of OTTI that were recognized in "Net income" and included in net realized gains on securities were as follows: Year ended September 30, 2016 2015 2014 OTTI recognized in net income: Asset-backed securities $ 12 $ 36 $ — Corporates 6 2 — Related party loans 4 — — Residential mortgage-backed securities — 8 — Other invested assets 22 36 1 Total $ 44 $ 82 $ 1 The portion of OTTI recognized in AOCI is disclosed in the Consolidated Statements of Comprehensive Income. In the second quarter ended March 31, 2015, the Company recognized credit-related impairment losses of $59 , net of reinsurance, on available-for-sale fixed maturity securities, available-for-sale equity securities and other invested assets related to direct and indirect investments in RadioShack Corporation ("RSH") and other loans because the Company concluded the decline in the fair value of these investments was other than temporary. A summary of the RSH-related impairments by investment is as follows: Year Ended September 30, 2015 Type Balance Sheet Classification OTTI Losses Collateralized loan obligations ("CLOs") (a) Fixed maturities, available-for-sale $ 25 Preferred equity (a) Equity securities, available-for-sale 21 Participations Other invested assets 35 OTTI, gross of reinsurance $ 81 CLOs (a) Fixed maturities, available-for-sale (1 ) Preferred equity (a) Equity securities, available-for-sale (21 ) OTTI, net of reinsurance $ 59 (a) Preferred equity and a portion of the CLOs are included in the FSRCI funds withheld portfolio, accordingly all income and losses on these assets are ceded to FSRCI. The fair values of the impairments summarized above were determined using the following inputs as follows: • CLOs - The Company utilized a price from a third party valuation firm which considered the sufficiency of underlying loan collateral for the RSH loan and other loans. • Preferred equity - The Company utilized a price from a third party valuation firm which considered the updated fair value estimates of the Salus Capital Partners LLC ("Salus") CLO and the Salus participation in RSH, in which Salus owns investment interests. • Participations - The Company considered the recovery of the underlying loan collateral for RSH based on the evidence obtained. RSH filed for bankruptcy on February 5, 2015. In late March 2015, the Court awarded a sale of assets at auction to another bidder, causing our collateral claim to become more junior to other claimants and resulting in our conclusion that the Company had realized an OTTI. As of September 30, 2015, substantially all of RSH assets in the estate had been converted to cash through liquidation and the fair value of the Company's RSH-related holdings reflects these cash balances, net of expenses. As of September 30, 2015 while substantially all assets represent cash, the wind-down process still continued; therefore, some variability still existed in the fair value related to these costs. Please refer to "Note 6. Fair Value of Financial Instruments” to the Company’s Consolidated Financial Statements for more detail on the investments impacted by this impairment. During 2016, the cash proceeds from the RSH liquidation trust were distributed and the Company received $23 . This reflected a recovery of 45% of par value, an increase over the 30% estimated recovery value recorded in the second fiscal quarter of 2015. As a result, the Company recognized a realized gain of $8 in the year ended September 30, 2016. The Company has a remaining direct investment in RSH of $2 as of September 30, 2016 . Additionally, during the years ended September 30, 2016 and 2015, the Company recognized credit-related impairment losses of $33 and $13 , respectively, net of reinsurance, on available-for-sale fixed maturity securities, available-for-sale equity securities and other invested assets related to CLOs, loan participations and a direct preferred equity investment with Salus. A summary of the Salus-related impairments by investment is as follows: Year ended September 30, 2016 2015 Type Balance Sheet Classification OTTI Losses CLOs Fixed maturities, available-for-sale $ 12 $ 13 Preferred equity (a) Equity securities, available-for-sale — 9 Participations Other invested assets 24 2 OTTI, gross of reinsurance $ 36 $ 24 CLOs (a) Fixed maturities, available-for-sale (1 ) (1 ) Preferred equity (a) Equity securities, available-for-sale — (9 ) Participations (a) Other invested assets (2 ) (1 ) OTTI, net of reinsurance $ 33 $ 13 (a) Preferred equity and a portion of the CLOs and participations are included in the FSRCI funds withheld portfolio, accordingly all income and losses on these assets are ceded to FSRCI. The CLO OTTI above related to a decline in valuation of the equity tranche of the Salus CLOs resulting from a decrease in the expected recovery of a loan in the underlying CLO portfolio. The preferred equity OTTI primarily related to business restructuring at Salus which eliminated the loan origination function lowering the expected future fee income to be earned by Salus. Please refer to "Note 14. Related Party Transactions" to the Company's Consolidated Financial Statements for detail on the HGI Energy exchange of notes in 2016. Commercial Mortgage Loans Commercial mortgage loans ("CMLs") represented approximately 3% and 3% of the Company’s total investments as of September 30, 2016 and September 30, 2015 , respectively. The Company primarily makes mortgage loans on income producing properties including hotels, industrial properties, retail buildings, multifamily properties and office buildings. The Company diversifies its CML portfolio by geographic region and property type to attempt to reduce concentration risk. Subsequent to origination, the Company continuously evaluates CMLs based on relevant current information to ensure properties are performing at a consistent and acceptable level to secure the related debt. The distribution of CMLs, gross of valuation allowances, by property type and geographic region is reflected in the following tables: September 30, 2016 September 30, 2015 Gross Carrying Value % of Total Gross Carrying Value % of Total Property Type: Funeral Home $ 1 — % $ 1 — % Hotel 23 4 % 13 3 % Industrial - General 58 10 % 38 8 % Industrial - Warehouse 64 11 % 76 15 % Multifamily 70 11 % 64 13 % Office 160 27 % 137 28 % Retail 220 37 % 163 33 % Total commercial mortgage loans, gross of valuation allowance $ 596 100 % $ 492 100 % Allowance for loan loss (1 ) (1 ) Total commercial mortgage loans $ 595 $ 491 U.S. Region: East North Central $ 137 23 % $ 121 25 % East South Central 21 4 % 12 2 % Middle Atlantic 97 16 % 87 18 % Mountain 67 12 % 42 9 % New England 14 2 % 9 2 % Pacific 136 23 % 113 23 % South Atlantic 67 11 % 69 13 % West North Central 14 2 % 14 3 % West South Central 43 7 % 25 5 % Total commercial mortgage loans, gross of valuation allowance $ 596 100 % $ 492 100 % Allowance for loan loss (1 ) (1 ) Total commercial mortgage loans $ 595 $ 491 Within the Company's CML portfolio, 100% of all CMLs had a loan-to-value ("LTV") ratio of less than 75% at inception at September 30, 2016 and September 30, 2015 . As of September 30, 2016 , all CMLs are current and have not experienced credit or other events which would require the recording of an impairment loss. LTV and debt service coverage ("DSC") ratios are measures commonly used to assess the risk and quality of mortgage loans. The LTV ratio, calculated at time of origination, is expressed as a percentage of the amount of the loan relative to the value of the underlying property. A LTV ratio in excess of 100% indicates the unpaid loan amount exceeds the underlying collateral. The DSC ratio, based upon the most recently received financial statements, is expressed as a percentage of the amount of a property’s net income to its debt service payments. A DSC ratio of less than 1.00 indicates that a property’s operations do not generate sufficient income to cover debt payments. The following table presents the recorded investment in CMLs by LTV and DSC ratio categories and estimated fair value by the indicated loan-to-value ratios at September 30, 2016 and September 30, 2015 : Debt-Service Coverage Ratios Total Amount % of Total Estimated Fair Value % of Total >1.25 1.00 - 1.25 N/A(a) September 30, 2016 LTV Ratios: Less than 50% $ 158 $ 18 $ 1 $ 177 29 % $ 181 29 % 50% to 60% 189 — — 189 32 % 194 32 % 60% to 75% 230 — — 230 39 % 239 39 % Commercial mortgage loans $ 577 $ 18 $ 1 $ 596 100 % $ 614 100 % September 30, 2015 LTV Ratios: Less than 50% $ 115 $ — $ 11 $ 126 25 % $ 125 25 % 50% to 60% 161 20 — 181 37 % 180 37 % 60% to 75% 185 — — 185 38 % 185 38 % Commercial mortgage loans $ 461 $ 20 $ 11 $ 492 100 % $ 490 100 % (a) N/A - Current DSC ratio not available. We establish a general mortgage loan allowance based upon the underlying risk and quality of the mortgage loan portfolio using DSC ratio and LTV ratio. A higher LTV ratio will result in a higher allowance. A higher DSC ratio will result in a lower allowance. We believe that the DSC ratio is an indicator of default risk on loans. We believe that the LTV ratio is an indicator of the principal recovery risk for loans that default. September 30, 2016 September 30, 2015 Gross balance commercial mortgage loans $ 596 $ 492 Allowance for loan loss (1 ) (1 ) Net balance commercial mortgage loans $ 595 $ 491 The Company recognizes a mortgage loan as delinquent when payments on the loan are greater than 30 days past due. At September 30, 2016 and 2015, we had no CMLs that were delinquent in principal or interest payments. The following provides the current and past due composition of our CMLs: September 30, 2016 September 30, 2015 Current to 30 days $ 596 $ 492 Past due — — Total carrying value $ 596 $ 492 A Troubled Debt Restructuring ("TDR") is a situation where we have granted a concession to a borrower for economic or legal reasons related to the borrower's financial difficulties that we would not otherwise consider. A mortgage loan that has been granted new terms, including workout terms as described previously, would be considered a TDR if it meets conditions that would indicate a borrower is experiencing financial difficulty and the new terms constitute a concession on our part. We analyze all loans where we have agreed to workout terms and all loans that we have refinanced to determine if they meet the definition of a TDR. We consider the following factors in determining whether or not a borrower is experiencing financial difficulty: • borrower is in default, • borrower has declared bankruptcy, • there is growing concern about the borrower's ability to continue as a going concern, • borrower has insufficient cash flows to service debt, • borrower's inability to obtain funds from other sources, and • there is a breach of financial covenants by the borrower. If the borrower is determined to be in financial difficulty, we consider the following conditions to determine if the borrower will be granted a concession: • assets used to satisfy debt are less than our recorded investment, • interest rate is modified, • maturity date extension at an interest rate less than market rate, • capitalization of interest, • delaying principal and/or interest for a period of three months or more, and • partial forgiveness of the balance or charge-off. Mortgage loan workouts, refinances or restructures that are classified as TDRs are individually evaluated and measured for impairment. As of September 30, 2016 and 2015, our CML portfolio had no impairments, modifications or troubled debt restructuring. Net Investment Income The major sources of “Net investment income” on the accompanying Consolidated Statements of Operations were as follows: Year ended September 30, 2016 2015 2014 Fixed maturity securities, available-for-sale $ 869 $ 799 $ 723 Equity securities, available-for-sale 32 33 23 Commercial mortgage loans 24 11 3 Related party loans 4 6 7 Invested cash and short-term investments 3 2 — Other investments 9 20 20 Gross investment income 941 871 776 Investment expense (18 ) (20 ) (16 ) Net investment income $ 923 $ 851 $ 760 During the fiscal quarter ended June 30, 2015, the Company received notice that we are entitled to receive a settlement as a result of our ownership of certain RMBS that were issued by Countrywide Financial Corp ("Countrywide"), an entity which was later acquired by Bank of America Corporation. An $18 cash settlement was received in the fiscal quarter ended June 30, 2016 for a majority of the Countrywide securities, and another $2 is expected to be paid in the second fiscal quarter of 2017. In compliance with the Company's accounting policy described in "Note 2. Significant Accounting Policies and Practices", the Company updated its cash flow projections for its best estimate of the recovery as of May 31, 2016 and determined the new effective yield with the resulting immaterial impact recognized in "Net investment income". Net Investment Gains (Losses) Details underlying “Net investment gains (losses)” reported on the accompanying Consolidated Statements of Operations were as follows: Year ended September 30, 2016 2015 2014 Net realized gains on fixed maturity available-for-sale securities $ 11 $ 11 $ 104 Realized gains (losses) on equity securities 1 — (1 ) Change in fair value of other derivatives and embedded derivatives — 7 2 Realized losses on other invested assets (26 ) (40 ) (2 ) Net realized (losses) gains on available-for-sale securities (14 ) (22 ) 103 Realized (losses) gains on certain derivative instruments (84 ) 108 209 Unrealized gains (losses) on certain derivative instruments 166 (215 ) 37 Change in fair value of reinsurance related embedded derivative (49 ) 92 (42 ) Realized gains (losses) on hedging derivatives and reinsurance-related embedded derivatives 33 (15 ) 204 Net investment gains (losses) $ 19 $ (37 ) $ 307 For the year ended September 30, 2016 , proceeds from the sale of fixed maturity available-for-sale securities totaled $1,318 , gross gains on such sales totaled $40 and gross losses totaled $23 , respectively. For the year ended September 30, 2015 , proceeds from the sale of fixed maturity available-for-sale securities, totaled $3,200 , gross gains on such sales totaled $104 and gross losses totaled $44 , respectively. For the year ended September 30, 2014 , proceeds from the sale of fixed maturity available-for-sale securities, totaled $2,775 , gross gains on such sales totaled $113 and gross losses totaled $13 , respectively. Unconsolidated Variable Interest Entities The Company owns investments in VIEs that are not consolidated within the Company’s financial statements. VIEs do not have sufficient equity to finance their own activities without additional financial support and certain of its investors lack certain characteristics of a controlling financial interest. These VIEs are not consolidated in the Company’s financial statements for the following reasons: 1) FGL Insurance does not have any voting rights or notice rights; 2) the Company does not have any rights to remove the investment manager; and 3) the Company was not involved in the design of the investment. These characteristics indicate that FGL Insurance lacks the ability to direct the activities, or otherwise exert control, of the VIEs and is not considered the primary beneficiary of them. FGL Insurance participates in loans to third parties originated by Salus. Salus is an affiliated, limited liability company indirectly owned by HRG that originates senior secured asset-based loans to unaffiliated third-party borrowers. FGL Insurance also participates in CLOs managed by Salus and owns preferred equity in Salus within the funds withheld portfolio of the FSRCI treaty. The Company’s maximum exposure to loss as a result of its investments in or with Salus is limited to the carrying value of its investments in Salus which totaled $22 and $251 as of September 30, 2016 and 2015 , respectively. FGL’s investments in or with Salus are detailed in “Note 14. Related Party Transactions” to the Company’s Consolidated Financial Statements. During the fiscal quarter ended June 30, 2015, FGL invested in Boardwalk, an unaffiliated limited partnership fund that will invest in consumer whole loans, asset-backed investments, high yield, private investments, bank portfolio liquidations, bridge financing and other investments. The initial funding occurred March 20, 2015 with the remaining commitment expected to fund over the course of the next 3 years . FGL has funded $12 of a $35 commitment as of September 30, 2016 . FGL also executed a commitment of $75 to purchase common shares in an unaffiliated private business development company ("BDC"). The BDC invests in secured and unsecured fixed maturity and equity securities of middle market companies in the United States. Due to the voting structure of the transaction, FGL does not have voting power. The initial capital call occurred June 30, 2015, with the remaining commitment expected to fund through 2017. FGL has funded $42 as of September 30, 2016 .

Derivative Financial Instrument

Derivative Financial Instruments	12 Months Ended
	Sep. 30, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments The carrying amounts of derivative instruments, including derivative instruments embedded in fixed indexed annuity ("FIA") contracts, is as follows: September 30, 2016 September 30, 2015 Assets: Derivative investments: Call options $ 276 $ 81 Futures contracts — 1 Other invested assets: Other derivatives and embedded derivatives 13 21 Other assets: Reinsurance related embedded derivative 119 168 $ 408 $ 271 Liabilities: Contractholder funds: FIA embedded derivative $ 2,383 $ 2,149 Funds withheld for reinsurance liabilities Call options payable to FSRCI 11 5 Other liabilities: Futures contracts — — $ 2,394 $ 2,154 The change in fair value of derivative instruments included in the accompanying Consolidated Statements of Operations is as follows: Year ended September 30, 2016 2015 2014 Revenues: Net investment (losses) gains: Call options $ 74 $ (100 ) $ 220 Futures contracts 8 (7 ) 26 Other derivatives and embedded derivatives — 7 2 Reinsurance related embedded derivative (49 ) 92 (42 ) $ 33 $ (8 ) $ 206 Benefits and other changes in policy reserves: FIA embedded derivatives $ 234 $ 241 $ 363 Additional Disclosures Other Derivatives and Embedded Derivatives On June 16, 2014, FGL Insurance invested in a $35 fund-linked note issued by Nomura International Funding Pte. Ltd. The note provides for an additional payment at maturity based on the value of an embedded derivative in AnchorPath Dedicated Return Fund (the "AnchorPath Fund") of $11 which was based on the actual return of the fund. At September 30, 2016 , the fair value of the fund-linked note and embedded derivative were $26 and $13 , respectively. At maturity of the fund-linked note, FGL Insurance will receive the $35 face value of the note plus the value of the embedded derivative in the AnchorPath Fund. The additional payment at maturity is an embedded derivative reported in "Other invested assets", while the host is an available-for-sale security reported in "Fixed maturities, available-for-sale". FGL Insurance participates in loans to third parties originated by Salus, an affiliated VIE, indirectly owned by HRG that provides asset-based financing. As of September 30, 2016 , one of the participating loans is denominated in Canadian ("CAD") currency which is different from FGL Insurance's functional currency. At September 30, 2015 , three additional loan participations were denominated in CAD currency. Three of the four loans denominated in CAD currency were settled in 2016. Two of the loan participations included a provision for reimbursement from the borrower to FGL Insurance for any net foreign exchange losses realized by FGL Insurance under the loan agreements. FGL Insurance's ability to recover the foreign exchange losses under these loan participations was such that the Company established embedded derivatives equal to FGL Insurance's cumulative net foreign exchange loss on these loan participations. The value of the embedded derivatives, which is equal to the cumulative net foreign exchange loss recognized on these loan participations, net of an allowance for counterparty credit risk, was reflected in "Other invested assets" as of the balance sheet date with changes in fair value reflected in the Company's Consolidated Statements of Operations . As of September 30, 2016 , all of the loan participations were settled in full and the related embedded derivative balance was reduced to zero . The value of the embedded derivative was $1 at September 30, 2015 . The Company had realized gains (losses) of $(1) , $(1) and $2 for the years ended September 30, 2016 , 2015 and 2014 , respectively, related to these foreign exchange embedded derivatives included in "Net investment gains (losses)". FGL Insurance also had two participating loans denominated in CAD currency which also required reimbursement from the borrower in CAD currency, but did not include a provision for reimbursement for any net foreign exchange losses from the borrower. Salus executed CAD swap agreements with FGL Insurance to convert the CAD cash flows into United States dollar ("USD") cash flows. Under these swap agreements, Salus reimbursed the Company for certain realized foreign exchange losses related to cash flows on these loan participations from origination date through the earlier of the maturity date of the loan or expiration of the swap agreement. Reimbursement under the swap agreements was reduced in the event the counterparties on the underlying loan participations were unable to fully repay amounts due on those loan participations. FGL Insurance's ability to recover the foreign exchange losses under these swap agreements was such that the Company established derivatives equal to FGL Insurance's cumulative net foreign exchange losses on these loan participations. During the year ended September 30, 2016, one of the loan participations was repaid in full and FGL Insurance recovered the full amount due under the related swap agreement. The other loan participation remains outstanding at September 30, 2016. The Company recognized an OTTI loss on the loan during the quarter ended September 30, 2016 and also recorded a reduction in the amount recoverable under the swap agreement. The related swap agreement with Salus expired in July 2016 and FGL Insurance recovered the amount due under the swap agreement. The value of these derivatives was reflected in “Other invested assets” with the changes in the fair value reflected in the Company’s Consolidated Statements of Operations . The value of these derivatives was $0 and $10 at September 30, 2016 and 2015 , respectively, which is equal to the cumulative net realized foreign exchange loss recognized on these loan participations net of allowance for counterparty credit risk. The Company had realized (losses) gains of $(2) and $10 for the years ended September 30, 2016 and 2015 , respectively, related to these foreign exchange derivatives included in "Net investment gains (losses)". Additionally, a subsidiary of HRG, HGI Funding LLC, executed an agreement with the Company to guarantee, subject to the terms of the agreement, the fulfillment of the accumulated foreign exchange loss recoverable from Salus. The guarantee was terminated in the quarter ended September 30, 2016 concurrent with the settlement of the Salus swap agreement. FGL Insurance entered into two CAD currency forward contracts in August 2016 to economically hedge against unfavorable movements in CAD on the one CAD-denominated loan participation which remains outstanding at September 30, 2016 . Under the forward contracts, FGL Insurance sold CAD equal to the estimated recovery amounts on the loan participation and will receive USD. The forward contracts will be settled in cash. No cash was exchanged upon execution of the forward contracts. The value of these derivatives at each balance sheet date is equal to the cumulative unrealized value and is reflected in “Other invested assets” with the changes in the fair value reflected in the Company’s Consolidated Statements of Operations. The value of the forward contracts as of September 30, 2016 was not material. The Company had realized gains of $0 for the year ended September 30, 2016 related to the forward contracts included in "Net investment gains". Reinsurance Related Embedded Derivatives FGL Insurance has a modified coinsurance arrangement with FSRCI, meaning that funds are withheld by FGL Insurance. This arrangement creates an obligation for FGL Insurance to pay FSRCI at a later date, which results in an embedded derivative. This embedded derivative is considered a total return swap with contractual returns that are attributable to the assets and liabilities associated with this reinsurance arrangement. The fair value of the total return swap is based on the change in fair value of the underlying assets held in the funds withheld portfolio. Investment results for the assets that support the coinsurance with funds withheld reinsurance arrangement, including gains and losses from sales, are passed directly to the reinsurer pursuant to contractual terms of the reinsurance arrangement. The reinsurance related embedded derivative is reported in “Other assets”, if in a net gain position, or "Other liabilities", if in a net loss position, on the Consolidated Balance Sheets and the related gains or losses are reported in “Net investment gains” on the Consolidated Statements of Operations. FIA Contracts The Company has FIA Contracts that permit the holder to elect an interest rate return or an equity index linked component, where interest credited to the contracts is linked to the performance of various equity indices, primarily the S&P 500 Index. This feature represents an embedded derivative under U.S. GAAP. The FIA embedded derivative is valued at fair value and included in the liability for contractholder funds in the accompanying Consolidated Balance Sheets with changes in fair value included as a component of “Benefits and other changes in policy reserves” in the Consolidated Statements of Operations. The Company purchases derivatives consisting of a combination of call options and futures contracts on the applicable market indices to fund the index credits due to FIA contractholders. The call options are one , two , three , and five year options purchased to match the funding requirements of the underlying policies. On the respective anniversary dates of the index policies, the index used to compute the interest credit is reset and the Company purchases new one , two , three , or five year call options to fund the next index credit. The Company manages the cost of these purchases through the terms of its FIA contracts, which permit the Company to change caps, spreads or participation rates, subject to guaranteed minimums, on each contract’s anniversary date. The change in the fair value of the call options and futures contracts is generally designed to offset the portion of the change in the fair value of the FIA embedded derivative related to index performance. The call options and futures contracts are marked to fair value with the change in fair value included as a component of “Net investment gains.” The change in fair value of the call options and futures contracts includes the gains and losses recognized at the expiration of the instrument term or upon early termination and the changes in fair value of open positions. Other market exposures are hedged periodically depending on market conditions and the Company’s risk tolerance. The Company’s FIA hedging strategy economically hedges the equity returns and exposes the Company to the risk that unhedged market exposures result in divergence between changes in the fair value of the liabilities and the hedging assets. The Company uses a variety of techniques, including direct estimation of market sensitivities and value-at-risk to monitor this risk daily. The Company intends to continue to adjust the hedging strategy as market conditions and the Company’s risk tolerance change. Call option payable to FSRCI Under the terms of the modified coinsurance arrangement with FSRCI, FGL Insurance is required to pay FSRCI a portion of the net cost of equity option purchases and the proceeds from expirations related to the equity options which hedge the index credit feature of the reinsured FIA contracts. Accordingly, the payable to FSRCI is reflected in "Funds withheld for reinsurance liabilities" as of the balance sheet date with changes in fair value reflected in the Company's Consolidated Statements of Operations. Credit Risk The Company is exposed to credit loss in the event of non-performance by its counterparties on the call options and reflects assumptions regarding this non-performance risk in the fair value of the call options. The non-performance risk is the net counterparty exposure based on the fair value of the open contracts less collateral held. The Company maintains a policy of requiring all derivative contracts to be governed by an International Swaps and Derivatives Association (“ISDA”) Master Agreement. Information regarding the Company’s exposure to credit loss on the call options it holds is presented in the following table: September 30, 2016 September 30, 2015 Counterparty Credit Rating (Fitch/Moody's/S&P) (a) Notional Amount Fair Value Collateral Net Credit Risk Notional Amount Fair Value Collateral Net Credit Risk Merrill Lynch A/*/A $ 2,302 $ 55 $ 10 $ 45 $ 2,233 $ 16 $ — $ 16 Deutsche Bank */Baa3/BBB+ 1,620 46 12 34 2,482 26 — 26 Morgan Stanley */A1/A 2,952 87 58 29 4,086 35 7 28 Barclay's Bank */A2/A- 1,389 39 — 39 392 4 — 4 Canadian Imperial Bank of Commerce AA-/A3/A+ 1,623 49 48 1 — — — — Total $ 9,886 $ 276 $ 128 $ 148 $ 9,193 $ 81 $ 7 $ 74 (a) An * represents credit ratings that were not available. Collateral Agreements The Company is required to maintain minimum ratings as a matter of routine practice as part of its over-the-counter derivative agreements on ISDA forms. Under some ISDA agreements, the Company has agreed to maintain certain financial strength ratings. A downgrade below these levels provides the counterparty under the agreement the right to terminate the open derivative contracts between the parties, at which time any amounts payable by the Company or the counterparty would be dependent on the market value of the underlying derivative contracts. The Company’s current rating allows multiple counterparties the right to terminate ISDA agreements. No ISDA agreements have been terminated, although the counterparties have reserved the right to terminate the ISDA agreements at any time. In certain transactions, the Company and the counterparty have entered into a collateral support agreement requiring either party to post collateral when the net exposures exceed pre-determined thresholds. These thresholds vary by counterparty and credit rating. As of September 30, 2016 and 2015 , counterparties posted $ 128 and $7 of collateral, respectively, of which $118 and $7 is included in "Cash and cash equivalents" with an associated payable for this collateral included in "Other liabilities" on the Consolidated Balance Sheets . The remaining $10 and $0 of non-cash collateral was held by a third-party custodian and is not included in the Company's Consolidated Balance Sheets at September 30, 2016 and 2015 , respectively. Accordingly, the maximum amount of loss due to credit risk that the Company would incur if parties to the call options failed completely to perform according to the terms of the contracts was $ 148 and $ 74 at September 30, 2016 and 2015 , respectively. The Company held 559 and 738 futures contracts at September 30, 2016 and 2015 , respectively. The fair value of the futures contracts represents the cumulative unsettled variation margin (open trade equity, net of cash settlements). The Company provides cash collateral to the counterparties for the initial and variation margin on the futures contracts which is included in "Cash and cash equivalents" in the accompanying Consolidated Balance Sheets. The amount of cash collateral held by the counterparties for such contracts was $3 and $3 at September 30, 2016 and 2015 , respectively.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	12 Months Ended
	Sep. 30, 2016
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company’s measurement of fair value is based on assumptions used by market participants in pricing the asset or liability, which may include inherent risk, restrictions on the sale or use of an asset or non-performance risk, which may include the Company’s own credit risk. The Company’s estimate of an exchange price is the price in an orderly transaction between market participants to sell the asset or transfer the liability (“exit price”) in the principal market, or the most advantageous market in the absence of a principal market, for that asset or liability, as opposed to the price that would be paid to acquire the asset or receive a liability (“entry price”). The Company categorizes financial instruments carried at fair value into a three-level fair value hierarchy, based on the priority of inputs to the respective valuation technique. The three-level hierarchy for fair value measurement is defined as follows: Level 1 -Values are unadjusted quoted prices for identical assets and liabilities in active markets accessible at the measurement date. Level 2 - Inputs include quoted prices for similar assets or liabilities in active markets, quoted prices from those willing to trade in markets that are not active, or other inputs that are observable or can be corroborated by market data for the term of the instrument. Such inputs include market interest rates and volatilities, spreads and yield curves. Level 3 - Certain inputs are unobservable (supported by little or no market activity) and significant to the fair value measurement. Unobservable inputs reflect the Company’s best estimate of what hypothetical market participants would use to determine a transaction price for the asset or liability at the reporting date based on the best information available in the circumstances. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lower level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. When a determination is made to classify an asset or liability within Level 3 of the fair value hierarchy, the determination is based upon the significance of the unobservable inputs to the overall fair value measurement. Because certain securities trade in less liquid or illiquid markets with limited or no pricing information, the determination of fair value for these securities is inherently more difficult. However, Level 3 fair value investments may include, in addition to the unobservable or Level 3 inputs, observable components, which are components that are actively quoted or can be validated to market-based sources. The carrying amounts and estimated fair values of the Company’s financial instruments for which the disclosure of fair values is required, including financial assets and liabilities measured and carried at fair value on a recurring basis, with the exception of investment contracts, related party loans, portions of other invested assets and debt which are disclosed later within this footnote, are summarized according to the hierarchy previously described, as follows: September 30, 2016 Level 1 Level 2 Level 3 Fair Value Carrying Amount Assets Cash and cash equivalents $ 864 $ — $ — $ 864 $ 864 Fixed maturity securities, available-for-sale: Asset-backed securities — 2,327 172 2,499 2,499 Commercial mortgage-backed securities — 785 79 864 864 Corporates — 10,219 1,121 11,340 11,340 Hybrids — 1,386 — 1,386 1,386 Municipals — 1,676 41 1,717 1,717 Residential mortgage-backed securities — 1,362 — 1,362 1,362 U.S. Government 61 182 — 243 243 Equity securities, available-for-sale 22 617 44 683 683 Derivative financial instruments — 276 — 276 276 Reinsurance related embedded derivative, included in other assets — 119 — 119 119 Other invested assets — — 34 34 34 Total financial assets at fair value $ 947 $ 18,949 $ 1,491 $ 21,387 $ 21,387 Liabilities Derivatives: FIA embedded derivatives, included in contractholder funds $ — $ — $ 2,383 $ 2,383 $ 2,383 Call options payable for FSRCI, included in funds withheld for reinsurance liabilities — 11 — 11 11 Total financial liabilities at fair value $ — $ 11 $ 2,383 $ 2,394 $ 2,394 September 30, 2015 Level 1 Level 2 Level 3 Fair Value Carrying Amount Assets Cash and cash equivalents $ 502 $ — $ — $ 502 $ 502 Fixed maturity securities, available-for-sale: Asset-backed securities — 2,068 38 2,106 2,106 Commercial mortgage-backed securities — 738 144 882 882 Corporates — 8,566 964 9,530 9,530 Hybrids — 1,214 — 1,214 1,214 Municipals — 1,569 39 1,608 1,608 Residential mortgage-backed securities — 2,162 — 2,162 2,162 U.S. Government 60 184 — 244 244 Equity securities available-for-sale 26 560 34 620 620 Derivative financial instruments 1 81 — 82 82 Reinsurance related embedded derivative, included in other assets — 168 — 168 168 Other invested assets — 11 129 140 140 Total financial assets at fair value $ 589 $ 17,321 $ 1,348 $ 19,258 $ 19,258 Liabilities Derivatives: FIA embedded derivatives, included in contractholder funds $ — $ — $ 2,149 $ 2,149 $ 2,149 Call options payable for FSRCI, included in funds withheld for reinsurance liabilities — 5 — 5 5 Total financial liabilities at fair value $ — $ 5 $ 2,149 $ 2,154 $ 2,154 The carrying amounts of accrued investment income, and portions of other insurance liabilities, approximate fair value due to their short duration and, accordingly, they are not presented in the tables above. Valuation Methodologies Fixed Maturity Securities & Equity Securities The Company measures the fair value of its securities based on assumptions used by market participants in pricing the security. The most appropriate valuation methodology is selected based on the specific characteristics of the fixed maturity or equity security, and the Company will then consistently apply the valuation methodology to measure the security’s fair value. The Company's fair value measurement is based on a market approach, which utilizes prices and other relevant information generated by market transactions involving identical or comparable securities. Sources of inputs to the market approach include a third-party pricing service, independent broker quotations or pricing matrices. The Company uses observable and unobservable inputs in its valuation methodologies. Observable inputs include benchmark yields, reported trades, broker-dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data. In addition, market indicators and industry and economic events are monitored and further market data will be acquired when certain thresholds are met. For certain security types, additional inputs may be used, or some of the inputs described above may not be applicable. The Company has an equity investment in a private business development company which is not traded on an exchange or valued by other sources such as analytics or brokers. The Company based the fair value of this investment on an estimated net asset value provided by the investee. Management did not make any adjustments to this valuation. The significant unobservable input used in the fair value measurement of equity securities available-for-sale for which the market-approach valuation technique is employed is yields for comparable securities. Increases (decreases) in the yields would result in lower or higher, respectively, fair value measurements. For broker-quoted only securities, quotes from market makers or broker-dealers are obtained from sources recognized to be market participants. The fair value of the Company's investment in mutual funds is based on the net asset value published by the respective mutual fund and represents the value the Company would have received if it withdrew its investment on the balance sheet date. Management believes the broker quotes are prices at which trades could be executed based on historical trades executed at broker-quoted or slightly higher prices. The Company did not adjust prices received from third parties as of September 30, 2016 and 2015 . However, the Company does analyze the third-party valuation methodologies and its related inputs to perform assessments to determine the appropriate level within the fair value hierarchy. Derivative Financial Instruments The fair value of call option assets is based upon valuation pricing models, which represents what the Company would expect to receive or pay at the balance sheet date if it canceled the options, entered into offsetting positions, or exercised the options. Fair values for these instruments are determined internally, based on valuation pricing models which use market-observable inputs, including interest rates, yield curve volatilities, and other factors. The fair values of the embedded derivatives in the Company’s FIA products are derived using market indices, product pricing assumptions and historical data. The fair value of the reinsurance related embedded derivative in the funds withheld reinsurance agreement with FSRCI is estimated based upon the fair value of the assets supporting the funds withheld from reinsurance liabilities. As the fair value of the assets is based on a quoted market price of similar assets (Level 2), the fair value of the embedded derivative is based on market-observable inputs and is classified as Level 2. The fair value of futures contracts represents the cumulative unsettled variation margin (open trade equity, net of cash settlements) which represents what the Company would expect to receive or pay at the balance sheet date if it canceled the futures contract or entered into offsetting positions. Prior to December 31, 2015, futures contracts were classified as Level 2, but it was determined that these contracts be classified as Level 1 for subsequent reporting periods. The fair value measurement of the FIA embedded derivatives included in contractholder funds is determined through a combination of market observable information and significant unobservable inputs. The market observable inputs are market value of option, and interest swap rates. The significant unobservable inputs are the mortality multiplier, surrender rates, and non-performance spread. The mortality multiplier at September 30, 2016 and 2015 was applied to the Annuity 2000 mortality tables. Significant increases (decreases) in the market value of option in isolation would result in a higher or lower, respectively, fair value measurement. Significant increases (decreases) in interest swap rates, mortality multiplier, surrender rates, or non-performance spread in isolation would result in a lower (higher) fair value measurement. Generally, a change in any one unobservable input would not directly result in a change in any other unobservable input. Investment Contracts Investment contracts include deferred annuities, FIAs, indexed universal life policies ("IULs") and immediate annuities. The fair value of deferred annuity, FIA, and IUL contracts is based on their cash surrender value (i.e. the cost the Company would incur to extinguish the liability) as these contracts are generally issued without an annuitization date. The fair value of immediate annuities contracts is derived by calculating a new fair value interest rate using the updated yield curve and treasury spreads as of the respective reporting date. At September 30, 2016 and 2015 , this resulted in higher and higher , respectively, fair value reserves relative to the carrying value. The Company is not required to, and has not, estimated the fair value of the liabilities under contracts that involve significant mortality or morbidity risks, as these liabilities fall within the definition of insurance contracts that are exceptions from financial instruments that require disclosures of fair value. Other Invested Assets Fair value of our loan participation interest securities approximates the unpaid principal balance of the participation interest as of September 30, 2016 . In making this assessment the Company considered the sufficiency of the underlying loan collateral, movements in the benchmark interest rate between origination date and September 30, 2016 , the primary market participant for these securities and the short-term maturity of these loans (less than 1 year ). Fair value of our loan participation interests in RSH and JSN Jewellery, Inc. are based upon a best estimate of the expected liquidation value of the underlying collateral. As of September 30, 2015, substantially all of RSH assets in the estate have been converted to cash through liquidation and the fair value of the Company’s RSH-related holdings reflects these cash balances, net of estimated expenses. The wind down process continues; therefore, some variability still exists in the fair value related to these costs. Fair value of the AnchorPath embedded derivative is based on an unobservable input, the net asset value of the AnchorPath fund at the balance sheet date. The embedded derivative is similar to a call option on the net asset value of the AnchorPath fund with a strike price of zero since FGL Insurance will not be required to make any additional payments at maturity of the fund-linked note in order to receive the net asset value of the AnchorPath fund on the maturity date. Therefore, the Black Scholes model returns the net asset value of the AnchorPath fund as the fair value of the call option regardless of the values used for the other inputs to the option pricing model. The net asset value of the AnchorPath fund is provided by the fund manager at the end of each calendar month and represents the value an investor would receive if it withdrew its investment on the balance sheet date. Therefore, the key unobservable input used in the Black Scholes model is the value of the AnchorPath fund. As the value of the AnchorPath fund increases or decreases, the fair value of the embedded derivative will increase or decrease. Fair value of foreign exchange derivatives and embedded derivatives, including CAD currency forward contracts, is based on the quoted USD/CAD exchange rates. Related Party Loans - HGI Energy Loan The HGI Energy loan's (discussed in "Note 14. Related Party Transactions" to the Company's Consolidated Financial Statements) fair value is based on the discounted cash flows of the loan. The discount rate was set by observing the market rate on other debt instruments of the issuer with an adjustment for liquidity. Valuation Methodologies and Associated Inputs for Financial Instruments Not Carried at Fair Value The following discussion outlines the methodologies and assumptions used to determine the fair value of our financial instruments not carried at fair value. Considerable judgment is required to develop these assumptions used to measure fair value. Accordingly, the estimates shown are not necessarily indicative of the amounts that would be realized in a one-time, current market exchange of all of our financial instruments. Commercial Mortgage Loans The fair value of commercial mortgage loans is established using a discounted cash flow method based on credit rating, maturity and future income. This yield based approach was sourced from our third-party vendor. The ratings for mortgages in good standing are based on property type, location, market conditions, occupancy, debt-service coverage, loan-to-value, quality of tenancy, borrower and payment record. The carrying value for impaired mortgage loans is based on the present value of expected future cash flows discounted at the loan’s effective interest rate, the loan’s market price or the fair value of the collateral if the loan is collateral dependent. The inputs used to measure the fair value of our commercial mortgage loans are classified as Level 3 within the fair value hierarchy. Policy Loans (included within Other Invested Assets) Fair values for policy loans are estimated from a discounted cash flow analysis, using interest rates currently being offered for loans with similar credit risk. Loans with similar characteristics are aggregated for purposes of the calculations. Limited Partnership Investment (included in Other Invested Assets) Fair value of our limited partnership investment, a private equity fund, is based upon estimated net asset value information and is classified as Level 3. For further discussion about our limited partnership investment see “Note 4. Investments” to the Company's Consolidated Financial Statements. Related Party Loans The related party loans (discussed in "Note 14. Related Party Transactions" to the Company's Consolidated Financial Statements) carrying value at par approximates fair value, as this is the exit price for the obligation of these loans. Debt The fair value of debt is based on quoted market prices. The inputs used to measure the fair value of our outstanding debt are classified as Level 2 within the fair value hierarchy. Our revolving credit facility debt is classified as Level 3 within the fair value hierarchy, and the fair value reflects the transaction price on September 30, 2016. Quantitative information regarding significant unobservable inputs used for recurring Level 3 fair value measurements of financial instruments carried at fair value as of September 30, 2016 and 2015 are as follows: Fair Value at Range (Weighted average) September 30, 2016 Valuation Technique Unobservable Input(s) September 30, 2016 Assets Asset-backed securities $ 144 Broker-quoted Offered quotes 97.54% - 101.55% Asset-backed securities 9 Matrix Pricing Quoted prices 98.75% - 98.75% Asset-backed securities (Salus CLO equity tranche) 19 Third-Party Valuation Offered quotes 28.37% - 28.37% Discount rate 15.00% RSH Recovery 5.50% Other loan recoveries 0.00% - 100.00% Commercial mortgage-backed securities 75 Broker-quoted Offered quotes 104.31% - 122.19% Commercial mortgage-backed securities 4 Matrix Pricing Quoted prices 98.41% - 98.41% Corporates 920 Broker-quoted Offered quotes 50.00% - 118.33% Corporates 201 Matrix Pricing Quoted prices 99.00% - 150.23% Municipals 41 Broker-quoted Offered quotes 119.04% Equity securities available-for-sale 41 Net Asset Value Not applicable 100.00% Equity securities available-for-sale (Salus preferred equity) 3 Market-approach Yield 11.00% RSH Recovery 5.50% Discount rate 15.00% Salus CLO Equity 28.37% Other invested assets: Available-for-sale embedded derivative 13 Black-Scholes model Market value of AnchorPath fund 100.00% Loan participations - Other 2 Market Pricing Offered quotes 100.00% Loan participations - JSN Jewellery, Inc. 17 Liquidation value – 52.5% Recovery Estimate Recovery estimate (wind-down costs) 49.93% - 56.67% (52.50%) Loan participation - RadioShack (RSH) Corporation 2 Liquidation value – 5% Recovery Estimate Recovery estimate (wind-down costs) 1.36% - 14.28% Total $ 1,491 Liabilities Derivatives: FIA embedded derivatives, included in contractholder funds $ 2,383 Discounted Cash Flow Market value of option 0.00% - 26.64% SWAP rates 1.18% - 1.46% Mortality multiplier 80.00% - 80.00% Surrender rates 0.50% - 75.00% Non-performance spread 0.25% - 0.25% Future option budget 1.15% - 5.57% (2.91%) Total liabilities at fair value $ 2,383 Fair Value at Range (Weighted average) September 30, 2015 Valuation Technique Unobservable Input(s) September 30, 2015 Assets Asset-backed securities $ 10 Broker-quoted Offered quotes 100.37% - 107.84% Asset-backed securities (Salus CLO equity tranche) 28 Third-Party Valuation Offered quotes 41.80% Discount rate 15.00% Constant default rate 2.00% RSH Recovery 30.00% Other loan recoveries 4.00% - 100.00% Commercial mortgage-backed securities 144 Broker-quoted Offered quotes 99.32% - 119.00% Corporates 898 Broker-quoted Offered quotes 56.75% - 113.83% Corporates 66 Matrix Pricing Quoted prices 104.58% - 142.43% Municipals 39 Broker-quoted Offered quotes 111.47% Equity securities available-for-sale 25 Net Asset Value Not applicable 100.00% Equity securities available-for-sale 6 Matrix Pricing Quoted prices 100.00% Equity securities available-for-sale (Salus preferred equity) 3 Market-approach Yield 11.00% RSH recovery 30.00% Discount rate 15.00% Salus CLO Equity 41.80% Other invested assets: Available-for-sale embedded derivative 10 Black-Scholes model Market value of AnchorPath fund 100.00% Loan participations 104 Market Pricing Offered quotes 100.00% Salus participation - RSH Corporation 15 Liquidation value – 30% Recovery Estimate Recovery estimate (wind-down costs) 30.00% - 34.00% Total $ 1,348 Liabilities Derivatives: FIA embedded derivatives, included in contractholder funds $ 2,149 Discounted Cash Flow Market value of option 0.00% - 33.83% SWAP rates 1.38% - 2.00% Mortality multiplier 80.00% - 80.00% Surrender rates 0.50% - 75.00% Non-performance spread 0.25% - 0.25% Future option budget 1.19% - 5.25% (2.93%) Total liabilities at fair value $ 2,149 Changes in unrealized losses (gains), net in the Company’s FIA embedded derivatives are included in "Benefits and other changes in policy reserves" in the Consolidated Statements of Operations. The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the years ended September 30, 2016 , 2015 and 2014 , respectively. This summary excludes any impact of amortization of VOBA and DAC. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology. Year ended September 30, 2016 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 38 $ (12 ) $ 3 $ 141 $ — $ (3 ) $ 5 $ 172 Commercial mortgage-backed securities 144 — 4 — — (3 ) (66 ) 79 Corporates 964 — 32 154 (3 ) (26 ) — 1,121 Hybrids — — — — — — — — Municipals 39 — 2 — — — — 41 Equity securities available-for-sale 34 — (1 ) 17 (6 ) — — 44 Other invested assets: Available-for-sale embedded derivative 10 3 — — — — — 13 Loan participations 119 (21 ) 9 54 — (140 ) — 21 Total assets at Level 3 fair value $ 1,348 $ (30 ) $ 49 $ 366 $ (9 ) $ (172 ) $ (61 ) $ 1,491 Liabilities FIA embedded derivatives, included in contractholder funds $ 2,149 $ 234 $ — $ — $ — $ — $ — $ 2,383 Total liabilities at Level 3 fair value $ 2,149 $ 234 $ — $ — $ — $ — $ — $ 2,383 (a) The net transfers out of Level 3 during the year ended September 30, 2016 were exclusively to Level 2. Year ended September 30, 2015 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 74 $ (37 ) $ 3 $ 73 $ (15 ) $ (31 ) $ (29 ) $ 38 Commercial mortgage-backed securities 83 — (2 ) 63 — — — 144 Corporates 834 4 10 202 (1 ) (61 ) (24 ) 964 Municipals 37 — 2 — — — — 39 Equity securities available-for-sale 40 (30 ) (1 ) 25 — — — 34 Other invested assets: Available-for-sale embedded derivative 11 (1 ) — — — — — 10 Loan participations 213 (39 ) (5 ) 88 — (138 ) — 119 Total assets at Level 3 fair value $ 1,292 $ (103 ) $ 7 $ 451 $ (16 ) $ (230 ) $ (53 ) $ 1,348 Liabilities FIA embedded derivatives, included in contractholder funds $ 1,908 $ 241 $ — $ — $ — $ — $ — $ 2,149 Total liabilities at Level 3 fair value $ 1,908 $ 241 $ — $ — $ — $ — $ — $ 2,149 (a) The net transfers out of Level 3 during the year ended September 30, 2015 were exclusively to Level 2. Year ended September 30, 2014 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Level 3 (a) Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 246 $ — $ (1 ) $ 36 $ — $ — $ (207 ) $ 74 Commercial mortgage-backed securities 6 — — 83 — — (6 ) 83 Corporates 461 — 19 382 (12 ) (2 ) (14 ) 834 Municipals — — 2 35 — — — 37 Equity securities available-for-sale — — 1 39 — — — 40 Other invested assets: Available-for-sale embedded derivative — — — 11 — — — 11 Loan participations 157 — (1 ) 187 — (130 ) — 213 Total assets at Level 3 fair value $ 870 $ — $ 20 $ 773 $ (12 ) $ (132 ) $ (227 ) $ 1,292 Liabilities FIA embedded derivatives, included in contractholder funds $ 1,545 $ 363 $ — $ — $ — $ — $ — $ 1,908 Total liabilities at Level 3 fair value $ 1,545 $ 363 $ — $ — $ — $ — $ — $ 1,908 (a) The net transfers out of Level 3 during the year ended September 30, 2014 were exclusively to Level 2. The following tables provide the carrying value and estimated fair value of our financial instruments that are carried on the Consolidated Balance Sheet at amounts other than fair value, summarized according to the fair value hierarchy previously described. September 30, 2016 Level 1 Level 2 Level 3 Total Estimated Fair Value Carrying Amount Assets Commercial mortgage loans $ — $ — $ 614 $ 614 $ 595 Policy loans, included in other invested assets — — 13 13 14 Limited partnership investment, included in other invested assets — — 12 12 12 Related party loans — — 71 71 71 Total $ — $ — $ 710 $ 710 $ 692 Liabilities Investment contracts, included in contractholder funds $ — $ — $ 14,884 $ 14,884 $ 16,868 Debt — 300 100 400 400 Total $ — $ 300 $ 14,984 $ 15,284 $ 17,268 September 30, 2015 Level 1 Level 2 Level 3 Total Estimated Fair Value Carrying Amount Assets Commercial mortgage loans $ — $ — $ 490 $ 490 $ 491 Policy loans, included in other invested assets — — 9 9 11 Limited partnership investment, included in other invested assets — — 4 4 4 Related party loans — — 78 78 78 Total $ — $ — $ 581 $ 581 $ 584 Liabilities Investment contracts, included in contractholder funds $ — $ — $ 14,126 $ 14,126 $ 15,621 Debt — 312 — 312 300 Total $ — $ 312 $ 14,126 $ 14,438 $ 15,921 The Company reviews the fair value hierarchy classifications each reporting period. Changes in the observability of the valuation attributes may result in a reclassification of certain financial assets or liabilities. Such reclassifications are reported as transfers in and out of Level 3, or between other levels, at the beginning fair value for the reporting period in which the changes occur. There were no transfers between Level 1 and Level 2 for the year ended September 30, 2016 . There were no transfers between Level 1 into Level 2 for the year ended September 30, 2015 . There were no transfers between Level 1 into Level 2 for the year ended September 30, 2014 reflecting the level of market activity in these instruments. The transfers into and out of Level 3 were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value. Accordingly, the Company’s assessment resulted in gross transfers out of level 3 with valuation of $159 related to asset-backed, commercial mortgage-backed, corporate, hybrid and residential mortgage-backed securities during the year ended September 30, 2016 . The Company’s assessment resulted in gross transfers into level 3 with valuation of $97 related to asset-backed, corporate and hybrid securities during the year ended September 30, 2016 . During the year ended September 30, 2015 , there were gross transfers out of Level 3 of $53 related to asset-backed and corporate securities. The Company’s assessment resulted in a gross transfer out of Level 3 of $227 related to asset-backed, commercial mortgage-backed, and corporate securities during the year ended September 30, 2014 .

Intangible Assets

Intangible Assets	12 Months Ended
	Sep. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangible Assets Information regarding VOBA and DAC which includes deferred sales inducement, is as follows: VOBA DAC Total Balance at September 30, 2015 $ 187 $ 801 $ 988 Deferrals — 350 350 Adjustments Unlocking 25 2 27 Interest 11 34 45 Amortization (41 ) (85 ) (126 ) Adjustment for unrealized investment gains (163 ) (95 ) (258 ) Balance at September 30, 2016 $ 19 $ 1,007 $ 1,026 Accumulated amortization $ 396 VOBA DAC Total Balance at September 30, 2014 $ 59 $ 456 $ 515 Deferrals — 317 317 Adjustments Unlocking 19 4 23 Interest 12 22 34 Amortization (68 ) (53 ) (121 ) Adjustment for unrealized investment losses 165 55 220 Balance at September 30, 2015 $ 187 $ 801 $ 988 Accumulated amortization $ 391 VOBA DAC Total Balance at September 30, 2013 $ 192 $ 331 $ 523 Deferrals — 238 238 Adjustments Unlocking 22 3 25 Interest 15 14 29 Amortization (87 ) (56 ) (143 ) Adjustment for unrealized investment gains (83 ) (74 ) (157 ) Balance at September 30, 2014 $ 59 $ 456 $ 515 Accumulated amortization $ 354 Amortization of VOBA and DAC is based on the historical, current and future expected gross margins or profits recognized, including investment gains and losses. The interest accrual rate utilized to calculate the accretion of interest on VOBA ranged from 4% to 5% . The adjustment for unrealized net investment losses (gains) represents the amount of VOBA and DAC that would have been amortized if such unrealized gains and losses had been recognized. This is referred to as the “shadow adjustments” as the additional amortization is reflected in AOCI rather than the Consolidated Statement of Operations. As of September 30, 2016 and 2015 , the VOBA balance included cumulative adjustments for net unrealized investment losses (gains) of $(162) and $1 , respectively, and the DAC balances included cumulative adjustments for net unrealized investment losses (gains) of $(96) and $(1) , respectively. The above DAC balances include $86 and $59 of deferred sales inducements, net of shadow adjustments, as of September 30, 2016 and 2015 , respectively. The weighted average amortization period for VOBA is approximately 5.2 years . Estimated amortization expense for VOBA in future fiscal periods is as follows: Estimated Amortization Expense Fiscal Year VOBA 2017 $ 27 2018 25 2019 22 2020 18 2021 15 Thereafter 74

Debt

Debt	12 Months Ended
	Sep. 30, 2016
Debt Disclosure [Abstract]
Debt	Debt In March 2013, FGL's wholly owned subsidiary, FGLH, issued $300 aggregate principal amount of its 6.375% senior notes (“Notes Offering”) due April 1, 2021, at par value, which FGLH became eligible to redeem after April 1, 2016. Interest payments are due semi-annually, April 1 and October 1, commencing October 1, 2013. In connection with the Notes Offering, FGL capitalized $10 of debt issue costs. The fees are classified as “Other assets” in the accompanying Consolidated Balance Sheets and as of September 30, 2016 these have been fully amortized using the straight-line method, which approximated the effective yield method over the term of the debt. On August 26, 2014, FGLH, a wholly owned subsidiary of FGL, as borrower, and the Company as guarantor, entered into a three -year $150 unsecured revolving credit facility (the “Credit Agreement”) with certain lenders and RBC Capital Markets and Credit Suisse Securities (USA) LLC ("Credit Suisse"), acting as joint lead arrangers. The loan proceeds from the Credit Agreement may be used for working capital and general corporate purposes. FGL capitalized $4 of the debt issue cost, which are classified as “Other assets” in the accompanying Consolidated Balance Sheets and are being amortized using the straight-line method over the remaining term of the debt. On September 30, 2016, the Company drew $100 on the revolver and the total drawn as of September 30, 2016 was $100 . Various financing options are available within the credit facility, including overnight and term based borrowing. In each case, a margin is ascribed based on the Debt to Capitalization ratio of the Company. As of September 30, 2016 , the interest rate was equal to 5.5% when the Company drew on the revolver and would have been equal to 5.25% had the Company drawn on the revolver as of September 30, 2015 The Company's outstanding debt as of September 30, 2016 and 2015 is as follows: September 30, 2016 September 30, 2015 Debt $ 300 $ 300 Revolving credit facility 100 — The interest expense and amortization of debt issuance costs of the Company's debt for the years ended September 30, 2016 , 2015 and 2014 , respectively, were as follows: Year ended September 30, 2016 2015 2014 Interest Expense Amortization Interest Expense Amortization Interest Expense Amortization Debt $ 19 $ 2 $ 19 $ 4 $ 19 $ 4 Revolving credit facility — 1 — 1 — —

Equity

Equity	12 Months Ended
	Sep. 30, 2016
Equity [Abstract]
Equity	Equity Stock Split On November 26, 2013, the Company’s board of directors increased the number of authorized shares of the Company’s common stock, par value $0.01 per share, from 100 thousand to 500,000 thousand and approved a stock split of the issued and outstanding shares of common stock at a ratio of 4,700 -for- 1 , resulting in 47,000 thousand shares outstanding. Net income per common share and the weighted average common shares used in computing net income per share for the years ended September 30, 2016 , 2015 and 2014 , included in the Company’s Consolidated Statements of Operations, have been adjusted to give effect to the stock split. Likewise, the amount of shares authorized, issued, and outstanding disclosed in the Company’s Consolidated Balance Sheets have also been adjusted. Preferred Stock FGL's Board of Directors has the authority, without further action by our shareholders, to issue up to 50,000,000 shares of preferred stock in one or more series and to fix the designation, powers, preferences and the relative participating, optional or other special rights, and the qualifications, limitations and restrictions of each series, including dividend rights, dividend rates, conversion rights, voting rights, terms of redemption, liquidation preferences and the number of shares constituting any series. Currently, no shares of our authorized preferred stock are outstanding. Share Repurchases On September 2, 2014, the Company’s Board of Directors authorized the repurchase of up to 500 thousand shares of the Company’s outstanding shares of common stock over the next twelve months. This share repurchase program was completed as of June 30, 2015 and a total of 512 thousand shares of common stock were repurchased at cost for a total cost of $11 , which are held in treasury; of which 500 thousand shares were pursuant to the repurchase program and 12 thousand shares were acquired to satisfy employee income tax withholding pursuant to the Company’s stock compensation plan. During the year ended September 30, 2016 , an additional 25 thousand shares were acquired for a total cost of $1 to satisfy employee income tax withholding pursuant to the Company’s stock compensation plan, resulting in a total of 537 thousand shares repurchased, held in treasury, for a total cost of $12 . Subsequent to the Company's repurchase of shares, HRG indirectly held 47,000 thousand shares of FGL's outstanding common stock, representing an approximate 80% interest at September 30, 2016 . Dividends The Company declared and paid the following cash dividends during the years ended September 30, 2016 , 2015 , and 2014: Date Declared Date Paid Date Shareholders of record Shareholders of record (in thousands) Cash Dividend declared (per share) Total cash paid November 18, 2014 December 15, 2014 December 1, 2014 58,279 $0.065 $4 February 10, 2015 March 9, 2015 February 23, 2015 57,975 $0.065 $4 May 1, 2015 June 1, 2015 May 18, 2015 57,932 $0.065 $4 July 31, 2015 August 31, 2015 August 17, 2015 57,976 $0.065 $4 November 12, 2015 December 14, 2015 November 30, 2015 58,144 $0.065 $4 February 2, 2016 March 7, 2016 February 22, 2016 58,210 $0.065 $4 April 28, 2016 May 30, 2016 May 16, 2016 58,211 $0.065 $4 August 1, 2016 September 6, 2016 August 22, 2016 58,211 $0.065 $4 On November 10, 2016 , FGL’s Board of Directors declared a quarterly cash dividend of $0.065 per share. The dividend will be paid on December 12, 2016 to shareholders of record as of the close of business on November 28, 2016 . Restricted Net Assets of Subsidiaries FGLH’s equity in restricted net assets of consolidated subsidiaries was approximately $1,789 as of September 30, 2016 representing 94% of FGLH’s consolidated stockholder’s equity as of September 30, 2016 and consisted of net assets of FGLH which were restricted as to transfer to FGL in the form of cash dividends, loans or advances under regulatory restrictions.

Stock Compensation

Stock Compensation	12 Months Ended
	Sep. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Compensation	Stock Compensation On November 7, 2013, FGL’s Board of Directors adopted a long term stock-based incentive plan (the “FGL 2013 Stock Incentive Plan” or the “Omnibus Plan”) under which certain officers, employees, directors and consultants are eligible to receive equity based awards. The Omnibus Plan was approved by the stockholder on November 19, 2013, became effective on December 12, 2013 and expires in December 2023. FGL’s Compensation Committee approved the granting of awards under the Omnibus Plan to certain employees, officers and directors (other than the members of the Compensation Committee). In addition, FGL’s Board of Directors approved the granting of awards to members of FGL’s Compensation Committee (the “Compensation Committee Awards”). The Compensation Committee Awards were not made under the Omnibus Plan; however, these awards will be construed and administered as if subject to the terms of the Omnibus Plan. In February 2015, the Omnibus Plan was amended to permit the members of FGL’s Compensation Committee to receive awards thereunder. FGL’s Board of Directors and stockholder also approved the granting of unrestricted common shares to its directors in lieu of cash compensation at the election of each individual director (the “Unrestricted Share Awards”). The Omnibus Plan, Compensation Committee Awards and the Unrestricted Share Awards are collectively referred to as the “FGL Plans”. Stock options, restricted stock and unrestricted stock awarded under the FGL Plans are accounted for as equity awards. As of the date the stock awards are approved and communicated to the recipient, the fair value of stock options is determined using a Black-Scholes options valuation methodology, and the fair value of other stock awards is based upon the market value of the stock. The fair value of the awards is expensed over the service period, which generally corresponds to the vesting period, and is recognized as an increase to Additional paid-in capital in stockholders’ equity. At this time, FGL plans to issue new shares to satisfy stock option exercises, but may use treasury shares acquired under the repurchase program authorized on September 2, 2014. In fourth quarter 2016, FGL decided to settle the Performance Restricted Stock Unit (“PRSU”) awards granted under the FGL Plans in cash upon vesting and, therefore, reclassified these awards from equity to Other Liabilities. The liability for the PRSUs was valued at fair value (market value of the underlying stock) upon reclassification which resulted in the recognition of additional compensation cost of $3 . The PRSUs became fully vested as of September 30, 2016 with payment anticipated to be made in November 2016 based on the fair value of the award at the time of settlement. Prior to November 7, 2013, FGL did not offer stock-based compensation plans to any of its directors, employees or the directors or employees of its subsidiaries. FGL’s principal subsidiary, FGLH, sponsors stock-based incentive plans and dividend equivalent plans (“DEPs”) for its employees (the “FGLH Plans”). Awards under the FGLH Plans are based on the value of the common stock of FGLH. In 2013, FGLH determined that all equity awards will be settled in cash when exercised and therefore are classified as liability plans. For these awards, the settlement value is classified as a liability, in "Other liabilities", on the Consolidated Balance Sheets and the liability is adjusted to the current fair value through net income at the end of each reporting period, which causes volatility in net income (loss) as a result of changes in the fair value of FGLH’s stock. The fair value of stock options is determined using a Black-Scholes options valuation methodology and the fair value of restricted stock units is based upon the fair value of FGLH’s stock. In November 2013, the FGLH plans were frozen and no new awards will be granted under these plans. Outstanding awards will be permitted to vest in accordance with the award agreements and will be cash settled upon vesting or exercise. As described under “Recent Accounting Pronouncements” in Note 2, the Company early adopted ASU 2016-09 effective October 1, 2015. The Company elected to account for forfeitures as they occur. The adoption of ASU 2016-09 did not have a material effect on the Company’s financial statements and related disclosures. The Company recognized total stock compensation expense related to the FGL Plans and FGLH Plans as follows: Year ended September 30, 2016 2015 2014 FGL Plans Stock options $ — $ 1 $ — Restricted shares 2 6 1 Performance restricted stock units 10 3 1 Unrestricted shares — — 1 12 10 3 FGLH Plans Stock Incentive Plan - stock options — 1 6 2011 DEP — — 1 Amended and Restated Stock Incentive Plan - stock options 1 5 5 Amended and Restated Stock Incentive Plan - restricted stock units — 2 2 2012 DEP — 1 — 1 9 14 Total stock compensation expense 13 19 17 Related tax benefit 5 7 6 Net stock compensation expense $ 8 $ 12 $ 11 The stock compensation expense is included in "Acquisition and operating expenses, net of deferrals" in the Consolidated Statements of Operations. Total compensation expense related to the FGL Plans and FGLH Plans not yet recognized as of September 30, 2016 and the weighted-average period over which this expense will be recognized are as follows: Unrecognized Compensation Weighted Average Recognition FGL Plans Stock options $ — 1 Restricted shares 2 1 Total unrecognized stock compensation expense $ 2 1 FGL Plans FGL’s Compensation Committee is authorized to grant up to 2,838 thousand equity awards under the FGL Plans. At September 30, 2016 , 1,159 thousand equity awards are available for future issuance under the FGL Plans. FGL granted 119 thousand , 206 thousand , and 249 thousand stock options to certain officers, directors, other key employees and Compensation Committee members in 2016 , 2015 , and 2014 respectively. These stock options vest in equal installments over a period of three years and expire on the seventh anniversary of the grant date. The total fair value of the options granted in 2016 , 2015 , 2014 was $0 , $1 , and $1 respectively. On March 31, 2015, the Company entered into an agreement with its former Chief Executive Officer in connection with his resignation pursuant to which the vesting for certain FGL and FGLH equity awards to the former Chief Executive Officer were accelerated. The former Chief Executive Officer forfeited two-thirds of the performance restricted stock units granted in fiscal year 2014, and all other previously awarded equity grants became vested as of March 31, 2015. The exercise date of the outstanding stock options was extended to December 31, 2015. No other terms of the equity awards were modified. The Company recognized total incremental compensation expense of $2 as a result of these modifications. At September 30, 2016 , the intrinsic value of stock options outstanding, exercisable and vested was $1 , $0 and $1 , respectively. At September 30, 2016 , the weighted average remaining contractual term of stock options outstanding, exercisable and vested was 5 years , 4 years and 5 years , respectively. During the year ended September 30, 2016 , the intrinsic value of stock options exercised, total cash received upon exercise and the related tax benefit was $0 , $2 , and $0 , respectively. During the year ended September 30, 2015 , the intrinsic value of stock options exercised, total cash received upon exercise and the related tax benefit realized was $1 , $2 , and $0 , respectively. During the year ended September 30, 2014 the intrinsic value of stock options exercised, total cash received upon exercise and the related tax benefit was $0 , $0 , and $0 , respectively. A summary of FGL’s outstanding stock options as of September 30, 2016 , and related activity during the period, is as follows (share amount in thousands): Stock Option Awards Options Weighted Average Exercise Price Stock options outstanding at September 30, 2015 317 $ 21.60 Granted 119 25.75 Exercised (77 ) 24.31 Forfeited or expired (13 ) 22.12 Stock options outstanding at September 30, 2016 346 22.40 Vested and exercisable at September 30, 2016 114 19.52 The following assumptions were used in the determination of the grant date fair values using the Black-Scholes option pricing model and based on the value of FGL's common stock: 2016 2015 2014 Weighted average fair value per options granted $1.01 $4.96 $3.76 Risk-free interest rate 0.42% 1.41%-1.50% 1.40% - 1.41% Assumed dividend yield 1.14% 1.18%-1.19% 1.30%-1.50% Expected option term 0.5 years 4.5 years 4.5 years Volatility 14.55% 25.00% 25.00% The following assumptions were used in the determination of the grant date fair values using the Black-Scholes option pricing model for the former Chief Executive Officer's modified stock options and based on the value of FGL's common stock: Weighted average fair value per option modified $2.53 Risk-free interest rate 0.20% Assumed dividend yield 1.18% Expected option term 0.75 years Volatility 25.00% The dividend yield is based on the expected dividend rate during the expected life of the option. Expected volatility is based on the historical volatility of FGL’s stock price for awards granted or modified in 2015 and the implied volatility of exchange-traded securities for life insurance companies for awards granted in 2014. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of the grant. The expected life of the options granted represents the weighted-average period of time from the grant date to the date of exercise, expiration or cancellation based upon a simplified method as the Company lacks sufficient historical data due to the recent implementation of the FGL Plans. FGL granted 26 thousand , 173 thousand , and 171 thousand restricted shares to certain officers, directors, other key employees and Compensation Committee members in 2016 , 2015 , and 2014 respectively. These shares vest in equal installments over a period of three years . FGL granted 12 thousand restricted shares to an officer in 2015 that vest over the period of one year and granted 8 thousand restricted shares in 2014 to another officer that vest in equal installments over the period of 2 years . In 2015, FGL also granted 140 thousand restricted shares to certain directors which vest in three tranches; 20% on the first anniversary of the grant date; 50% on the second anniversary of the grant date; and 30% on the third anniversary of the grant date. The total fair value of the restricted shares granted in 2016 , 2015 , and 2014 was $1 , $7 , and $3 respectively. On March 18, 2015, the expected requisite service periods for the 140 thousand restricted shares granted to certain directors were completed resulting in expense acceleration under the terms of the original awards due to their resignation from the Company’s Board and all related committee positions of the two grantees. The Company recognized additional compensation expense of $3 as a result of the related equity compensation expense acceleration. The restricted shares are entitled to any cash dividends paid on FGL’s stock prior to vesting of the restricted shares. The cash dividends are held by FGL until the shares become vested and are paid to the recipient at that time or are forfeited if the restricted shares do not vest. A summary of FGL’s nonvested restricted shares outstanding as of September 30, 2016 , and related activity during the year then ended, is as follows (share amount in thousands): Restricted Stock Awards Shares Weighted Average Grant Date Fair Value Restricted shares outstanding at September 30, 2015 246 $ 21.92 Granted 26 25.75 Vested (100 ) 21.32 Forfeited or expired (18 ) 22.46 Restricted shares outstanding at September 30, 2016 154 22.91 FGL granted 32 thousand and 541 thousand PRSUs to senior executive officers under the Omnibus Plan in 2015 and 2014, respectively. These units vested on September 30, 2016, contingent on the satisfaction of performance criteria and on the officer's continued employment unless otherwise noted in the agreement. PRSUs subject to vesting are adjusted based on FGL's financial yearly performance, which is evaluated on two non-GAAP measures: (1) pre-tax adjusted operating income, and (2) return on equity. Depending on the performance results for each year, the ultimate payout of PRSUs could range from zero to 200% of the target award for each year. One-half of the award is earned based on each year’s results for the awards granted in 2015. One-third of the award is earned based on each year's results for the awards granted in 2014. Based on the results achieved in 2016, 2015, and 2014, a total of 63 thousand , 14 thousand , and 44 thousand additional PRSUs were earned, respectively, subject to the satisfaction of the service requirement noted above. The total fair value of the PRSUs granted in 2015 and 2014 assuming attainment of the target performance level in each year was $ 1 and $9 . The total fair value of the additional PRSUs earned in 2016, 2015, and 2014 was $1 , $0 , and $1 , respectively. A summary of nonvested PRSUs outstanding as of September 30, 2016 , and related activity during the year then ended, is as follows (share amount in thousands): Performance Restricted Stock Units (PRSUs) Shares Weighted Average Grant PRSUs outstanding at September 30, 2015 515 $ 17.69 Granted 63 17.82 Vested (578 ) 17.71 Forfeited or expired — — PRSUs outstanding at September 30, 2016 — — At September 30, 2016 , the liability of $14 for the PRSUs was based on the fair value of FGL common stock which was $23.19 per share. Additionally, FGL granted unrestricted shares totaling 9 thousand and 58 thousand in 2015 and 2014 to certain directors in payment for services rendered. Total fair value of the unrestricted shares on the grant date was $0 and $1 , respectively. FGLH Plans Stock options issued under the FGLH Plans vest in three equal installments on each of the first three anniversaries of the grant date and expire on the seventh anniversary of the grant date. The FGLH plans were frozen in November 2013 and, therefore, no stock options were issued under these plans during the years ended September 30, 2016, 2015 and 2014. The dividend yield is based on the expected dividend rate during the expected life of the option. Expected volatility is based on the implied volatility of exchange-traded securities for life insurance companies. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of the grant. The expected life of the options granted represents the weighted-average period of time from the grant date to the date of exercise, expiration or cancellation based upon a simplified method as the Company lacked sufficient historical data due to the recent implementation of the FGLH Plans. A summary of FGLH's outstanding stock options as of September 30, 2016 and related activity during the year then ended is as follows (share amount in thousands): FGLH Stock Option Awards Options Weighted Average Exercise Price Stock options outstanding at September 30, 2015 87 $ 45.04 Granted — — Exercised (4 ) 48.71 Forfeited or expired (1 ) 49.45 Stock options outstanding at September 30, 2016 82 44.82 Vested and exercisable at September 30, 2016 82 44.82 At September 30, 2016 , the liability for vested stock options was based on the fair values of the outstanding options. The following assumptions were used in the determination of these fair values using the Black-Scholes option pricing model and based on the value of FGLH's common stock: 2016 2015 Weighted average stock option fair value $78.62 $74.99 FGLH common stock fair value $123.76 $122.02 FGL common stock value $23.19 $24.54 Risk-free interest rate 0.26% 0.48%-0.74% Assumed dividend yield 1.12% 1.16% Expected option term 0.25 years 1.50 - 2.25 years Volatility 15.0% 25.0% The primary input used in the determination of the fair value of FGLH's common stock is the value of the Company's common stock and a discount for lack of liquidity. The dividend yield is based on the expected dividend rate during the expected life of the option. Expected volatility is based on the historical volatility of FGL's stock price after the announcement of the pending merger transaction with Anbang. The expected life of the options granted represents the period of time from the grant date to the estimated closing date of the merger transaction with Anbang. Upon closing of the merger transaction, the vesting of the options will be accelerated and the options will be paid out as described in “Note 1. Basis of Presentation”, and the option agreements contain a “change in control” provision which requires vesting of the options to be accelerated if the options are not replaced by substantially similar awards after the change in control. At September 30, 2016 , the intrinsic value of stock options outstanding, exercisable and vested was $6 , $6 and $6 , respectively. At September 30, 2016 , the weighted average remaining contractual term of stock options outstanding, exercisable and vested was 3 years , 3 years and 3 years , respectively. The intrinsic value of stock options exercised and the amount of cash paid upon exercise during the years ended September 30, 2016 , 2015 , and 2014 was $0 , $9 , and $6 , respectively. Restricted stock units issued under the FGLH Plans vest in three equal installments on each of the first three anniversaries of the grant date. During the years ended September 30, 2016 , 2015 , and 2014 , FGLH issued 0 thousand , 0 thousand , and 0 thousand restricted stock units which had a weighted average grant date fair value per unit of $0 , $0 , and $0 , respectively. A summary of FGLH's nonvested restricted stock units as of September 30, 2016 and related activity during the year then ended is as follows (share amount in thousands): Restricted Stock Awards Shares Weighted Average Grant Date Fair Value (a) Restricted shares outstanding at September 30, 2015 11 $ 49.57 Granted — — Vested (11 ) 49.57 Forfeited or expired — 49.45 Restricted shares outstanding at September 30, 2016 — — (a) Fair value is based on the value of FGLH’s common stock, not the value of the Company’s common stock. The amount of cash paid upon vesting of restricted stock units during the years ended September 30, 2016 , 2015 , and 2014 was $2 , $2 , and $2 , respectively. FGLH also granted dividend equivalent awards that permit holders of FGLH’s stock option and restricted stock awards to receive a payment in cash in an amount equal to the ordinary dividends declared and paid or debt service payments to HRG by FGLH in each calendar year starting in the year in which the dividend equivalent is granted through the year immediately prior to the year in which the dividend equivalent award vests, divided by the total number of common shares outstanding. Dividend equivalent awards granted in November 2011 vested on March 31, 2014. Dividend equivalent awards granted in December 2012 vested on March 31, 2016. FGLH determined that it was probable the dividend equivalent awards would vest and recognized compensation expense ratably over the dividend equivalent vesting periods. The amount of cash paid upon vesting of dividend equivalent awards during the years ended September 30, 2016 , 2015 , and 2014 was $1 , $1 and $3 , respectively.

Income Taxes

Income Taxes	12 Months Ended
	Sep. 30, 2016
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes FGL is a U.S. taxpayer and does not file income tax returns in any foreign jurisdiction other than Puerto Rico. FGL’s non-life subsidiaries file as part of HRG’s consolidated U.S. Federal income tax return. FGL’s insurance company subsidiaries file their own consolidated U.S. Federal life insurance tax return and will not be eligible to join the consolidated HRG return until January 1, 2017. The income tax liabilities of the FGL members of the consolidated HRG return are calculated using the separate return method. Income tax (expense) benefit was calculated based upon the following components of income before income taxes: Year ended September 30, 2016 2015 2014 Pretax income (loss): United States $ 153 $ 182 $ 189 Outside the United States — — — Total pretax income $ 153 $ 182 $ 189 The components of income tax (expense) benefit were as follows: Year ended September 30, 2016 2015 2014 Current: Federal $ (5 ) $ (14 ) $ (51 ) State — — — Total current $ (5 ) $ (14 ) $ (51 ) Deferred: Federal $ (51 ) $ (50 ) $ 25 State — — — Total deferred $ (51 ) $ (50 ) $ 25 Income tax (expense)/benefit $ (56 ) $ (64 ) $ (26 ) The difference between income taxes expected at the U.S. Federal statutory income tax rate of 35% and reported income tax (expense) benefit is summarized as follows: Year ended September 30, 2016 2015 2014 Expected income tax (expense)/benefit at Federal statutory rate $ (54 ) $ (64 ) $ (66 ) Valuation allowance for deferred tax assets 69 (1 ) 40 Amortization of low income housing tax credits (2 ) (1 ) — Benefit on LIHTC under proportional amortization method 3 1 — Write off of expired capital loss carryforward (73 ) — — Other 1 1 — Reported income tax (expense)/benefit $ (56 ) $ (64 ) $ (26 ) Effective tax rate 37 % 35 % 14 % For the year ended September 30, 2016 , the Company’s effective tax rate was 37% . The negative impact of the valuation allowance expense of the non-life companies was partially offset by the net impact of positive permanent adjustments, including low income housing tax credits and dividends received deduction. For the year ended September 30, 2016 , the remaining unutilized life company capital loss carryforwards deferred tax assets expired and were written off, resulting in $73 in deferred income tax expense which was entirely offset by a valuation allowance release of the same amount. For the year ended September 30, 2015 , the Company’s effective tax rate was 35% . The impact of valuation allowance expense was offset by the net impact of positive permanent adjustments. For the year ended September 30, 2014 , the Company’s effective tax rate of 14% , was positively impacted by the partial release of valuation allowance attributed to the Company’s implementation of a tax planning strategy that allowed for the utilization of capital loss carry forwards that management originally concluded were more-likely-than-not unrealizable. For the year ended September 30, 2016 , the Company recorded net valuation allowance release of $69 (comprised of a full year valuation allowance release of $74 related to the life insurance companies, offset by a net increase to valuation allowance of $5 related to FGL’s non-life companies). During the year ended September 30, 2016 , the remaining unutilized life company capital loss carryforward deferred tax assets expired and were written off, resulting in $73 in deferred income tax expense. Most of the valuation allowance release during the year was attributable to this write-off. For the year ended September 30, 2015 , the Company recorded net valuation allowance expense of $1 (comprised of a full year valuation allowance release of $4 related to the life insurance companies, offset by a net increase to valuation allowance of $5 related to FGL’s non-life companies). For the year ended September 30, 2014 , the company recorded net valuation allowance release of $40 (comprised of a full year valuation allowance release of $43 related to the life insurance companies, partially offset by a net increase to valuation allowance of $3 related to FGL’s non-life companies). The Company records tax expense (benefit) that results from a change in other comprehensive income (“OCI”) directly to OCI. Tax expense recorded directly to OCI includes deferred tax expense arising from a change in unrealized gain (loss) on available-for-sale securities and the tax-effects of other income items that are recorded to OCI. Changes in valuation allowance that are solely due to a deferred tax liability related to the unrealized gain on an available-for-sale security are allocated to other comprehensive income in accordance with ASC 740-10-45-20, "Income Taxes: Other Presentation Matters" . For the year ended September 30, 2016 , the Company recorded $188 in deferred tax expense, partially offset by $1 in valuation allowance release, to OCI. An excess tax benefit is the realized tax benefit related to the amount of deductible compensation cost reported on an employer’s tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes. The Company adopted ASU-2016-09 (Stock Compensation) effective October 1, 2015. ASU-2016-09 eliminates the requirement for excess tax benefits to be recorded as additional paid-in capital when realized. For the year ended September 30, 2016 , FGL recorded all excess tax benefits in the Consolidated Statements of Operations as a component of current income tax expense in accordance with the newly adopted guidance. Please refer to the “Note 2. Significant Accounting Policies and Practices” section for additional information on ASU-2016-09. The following table is a summary of the components of deferred income tax assets and liabilities: Year ended September 30, 2016 2015 Deferred tax assets: Net operating loss, credit and capital loss carryforwards $ 93 $ 169 Insurance reserves and claim related adjustments 511 424 Investments — 24 Other 44 32 Valuation allowance (51 ) (120 ) Total deferred tax assets $ 597 $ 529 Deferred tax liabilities: Value of business acquired $ (7 ) $ (65 ) Investments (312 ) — Deferred acquisition costs (277 ) (209 ) Other (11 ) (27 ) Total deferred tax liabilities $ (607 ) $ (301 ) Net deferred tax assets and (liabilities) $ (10 ) $ 228 At September 30, 2016 , the Company’s valuation allowance of $51 consisted of a valuation allowance of $0 on life company deferred tax assets and a full valuation allowance of $51 on FGL’s non−life insurance net deferred taxes. The life company's remaining capital loss carryforwards expired on December 31, 2015, and the capital loss carryforward deferred tax assets and related valuation allowance were written off at that time. At September 30, 2015 , the Company’s valuation allowance of $120 consisted of a valuation allowance of $74 on life company capital loss carryforwards and a full valuation allowance of $46 on FGL’s non−life insurance net deferred taxes. The Company maintains a valuation allowance against the deferred tax assets of its non-life insurance company subsidiaries. The non-life insurance company subsidiaries have a history of losses and insufficient sources of future income in order to recognize any portion of their deferred tax assets. All other deferred tax assets are more likely than not to be realized based on expectations as to our future taxable income and considering all other available evidence, both positive and negative. The net operating losses ("NOLs"), capital losses and tax credits of FGL’s subsidiaries were subject to limitation under IRC Section 382, as a result of the change of ownership that occurred when the companies were purchased in 2011. This caused the net value of attributes that could be utilized to be limited to $5 each year, subject to increases for realized built-in gains on certain assets on the date of the change of ownership. On September 27, 2013, the Company underwent a second change of control within the meaning of IRC Section 382(g), triggered by the sale of HRG shares by Harbinger Capital Partners. At the time of this ownership change, FGL’s tax attributes consisted of capital loss carry forwards totaling approximately $350 , investment tax credits of approximately $54 , and alternative minimum tax ("AMT") credits of approximately $6 . The second 382 annual limitation is higher than the 2011 limitation and is not expected to have an impact on the utilization of tax attributes. At September 30, 2016 and 2015 , FGL has NOL carryforwards of $92 and $92 , respectively, which, if unused, will expire in years 2026 through 2036. FGL has capital loss carryforwards totaling $6 and $217 at September 30, 2016 and 2015 , respectively, which if unused, will expire in years 2016 through 2021. In addition, at September 30, 2016 and 2015 , FGL has low income housing tax credit carryforwards totaling $52 and $54 , respectively, which, if unused, will expire in years 2020 through 2036, and alternative minimum tax credits of $6 and $6 , respectively, that may be carried forward indefinitely. FGL’s non-life subsidiaries file as part of HRG’s consolidated U.S. Federal income tax return. FGL’s insurance company subsidiaries file their own consolidated U.S. Federal life insurance tax return and will not be eligible to join the consolidated HRG return January 1, 2017. The income tax liabilities of the FGL members of the consolidated HRG return are calculated using the separate return method with any payable or receivable reflecting an amount they would have recorded had they filed their own return. As of September 30, 2016 and 2015 , FGL and its subsidiaries have an income tax liability totaling $2 and $1 , respectively, which represents what they would have owed the IRS had they filed their own tax return. The U.S. Federal income tax returns of FGL for years prior to 2013 are no longer subject to examination by the taxing authorities. With limited exception, FGL is no longer subject to state and local income tax audits for years prior to 2011. FGL does not have any unrecognized tax benefits (“UTBs”) at September 30, 2016 and 2015 . In the event the Company has UTBs, interest and penalties related to uncertain tax positions would be recorded as part of income tax expense in the financial statements. The Company regularly assesses the likelihood of additional tax assessments by jurisdiction and, if necessary, adjusts its tax reserves based on new information or developments.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Sep. 30, 2016
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Commitments The Company has unfunded investment commitments as of September 30, 2016 based upon the timing of when investments are executed compared to when the actual investments are funded, as some investments require that funding occur over a period of months or years. A summary of unfunded commitments by invested asset class are included below: Asset Type September 30, 2016 Other invested assets $ 55 Fixed maturity securities, available-for-sale 16 Other assets 32 Total $ 103 Lease Commitments The Company leases office space under non-cancelable operating leases that expire in May 2021. The Company also leased office furniture and office equipment under non-cancelable operating leases that expired in 2012. For the years ended September 30, 2016 , 2015 and 2014 , the Company’s total rent expense was $2 , $2 and $2 , respectively. As of September 30, 2016 , the minimum rental commitments under the non-cancelable leases are as follows: Fiscal Year Amount 2017 $ 2 2018 2 2019 2 2020 2 2021 1 Thereafter — Total $ 9 Contingencies Regulatory and Litigation Matters FGL is involved in various pending or threatened legal proceedings, including purported class actions, arising in the ordinary course of business. In some instances, these proceedings include claims for unspecified or substantial punitive damages and similar types of relief in addition to amounts for alleged contractual liability or requests for equitable relief. In the opinion of FGL management and in light of existing insurance and other potential indemnification, reinsurance and established accruals, such litigation is not expected to have a material adverse effect on FGL’s financial position, although it is possible that the results of operations and cash flows could be materially affected by an unfavorable outcome in any one period. FGL is assessed amounts by the state guaranty funds to cover losses to policyholders of insolvent or rehabilitated insurance companies. Those mandatory assessments may be partially recovered through a reduction in future premium taxes in certain states. At September 30, 2016 , FGL has accrued $3 for guaranty fund assessments which is expected to be offset by estimated future premium tax deductions of $3 . The Company has received inquiries from a number of state regulatory authorities regarding its use of the U.S. Social Security Administration’s Death Master File (the "Death Master File") and compliance with state claims practices regulation. Legislation requiring insurance companies to use the Death Master File to identify potential claims has been enacted in a number of states. As a result of these legislative and regulatory developments, in May 2012, the Company undertook an initiative to use the Death Master File and other publicly available databases to identify persons potentially entitled to benefits under life insurance policies, annuities and retained asset accounts. In addition, FGL has received audit and examination notices from several state agencies responsible for escheatment and unclaimed property regulation in those states and in some cases has challenged the audits including litigation against the Controller for the State of California which is subject to a stay. FGL believes its current accrual will cover the reasonably estimated liability arising out of these developments, however costs that cannot be reasonably estimated as of the date of this filing are possible as a result of ongoing regulatory developments and other future requirements related to these matters. On July 5, 2013, Eddie L. Cressy filed a putative class Complaint captioned Eddie L. Cressy v. Fidelity Guaranty [sic] Life Insurance Company, et. al. in the Superior Court of California, County of Los Angeles (the "Court"), Case No. BC-514340. The Complaint was filed after the Plaintiff was unable to maintain an action in federal court. The Complaint asserts, inter alia, that the Plaintiff and members of the putative class relied on Defendants’ advice in purchasing allegedly unsuitable equity-indexed insurance policies. On January 2, 2015, the Court entered Final Judgment in Cressy , certifying the class for settlement purposes, and approving the class settlement reached on April 4, 2014. On August 10, 2015, the Company tendered $1 to the Settlement Administrator for a claim review fund. The Company implemented an interest enhancement feature for certain policies as part of the class settlement, which enhancement began on October 12, 2015. On October 24, 2016, the parties filed a Joint Motion to amend the January 2, 2015 Final Order and Judgment, to extend the deadline for settlement completion from October 24, 2016 to December 5, 2016. At September 30, 2016 , the Company estimated the total cost for the settlement, legal fees and other costs related to Cressy would be $9 with a liability for the unpaid portion of the estimate of less than $1 . The Company has incurred and paid $6 related to legal fees and other costs and $3 related to settlement costs as of September 30, 2016 . Based on the information currently available the Company does not expect the actual cost for settlement, legal fees and other related costs to differ materially from the amount accrued. During the third quarter of 2015, the Company, HRG and OM Group (UK) Limited reached a global settlement that resolved all prior outstanding claims arising under the First Amended and Restated Stock Purchase Agreement, dated February 17, 2011 (the "F&G Stock Purchase Agreement") between FGL (previously, HFG) and OMGUK. As a part of the settlement, the Company received $4 to settle its outstanding claim that OMGUK was obligated to indemnify the Company for the costs to defend and the settlement of the actions brought by Plaintiff Cressy. On January 7, 2015, a putative class action complaint was filed in the United States District Court, Western District of Missouri (the "District Court"), captioned Dale R. Ludwick, on behalf of Herself and All Others Similarly Situated v. Harbinger Group Inc., Fidelity & Guaranty Life Insurance Company, Raven Reinsurance Company, and Front Street Re (Cayman) Ltd. The complaint alleges violations of the Racketeer Influenced and Corrupt Organizations Act ("RICO"), requests injunctive and declaratory relief seeks unspecified compensatory damages for the putative class in an amount not presently determinable, treble damages, and other relief, and claims Plaintiff Ludwick overpaid at least $0 for her annuity. On April 13, 2015, the Company joined in the filing of a Joint Motion to Dismiss the complaint. On February 12, 2016, the District Court granted the defendants’ Joint Motion to Dismiss. Judgment was entered on February 12, 2016. On March 3, 2016, Plaintiff Ludwick filed a Notice of Appeal to the United States Court of Appeals for the Eighth Circuit (the “Court of Appeals”) from the District Court’s Order and Judgment. As of September 30, 2016 , the Company did not have sufficient information to determine whether the Company is exposed to any losses that would be either probable or reasonably estimable beyond an expense contingency estimate of $2 , which was accrued during the year ended September 30, 2016 . Guarantees The F&G Stock Purchase Agreement between HFG and OMGUK included a Guarantee and Pledge Agreement, which created a security interest in the equity of FGLH and FGLH’s equity interest in FGL Insurance for the benefit of OMGUK in the event that FGL failed to perform certain obligations under the F&G Stock Purchase Agreement. In the third quarter of 2015, in connection with the settlement of the litigation amongst the Company, HRG and OMGUK, the Guarantee and Pledge Agreement was terminated and the Company was released from its obligations thereunder.

Reinsurance

Reinsurance	12 Months Ended
	Sep. 30, 2016
Reinsurance Disclosures [Abstract]
Reinsurance	Reinsurance The Company reinsures portions of its policy risks with other insurance companies. The use of reinsurance does not discharge an insurer from liability on the insurance ceded. The insurer is required to pay in full the amount of its insurance liability regardless of whether it is entitled to or able to receive payment from the reinsurer. The portion of risks exceeding the Company's retention limit is reinsured with other insurers. The Company seeks reinsurance coverage in order to limit its exposure to mortality losses and enhance capital management. The Company follows reinsurance accounting when there is adequate risk transfer. Otherwise, the deposit method of accounting is followed. The Company also assumes policy risks from other insurance companies. The effect of reinsurance on premiums earned, benefits incurred and reserve changes (net benefits incurred) for the years ended September 30, 2016 , 2015 and 2014 were as follows: Year ended September 30, 2016 2015 2014 Net Premiums Earned Net Benefits Incurred Net Premiums Earned Net Benefits Incurred Net Premiums Earned Net Benefits Incurred Direct $ 261 $ 1,069 $ 260 $ 833 $ 267 $ 1,103 Assumed 1 1 — — 36 28 Ceded (192 ) (279 ) (202 ) (255 ) (247 ) (343 ) Net $ 70 $ 791 $ 58 $ 578 $ 56 $ 788 Amounts payable or recoverable for reinsurance on paid and unpaid claims are not subject to periodic or maximum limits. During the years ended September 30, 2016 , 2015 and 2014 , the Company did not write off any reinsurance balances. During the year ended September 30, 2016 , the Company did not commute any ceded reinsurance. Effective April 1, 2015, Security Life of Denver ("SLD") recaptured a traditional life block of business previously assumed and ceded by the Company and simultaneously ceded this business to Wilton Re. Effective September 1, 2016, FGL Insurance recaptured a certain block of life insurance ceded to Swiss Re and simultaneously ceded this business to Wilton Re. No policies issued by the Company have been reinsured with any foreign company, which is controlled, either directly or indirectly, by a party not primarily engaged in the business of insurance. The Company has not entered into any reinsurance agreements in which the reinsurer may unilaterally cancel any reinsurance for reasons other than non-payment of premiums or other similar credit issues. Wilton Agreement In September 2012, Wilton Re and FGL Insurance reached a final agreement on the initial settlements associated with the reinsurance transactions FGL Insurance entered into. The final settlement amounts did not result in any material adjustments to the amounts reflected in the financial statements. FGL Insurance recognized a net pre-tax gain of $18 on these reinsurance transactions which has been deferred and is being amortized over the remaining life of the underlying reinsured contracts. The unamortized portion of this deferred gain was $10 and $11 as of September 30, 2016 and 2015 , respectively. Commissioners Annuity Reserve Valuation Method Facility (“CARVM”) Effective October 1, 2012, FGL Insurance recaptured the CARVM reinsurance agreement from OM Re and simultaneously ceded the business to Raven Reinsurance Company ("Raven Re"), its wholly-owned captive reinsurance company. The recapture of the OM Re CARVM reinsurance agreement satisfies the Company’s obligation under the F&G Stock Purchase Agreement to replace the letter of credit provided by OM no later than December 31, 2015. In connection with the new CARVM reinsurance agreement, FGL Insurance and Raven Re entered into an agreement with Nomura Bank International plc (“NBI”) to establish a $295 reserve financing facility in the form of a letter of credit issued by NBI and NBI charged an upfront structuring fee in the amount of $3 . The reserve financing facility is set to be reduced by $6 each quarter subsequent to establishment. The structuring fee was paid by FGL Insurance and will be deferred and amortized over the expected life of the facility. As this letter of credit is provided by an unaffiliated financial institution, Raven Re is permitted to carry the letter of credit as an admitted asset on the Raven Re statutory balance sheet. As of September 30, 2016 , there was $201 available under the letter of credit facility. The Nomura Facility will terminate on September 30, 2017, although the facility may terminate earlier, in accordance with the terms of the Reimbursement Agreement. Under the terms of the Reimbursement Agreement, in the event the letter of credit is drawn upon, Raven Re is required to repay the amounts utilized, and FGLH is obligated to repay the amounts utilized if Raven Re fails to make the required reimbursement. FGLH also is required to make capital contributions to Raven Re in the event that Raven Re’s statutory capital and surplus falls below certain defined levels. As of December 31, 2015, Raven Re’s statutory capital and surplus was $28 in excess of the minimum level required under the Reimbursement Agreement.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Sep. 30, 2016
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions FSRCI We have reinsured certain of our liabilities and obligations to FSRCI. As we are not relieved of our liability to our policyholders for this business, the liabilities and obligations associated with the reinsured policies remain on our Condensed Consolidated Balance Sheets with a corresponding reinsurance recoverable from FSRCI. In addition to various remedies that we would have in the event of a default by FSRCI, we continue to hold assets in support of the transferred reserves. At September 30, 2016 and 2015 , the Company's reinsurance recoverable included $1,120 and $1,227 , respectively, and funds withheld for reinsurance liabilities included $1,172 and $1,258 , respectively, related to FSRCI. Below are the ceded operating results to FSRCI for the year ended September 30, 2016 , 2015 and 2014 : Revenues: Year ended September 30, 2016 Year ended September 30, 2015 Year ended September 30, 2014 Premiums $ 3 $ 1 $ 1 Net investment income 61 63 64 Net investment gains (losses) (8 ) (30 ) 25 Insurance and investment product fees 3 4 5 Total revenues 59 38 95 Benefits and expenses: Benefits and other changes in policy reserves (47 ) (42 ) (60 ) Acquisition & operating expenses, net of deferrals (4 ) (4 ) (6 ) Total benefits and expenses (51 ) (46 ) (66 ) Operating income (loss) $ 8 $ (8 ) $ 29 FGL Insurance invested in CLO securities issued by Fortress Credit Opportunities III CLO LP ("FCO III") and also invested in securities issued by Fortress Credit BSL Limited ("Fortress BSL"). The parent of both FCO III and Fortress BSL is Fortress Investment Group LLC, which acquired interests greater than 10% ownership in HRG as of September 30, 2014. In March 2016, Hildene Leveraged Credit, LLC (“HLC”) sold four CLOs to Fortress Investment Group LLC. The four Hildene CLOs are now managed by an affiliate of Fortress Investment Group LLC, Fortress Credit Advisors, LLC. As of September 30, 2016, the Company held two of these CLOs at par with a carrying value of $25 . In August 2016, FGL purchased $15 of a commercial real estate CLO from Fortress Investment Group LLC. During the year ended September 30, 2014, Leucadia National Corp's ("Leucadia") ownership interest in HRG's outstanding shares exceeded 10%; and Jefferies Group Inc. ("Jefferies") is a wholly owned subsidiary of Leucadia. Additionally, during the year ended September 30, 2014, Frederick's of Hollywood became a wholly owned subsidiary of HRG. The Company sold all of its holdings in its affiliates, Leucadia, Jefferies, and Frederick's of Hollywood, recognizing gains of $2 , $6 and $0 , respectively, during the year ended September 30, 2014. Accordingly, the Company had no holdings in these affiliates as of September 30, 2016 and 2015, respectively. FGL Insurance participates in loans to third parties originated by Salus, an affiliated, limited liability company indirectly owned by HRG. Salus is also considered a VIE as described in “Note 4. Investments” to the Company’s Consolidated Financial Statements. Salus originated senior secured asset-based loans to unaffiliated third-party borrowers. In January 2014, FSRCI acquired preferred equity interests in Salus which have a 10% per annum return and a total par value of $30 which is included in the FSRCI funds withheld portfolio. Accordingly all income on this asset is ceded to FSRCI. The Company’s maximum exposure to loss as a result of its investments in Salus is limited to the carrying value of the preferred equity interests. The carrying value of these investments in Salus as of September 30, 2016 and 2015 are disclosed in the tables below. During the year ended September 30, 2015, FGL Insurance entered into a transaction with Salus whereby Salus transferred $14 of loan participations and $16 of CLO subordinated debt (i.e., equity tranche) to FGL Insurance in exchange for retirement of the $20 promissory note and $10 revolving loan owed by Salus to FGL Insurance resulting in the termination of these facilities. Additionally, FGL Insurance also entered into a transaction with the Salus CLO whereby FGL insurance transferred $29 of loan participations into the CLO in exchange for $27 of CLO subordinated notes (i.e., equity tranche) and a promissory note of $3 from Salus. Both transactions qualified as sales of financial assets accounted for at fair value and therefore did not result in any gain or loss. FGL Insurance also concluded that it is not the primary beneficiary of the Salus CLO before and after these two transactions, and as of September 30, 2016, as FGL Insurance lacks the power to direct the activities that significantly affect the economic performance of the CLO and, to a lesser extent, FGL Insurance continues to own less than a majority ownership of the CLO subordinated notes after the two transactions. In June of 2016, the Salus promissory note was repaid for $2 and all obligations under the note were satisfied. Please refer to "Note 5. Derivative Financial Instruments" to the Company’s Consolidated Financial Statements for disclosure of Canadian dollar foreign exchange swap agreements for certain Salus loan participations. In August of 2015 and October of 2015, FGL entered into separate engagement letters with Credit Suisse and Jefferies, respectively, pursuant to which Credit Suisse and Jefferies agreed (on a non-exclusive basis) to provide financial advisory services to FGL in connection with a transaction involving a merger or other similar transaction with respect to at least a majority of the capital stock of FGL. HRG, the holder of a majority of shares of outstanding common stock of FGL, is also a party to each engagement letter. Under each engagement letter, Credit Suisse and Jefferies, respectively, are entitled to receive a fee which represents a percentage of the value of the transaction, plus reimbursement for all reasonable out-of-pocket expenses incurred by Credit Suisse or Jefferies, as applicable, in connection with their engagement. FGL has also agreed to indemnify Credit Suisse and Jefferies for certain liabilities in connection with their engagement. Under each engagement letter, HRG is required to reimburse FGL for compensation paid by FGL to Credit Suisse or Jefferies under certain circumstances. Specifically, if compensation to Credit Suisse or Jefferies becomes payable in respect of a transaction that involves a disposition of shares of FGL held by HRG (and not other stockholders of FGL), HRG will reimburse FGL for the full amount of such compensation. If compensation to Credit Suisse or Jefferies becomes payable in respect of a transaction that involves a disposition of shares of FGL held by HRG and a disposition of not more than 50% of the shares of FGL held by stockholders of FGL other than HRG, HRG will reimburse FGL for its pro rata portion of such compensation (based on its relative number of shares compared to those held by stockholders of FGL other than HRG). In 2016, HGI Energy Holdings, LLC (“HGI Energy”) disposed of a significant portion of its assets and HRG used this asset disposal to recapitalize HGI Energy by contributing $110 to HGI Energy. HGI Energy used these funds to purchase $110 of Spectrum Brands Holdings, Inc. public common stock from another HRG affiliate, HGI Funding, LLC. Concurrent with the asset sale and recapitalization of HGI Energy, FGL Insurance exchanged the notes issued by HGI Energy in 2013 (the "Old Notes") with a par value and fair value of $78 and $72 , respectively, for new notes issued by HGI Energy (the "New Notes") with a par value and fair value of $72 , respectively. As a result of these transactions, FGL Insurance reflected a change of intent with respect to the Old Notes and recognized an impairment loss of $6 . Old Notes with a par value of $28 and a fair value of $26 were held in the FSRCI funds withheld portfolio; accordingly $2 of the impairment loss was ceded to FSRCI. Concurrent with the exchange of Old Notes for the New Notes, FGL Insurance transferred, at fair value, the New Notes held in its general account to the FSRCI funds withheld portfolio in exchange for $46 cash. The Company’s related party investments as of September 30, 2016 and 2015 , and related net investment income for the years ended September 30, 2016 , 2015 , and 2014 are summarized as follows: September 30, 2016 Type Balance Sheet Classification Asset carrying value Accrued Investment Income Total carrying value Salus CLOs Fixed maturities, available for sale $ 19 $ — $ 19 Fortress Investment Group CLOs Fixed maturities, available for sale 225 2 227 Salus preferred equity (a) Equity securities, available for sale 3 — 3 Salus participations (b) Other invested assets 21 — 21 HGI energy loan (c) Related party loans 71 — 71 (a) Salus preferred equity is included in the FSRCI funds withheld portfolio, accordingly all income on this asset is ceded to FSRCI. (b) Includes loan participations with 4 different borrowers with an average loan fair value of $5 as of September 30, 2016 . (c) The total HGI energy loan is included in the FSRCI funds withheld portfolio, accordingly the income related to this portion is ceded to FSRCI. September 30, 2015 Type Balance Sheet Classification Asset carrying value Accrued Investment Income Total carrying value Salus CLOs Fixed maturities, available for sale $ 245 $ — $ 245 Fortress Investment Group CLOs Fixed maturities, available for sale 181 2 183 Salus preferred equity (a) Equity securities, available for sale 3 — 3 Salus participations (b) Other invested assets 110 1 111 EIC participations Other invested assets 9 — 9 Foreign exchange derivatives and embedded derivatives Other invested assets 11 — 11 HGI energy loan (c) Related party loans 70 1 71 Salus 2012 participations Related party loans 4 — 4 Salus promissory note Related party loans 3 — 3 (a) Salus preferred equity is included in the FSRCI funds withheld portfolio, accordingly all income on this asset is ceded to FSRCI. (b) Includes loan participations with 17 different borrowers with an average loan fair value of $6 as of September 30, 2015 (c) $20 of the total HGI energy loan is included in the FSRCI funds withheld portfolio, accordingly the income related to this portion is ceded to FSRCI. Year ended September 30, 2016 2015 2014 Type Investment Income Classification Net investment income Net investment income Net investment income Salus CLOs Fixed maturities $ 9 $ 11 $ 13 Fortress Investment Group CLOs Fixed maturities 11 8 2 Leucadia National Corporation Fixed maturities — — 1 Jefferies Group Inc. Fixed maturities — — 1 Salus preferred equity Equity securities — — 2 Salus participations Other invested assets 4 15 19 EIC participations Other invested assets 1 — — HGI energy loan Related party loans 4 5 6 Salus 2012 participations Related party loans — — 1 Salus promissory note Related party loans — 1 1 Salus revolver Related party loans — — 1 The Company had realized foreign exchange losses of $5 , $4 and $1 for the years ended September 30, 2016 , 2015 and 2014 , respectively, related to its CAD denominated loan participations originated by Salus. Additionally, the Company had foreign exchange derivative and embedded derivative losses, including losses on CAD currency forward contracts, of $2 for the year ended September 30, 2016 , and gains of $9 and $2 for the years ended September 30, 2015 and 2014 , respectively, included in other invested assets. See "Note 5. Derivative Financial Instruments" to the Company’s Consolidated Financial Statements for further details. During 2016, the Company received proceeds from the RSH liquidation trust of $23 resulting in a realized gain of $8 . See "Note 4. Investments" to the Company's Consolidated Financial Statements for further details. In August 2016, FGL Insurance exchanged the $71 2013 HGI Energy Loan issued by HGI Energy for new notes issued by HGI Energy for the same fair value with an August 2017 maturity date. The new notes issued are held in the FSRCI funds withheld portfolio . The Company had realized impairment losses of $11 and $46 on available-for-sale fixed maturity securities, $22 and $36 on other invested assets, and $4 and $0 on related party loans, for the year ended September 30, 2016 and 2015 , respectively, related to affiliated investments. The 2015 amount included $35 in fixed maturities, available for sale and other invested assets, respectively due to direct and indirect investments in RSH included within the Salus CLOs and the Salus participations. During the year, the Company has investment management agreements with Salus, CorAmerica Capital, LLC, and Energy & Infrastructure Capital, LLC ("EIC"), all wholly-owned subsidiaries of HGI Asset Management Holdings, LLC, which is also a wholly owned subsidiary of HRG. The agreement for EIC was terminated in July 2016, and CorAmerica is no longer a wholly-owned subsidiary of HGI Asset Management Holdings. The Company paid management fees to these entities for the services provided under these agreements which are usual and customary for these types of services. The Company paid Salus $0 , $1 and $0 during the year ended September 30, 2016, 2015 and 2014, respectively, paid CorAmerica Capital, LLC $3 , $1 and $0 during the year ended September 30, 2016, 2015 and 2014, respectively and paid EIC $0 , $0 and $0 during the year ended September 30, 2016, 2015 and 2014, respectively. The F&G Stock Purchase Agreement included a Guarantee and Pledge Agreement, which created a security interest in the equity of FGLH and FGLH’s equity interest in FGL Insurance for the benefit of OMGUK in the event that FGL failed to perform certain obligations under the F&G Stock Purchase Agreement. In the third quarter of 2015, in connection with the settlement of the litigation amongst the Company, HRG and OMGUK, the Guarantee and Pledge Agreement was terminated, and the Company was released from its obligations thereunder.

Earnings Per Share

Earnings Per Share	12 Months Ended
	Sep. 30, 2016
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share The following table sets forth the computation of basic and diluted earnings per share (share amounts in thousands): Year ended September 30, 2016 2015 2014 Net income attributable to common shares - basic $ 97 $ 118 $ 163 Weighted-average common shares outstanding - basic 58,275 58,118 55,970 Dilutive effect of unvested restricted stock and unvested performance restricted stock 271 208 31 Dilutive effect of stock options 32 35 10 Weighted-average shares outstanding - diluted 58,578 58,361 56,011 Net income per common share: Basic $ 1.67 $ 2.03 $ 2.91 Diluted $ 1.66 $ 2.02 $ 2.90 The number of shares of common stock outstanding used in calculating the weighted average thereof reflects the actual number of FGL shares of common stock outstanding, excluding unvested restricted stock and shares held in treasury. The calculation of diluted earnings per share for the years ended September 30, 2016 , 2015 , and 2014 excludes the incremental effect related to certain outstanding stock options and restricted shares due to their anti-dilutive effect. The number of weighted average equivalent shares excluded in 2016 , 2015 , and 2014 are 19 thousand shares, 17 thousand shares, and less than 1 thousand shares, respectively. Also, stock-based compensation awards under the FGLH Plans are settled in cash, therefore, are excluded from the computation of diluted earnings per share. In the fourth quarter 2016, we decided to settle the performance restricted stock units in cash upon vesting, therefore, the performance restricted stock units are excluded from the computation of diluted earnings per share in the fourth quarter.

Insurance Subsidiary Financial

Insurance Subsidiary Financial Information and Regulatory Matters	12 Months Ended
	Sep. 30, 2016
Insurance [Abstract]
Insurance Subsidiary Financial Information and Regulatory Matters	Insurance Subsidiary Financial Information and Regulatory Matters The Company’s insurance subsidiaries file financial statements with state insurance regulatory authorities and the National Association of Insurance Commissioners (“NAIC”) that are prepared in accordance with Statutory Accounting Principles (“SAP”) prescribed or permitted by such authorities, which may vary materially from GAAP. Prescribed SAP includes the Accounting Practices and Procedures Manual of the NAIC as well as state laws, regulations and administrative rules. Permitted SAP encompasses all accounting practices not so prescribed. The principal differences between statutory financial statements and financial statements prepared in accordance with GAAP are that statutory financial statements do not reflect DAC and VOBA, some bond portfolios may be carried at amortized cost, assets and liabilities are presented net of reinsurance, contractholder liabilities are generally valued using more conservative assumptions and certain assets are non-admitted. Accordingly, statutory operating results and statutory capital and surplus may differ substantially from amounts reported in the GAAP basis financial statements for comparable items. The Company’s principal insurance subsidiaries’ statutory financial statements are based on a December 31 year end. Statutory net income and statutory capital and surplus of the Company’s wholly owned insurance subsidiaries were as follows: Subsidiary (state of domicile)(a) FGL Insurance (IA)(b) FGL NY Insurance (NY) Statutory Net Income (loss): Year ended December 31, 2015 $ (53 ) $ (1 ) Year ended December 31, 2014 105 2 Year ended December 31, 2013 118 1 Statutory Capital and Surplus: December 31, 2015 $ 1,239 $ 59 December 31, 2014 1,212 61 (a) FGL NY Insurance is a subsidiary of FGL Insurance, and the columns should not be added together. (b) FGL Insurance Company re-domesticated to Iowa effective November 1, 2013. Prior to November 1, 2013, the Company was domiciled in the state of Maryland. The amount of statutory capital and surplus necessary to satisfy the applicable regulatory requirements is less than FGL Insurance’s and FGL NY Insurance’s respective statutory capital and surplus. Life insurance companies are subject to certain Risk-Based Capital (“RBC”) requirements as specified by the NAIC. The RBC is used to evaluate the adequacy of capital and surplus maintained by an insurance company in relation to risks associated with: (i) asset risk, (ii) insurance risk, (iii) interest rate risk and (iv) business risk. The Company monitors the RBC of FGLH’s insurance subsidiaries. As of December 31, 2015 and 2014 , each of FGLH’s insurance subsidiaries had exceeded the minimum RBC requirements. The Company’s insurance subsidiaries are restricted by state laws and regulations as to the amount of dividends they may pay to their parent without regulatory approval in any year, the purpose of which is to protect affected insurance policyholders, depositors or investors. Any dividends in excess of limits are deemed “extraordinary” and require approval. Based on statutory results as of December 31, 2015, in accordance with applicable dividend restrictions, the Company’s subsidiaries could pay “ordinary” dividends of $124 to FGLH in 2016, less any dividends paid during the immediately preceding 12 month period. The Company did not declare or pay any dividends to FGLH during the 12 month period ended September 30, 2016 . Therefore, FGL Insurance is able to declare an ordinary dividend up to $124 with respect to its 2015 statutory results, subject to management’s discretion. On November 1, 2013, FGL Insurance re-domesticated from Maryland to Iowa. After re-domestication, FGL Insurance elected to apply Iowa-prescribed accounting practices that permit Iowa-domiciled insurers to report equity call options used to economically hedge FIA index credits at amortized cost for statutory accounting purposes and to calculate FIA statutory reserves such that index credit returns will be included in the reserve only after crediting to the annuity contract. This resulted in an increase in statutory capital and surplus of $47 at December 31, 2015 and a decrease of $5 at December 31, 2014. Also, the Iowa Insurance Division granted FGL Insurance a permitted statutory accounting practice to reclassify its negative unassigned surplus balance of $806 to additional paid in capital as of April 6, 2011, the date the Company acquired FGL Insurance, which had the effect of setting FGL Insurance’s statutory unassigned surplus to zero as of this date. The prescribed and permitted statutory accounting practice has no impact on the Company’s Consolidated Financial Statements which are prepared in accordance with GAAP. FGL Insurance’s statutory carrying value of Raven Re reflects the effect of permitted practices Raven Re received to treat the available amount of a letter of credit as an admitted asset which increased Raven Re’s statutory capital and surplus by $220 and $245 at December 31, 2015 and 2014, respectively. Raven Re is also permitted to follow Iowa prescribed statutory accounting practice for its reserves on reinsurance assumed from FGL Insurance which increased Raven Re’s statutory capital and surplus by $4 and $17 at December 31, 2015 and 2014, respectively. Without such permitted statutory accounting practices Raven Re’s statutory capital and surplus would be negative $14 and $75 as of December 31, 2015 and 2014, respectively and its risk-based capital would fall below the minimum regulatory requirements. The letter of credit facility is collateralized by NAIC 1 rated fixed maturity securities. If the permitted practice was revoked, the letter of credit could be replaced by the collateral assets with NBI’s consent. FGL Insurance’s statutory carrying value of Raven Re at December 31, 2015 and 2014 was $210 and $187 , respectively As of December 31, 2015 , FGL NY Insurance does not follow any prescribed or permitted statutory accounting practices that differ from the NAIC’s statutory accounting practices.

Other Liabilities

Other Liabilities	12 Months Ended
	Sep. 30, 2016
Other Liabilities Disclosure [Abstract]
Other Liabilities	Other Liabilities Other liabilities consisted of the following: Year ended September 30, 2016 2015 Amounts payable for investment purchases $ 106 $ 125 Retained asset account 221 213 Option collateral liabilities 118 7 Remittances and items not allocated 77 42 Amounts payable to reinsurers 36 17 Accrued expenses 60 43 Deferred reinsurance revenue 25 27 Other 103 89 Total $ 746 $ 563

Employee Benefit Plans

Employee Benefit Plans	12 Months Ended
	Sep. 30, 2016
Compensation and Retirement Disclosure [Abstract]
Employee Benefit Plans	Employee Benefit Plans The Company sponsors a defined contribution plan in which eligible participants may defer a fixed amount or a percentage of their eligible compensation, subject to limitations, and the Company makes a discretionary matching contribution of up to 5% of eligible compensation. The Company has also established a nonqualified defined contribution plan for independent agents. The Company makes contributions to the plan based on both the Company’s and the agent’s performance. Contributions are discretionary and evaluated annually. Contributions charged to operations for the employee defined contribution plans, including discretionary amounts, were $2 , $2 and $1 , for the years ended September 30, 2016 , 2015 and 2014 , respectively.

Quarterly Results (Unaudited)

Quarterly Results (Unaudited)	12 Months Ended
	Sep. 30, 2016
Quarterly Financial Information Disclosure [Abstract]
Quarterly Results (Unaudited)	Quarterly Results (Unaudited) Unaudited quarterly results of operations are summarized below. Quarter Ended September 30, 2016 June 30, 2016 March 31, 2016 December 31, 2015 (Dollars in millions, except per share data) Premiums $ 18 $ 21 $ 16 $ 15 Net investment income 238 236 227 222 Net realized gains (losses) 26 (28 ) (42 ) 63 Insurance and investment product fees and other 34 32 32 29 Total revenue 316 261 233 329 Total expenses 262 240 212 250 Net income 30 10 9 48 Net income per common share - basic 0.52 0.16 0.16 0.82 Net income per common share - diluted 0.52 0.16 0.16 0.82 Quarter Ended September 30, 2015 June 30, 2015 March 31, 2015 December 31, 2014 (Dollars in millions, except per share data) Premiums $ 15 $ 17 $ 15 $ 11 Net investment income 223 212 208 208 Net realized (losses) gains (112 ) 74 (58 ) 59 Insurance and investment product fees and other 24 23 22 20 Total revenue 150 326 187 298 Total expenses 101 192 193 269 Net income (loss) 30 86 (12 ) 14 Net income (loss) per common share - basic 0.52 1.48 (0.21 ) 0.24 Net income (loss) per common share - diluted 0.51 1.48 (0.21 ) 0.24

Schedule I - Summary of Investm

Schedule I - Summary of Investments	12 Months Ended
	Sep. 30, 2016
Summary of Investments, Other than Investments in Related Parties [Abstract]
Schedule I - Summary of Investments	Summary of Investments - Other than Investments in Related Parties September 30, 2016 (in millions) Amortized Cost Fair Value Amount at which shown on the balance sheet Fixed Maturities: Bonds: United States Government and government agencies and authorities $ 345 $ 358 $ 358 States, municipalities and political subdivisions 1,515 1,717 1,717 Foreign governments 5 5 5 Public utilities 1,811 1,881 1,881 All other corporate bonds 14,623 15,215 15,215 Redeemable preferred stock 222 235 235 Total fixed maturities 18,521 19,411 19,411 Equity securities: Common stocks: Public utilities — — — Banks, trust, and insurance companies 104 103 103 Industrial, miscellaneous and all other 4 3 3 Nonredeemable preferred stock 532 577 577 Total equity securities 640 683 683 Derivative investments 221 276 276 Commercial mortgage loans 595 614 595 Other long-term investments 60 58 60 Total investments $ 20,037 $ 21,042 $ 21,025 See accompanying Report of Independent Registered Public Accounting Firm.

Schedule II - Condensed Financi

Schedule II - Condensed Financial Information	12 Months Ended
	Sep. 30, 2016
Condensed Financial Information of Parent Company Only Disclosure [Abstract]
Schedule II - Condensed Financial Information	CONDENSED BALANCE SHEETS (in millions) September 30, 2016 September 30, 2015 ASSETS Investments in consolidated subsidiaries $ 1,913 $ 1,464 Fixed maturity securities, available for sale 5 7 Equity securities, available-for-sale, at fair value 12 17 Cash and cash equivalents 2 13 Other assets 2 1 Total assets $ 1,934 $ 1,502 LIABILITIES AND SHAREHOLDERS' EQUITY Total liabilities — — Shareholders' equity Preferred stock — — Common stock 1 1 Additional paid in capital 714 714 Retained earnings 792 710 Accumulated other comprehensive income 439 88 Treasury stock (12 ) (11 ) Total shareholder's equity 1,934 1,502 Total liabilities and shareholder's equity $ 1,934 $ 1,502 See accompanying Report of Independent Registered Public Accounting Firm. CONDENSED STATEMENT OF OPERATIONS (in millions) Year ended September 30, 2016 2015 2014 Revenues $ (2 ) $ (9 ) $ 2 (2 ) (9 ) 2 Operating expenses: General and administrative expenses 3 6 6 Total operating expenses 3 6 6 Operating loss (5 ) (15 ) (4 ) Other income: Equity in net income of subsidiaries 103 133 167 Income before income taxes 98 118 163 Income tax expense 1 — — Net income $ 97 $ 118 $ 163 See accompanying Report of Independent Registered Public Accounting Firm. CONDENSED STATEMENT OF CASH FLOWS (in millions) Year ended September 30, 2016 2015 2014 Cash flows from operating activities Net income $ 97 $ 118 $ 163 Adjustments to reconcile net income to net cash (used in) provided by operating activities: Realized capital and other gains on investments 2 9 (1 ) Equity in net income of subsidiaries (103 ) (133 ) (167 ) Stock based compensation (2 ) 10 3 Other assets and other liabilities 2 2 (2 ) Net cash (used in) provided by operating activities (4 ) 6 (4 ) Cash flows from investing activities: Proceeds from available-for-sale investments, sold, matured or repaid: 5 30 125 Cost of available-for-sale investments: — (15 ) (174 ) Net cash provided by (used in) investing activities 5 15 (49 ) Cash flows from financing activities: Proceeds from issuance of common stock, net of transactions fees 2 2 173 Dividends payments (15 ) (15 ) (54 ) Treasury stock (1 ) (11 ) — Distribution to FGLH and subsidiaries 2 (50 ) — Net cash (used in) provided by financing activities (12 ) (74 ) 119 Change in cash and cash equivalents (11 ) (53 ) 66 Cash and cash equivalents at beginning of period 13 66 — Cash and cash equivalents at end of period $ 2 $ 13 $ 66 See accompanying Report of Independent Registered Public Accounting Firm.

Schedule III - Supplementary In

Schedule III - Supplementary Insurance Information	12 Months Ended
	Sep. 30, 2016
Supplementary Insurance Information [Abstract]
Schedule III - Supplementary Insurance Information	Supplementary Insurance Information (in millions) Year ended September 30, 2016 2015 2014 Life Insurance (single segment): Deferred acquisition costs $ 1,007 $ 801 $ 456 Future policy benefits, losses, claims and loss expenses 3,467 3,468 3,504 Other policy claims and benefits payable 55 55 58 Premium revenue 70 58 56 Net investment income 923 851 760 Benefits, claims, losses and settlement expenses (791 ) (578 ) (788 ) Amortization of deferred acquisition costs (49 ) (27 ) (39 ) Other operating expenses (119 ) (113 ) (102 ) See accompanying Report of Independent Registered Public Accounting Firm.

Schedule IV - Reinsurance

Schedule IV - Reinsurance	12 Months Ended
	Sep. 30, 2016
Supplemental Schedule of Reinsurance Premiums for Insurance Companies [Abstract]
Schedule IV - Reinsurance	Reinsurance (In millions) For the year ended September 30, 2016 Gross Amount Ceded to other companies Assumed from other companies Net Amount Percentage of amount assumed of net Life insurance in force $ 3,081 $ (2,024 ) $ — $ 1,057 — % Premiums and other considerations: Traditional life insurance premiums $ 261 $ (192 ) $ 1 $ 70 1 % Annuity product charges 191 (67 ) — 124 — % Total premiums and other considerations $ 452 $ (259 ) $ 1 $ 194 1 % For the year ended September 30, 2015 Gross Amount Ceded to other companies Assumed from other companies Net Amount Percentage of amount assumed of net Life insurance in force $ 2,933 $ (2,010 ) $ — $ 923 — % Premiums and other considerations: Traditional life insurance premiums $ 260 $ (202 ) $ — $ 58 — % Annuity product charges 156 (69 ) — 87 — % Total premiums and other considerations $ 416 $ (271 ) $ — $ 145 — % For the year ended September 30, 2014 Gross Amount Ceded to other companies Assumed from other companies Net Amount Percentage of amount assumed of net Life insurance in force $ 2,786 $ (2,014 ) $ 16 $ 788 2 % Premiums and other considerations: Traditional life insurance premiums $ 267 $ (247 ) $ 36 $ 56 65 % Annuity product charges 139 (73 ) — 66 — % Total premiums and other considerations $ 406 $ (320 ) $ 36 $ 122 30 % See accompanying Report of Independent Registered Public Accounting Firm.

Significant Accounting Polici31

Significant Accounting Policies and Practices (Policies)	12 Months Ended
	Sep. 30, 2016
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and all other entities in which FGL has a controlling financial interest. All intercompany accounts and transactions have been eliminated in consolidation.
VIE	We are involved in certain entities that are considered variable interest entities ("VIEs") as defined under GAAP. Our involvement with VIEs is primarily to invest in assets that allow us to gain exposure to a broadly diversified portfolio of asset classes. A VIE is an entity that does not have sufficient equity to finance its own activities without additional financial support or where investors lack certain characteristics of a controlling financial interest. We assess our relationships to determine if we have the ability to direct the activities, or otherwise exert control to evaluate if we are the primary beneficiary of the VIE. See "Note 4. Investments" to the Company’s Consolidated Financial Statements for additional information on the Company’s investments in unconsolidated VIEs.
Revenue Recognition	Revenue Recognition Insurance Premiums The Company’s insurance premiums for traditional life insurance products are recognized as revenue when due from the contractholder. The Company’s traditional life insurance products include those products with fixed and guaranteed premiums and benefits and consist primarily of term life insurance and certain annuities with life contingencies. Premium collections for fixed indexed and fixed rate annuities, indexed universal life (“IUL”) policies and immediate annuities without life contingency are reported as deposit liabilities (i.e., contractholder funds) instead of as revenues. Similarly, cash payments to policyholders are reported as decreases in the liability for contractholder funds and not as expenses. Sources of revenues for products accounted for as deposit liabilities are net investment income, surrender and other charges deducted from contractholder funds, and net realized gains (losses) on investments. Net Investment Income Dividends and interest income, recorded in “Net investment income”, are recognized when earned. Income or losses upon call or prepayment of available-for-sale fixed maturity securities is recognized in net investment income. Amortization of premiums and accretion of discounts on investments in fixed maturity securities are reflected in “Net investment income” over the contractual terms of the investments in a manner that produces a constant effective yield. For mortgage-backed and asset-backed securities, included in the fixed maturity available-for-sale (“AFS”) securities portfolios, the Company recognizes income using a constant effective yield based on anticipated prepayments and the estimated economic life of the securities. When actual prepayments differ significantly from originally anticipated prepayments, the effective yield is recalculated prospectively to reflect actual payments to date plus anticipated future payments. Any adjustments resulting from changes in effective yield are reflected in “Net investment income’’. Net Investment Gains (Losses) Net investment gains (losses) include realized gains and losses from the sale of investments, write-downs for other-than-temporary impairments ("OTTI") of AFS investments, other invested assets, commercial mortgage loans and related party loans, and gains and losses on derivatives. Realized gains and losses on the sale of investments are determined using the specific identification method. Product Fees Product fee revenue from IUL products and deferred annuities is comprised of policy and contract fees charged for the cost of insurance, and policy administration and rider fees. Fees are assessed on a monthly basis and recognized as revenue when assessed and earned. Product fee revenue also includes surrender charges which are collected and recognized as revenue when the policy is surrendered.
Benefits and Other Changes in Policy Reserves	Benefits and Other Changes in Policy Reserves Benefit expenses for deferred annuity, FIA and IUL policies include index credits and interest credited to contractholder account balances and benefit claims incurred during the period in excess of contract account balances. Interest crediting rates associated with funds invested in the general account of our insurance subsidiaries during 2014 through 2016 ranged from 0.0% to 6.0% for deferred annuities and FIA's, combined, and 0.0% to 4.5% for IUL's. Other changes in policy reserves include the change in the fair value of the FIA embedded derivative and the change in the reserve for secondary guarantee benefit payments. Other changes in policy reserves also include the change in reserves for life insurance products. For traditional life and immediate annuities, policy benefit claims are charged to expense in the period that the claims are incurred.
Stock-Based Compensation	Stock-Based Compensation In general, we expense the fair value of stock awards included in our incentive compensation plans. As of the date our stock awards are approved and communicated to the recipients, the fair value of stock options is determined using a Black-Scholes options valuation methodology, and the fair value of other stock awards is based upon the market value of the stock. The fair value of the awards is expensed over the performance or service period, which generally corresponds to the vesting period, and is recognized as an increase to “Additional paid-in capital” in “Shareholders’ equity”. We classify certain stock awards as liabilities. For these awards, the fair value is classified as a liability on our Consolidated Balance Sheets, and the liability is marked-to-market through net income at the end of each reporting period. Stock-based compensation expense is reflected in “Acquisition and operating expenses, net of deferrals” on our Consolidated Statements of Operations. If we modify an award or change our intent to settle an award in equity or cash, we recognize additional compensation expense for the increase in the fair value of the award between the grant date and the date of modification for change in intent and any periods subsequent to the modification, if applicable. As described under "Recent Accounting Pronouncements" in Note 2, the Company early adopted ASU 2016-09 effective October 1, 2015. The adoption of ASU 2016-09 did not have a material effect on the Company's financial statements and related disclosures.
Interest Expense	Interest Expense Interest expense on our debt is recognized as due and any associated premiums, discounts, and costs are amortized (accreted) over the term of the related borrowing utilizing the straight line method. Interest expense also includes non-use fees on the revolving credit facility entered into in August 2014.
Earnings Per Share	Earnings Per Share Basic earnings per share (“EPS”) is computed by dividing earnings available to common shareholders by the average common shares outstanding. Diluted EPS is computed assuming the conversion or exercise of nonvested stock, stock options, and performance share units outstanding during the year. Stock options are excluded from the computation of diluted EPS, based on the application of the treasury stock method, if they are anti-dilutive.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid debt instruments purchased with original maturities of three months or less to be cash equivalents. As of September 30, 2016 , the company held cash equivalents of $465 . As of September 30, 2015 there were no cash equivalents.
Investments	Investments Investment Securities The Company’s investments in fixed maturity and equity securities have been designated as AFS and are carried at fair value with unrealized gains and losses included in “Accumulated other comprehensive income” (“AOCI”), net of associated intangibles “shadow adjustments” (discussed in "Note 7. Intangibles" to the Company’s Consolidated Financial Statements ) and deferred income taxes. Available-for-Sale Securities Other-Than-Temporary Impairments The Company regularly reviews AFS securities for declines in fair value that it determines to be other-than-temporary. For an equity security, if the Company does not have the ability and intent to hold the security for a sufficient and reasonable period of time to allow for a recovery in value, it concludes that an OTTI has occurred and the cost of the equity security is written down to the current fair value, with a corresponding charge to “Net investment gains (losses)” in the accompanying Consolidated Statements of Operations. When assessing its ability and intent to hold an equity security to recovery, the Company considers, among other things, the severity and duration of the decline in fair value of the equity security as well as the cause of the decline, a fundamental analysis of the liquidity, business prospects and the overall financial condition of the issuer. For its available-for-sale securities, the Company generally considers the following in determining whether its unrealized losses are other-than-temporary: • The estimated range and period until recovery; • Current delinquencies and nonperforming assets of underlying collateral; • Expected future default rates; • Collateral value by vintage, geographic region, industry concentration or property type; • Subordination levels or other credit enhancements as of the balance sheet date as compared to origination; and • Contractual and regulatory cash obligations and the issuer's plans to meet such obligations. The Company recognizes OTTI on debt (including redeemable and perpetual preferred stocks) securities in an unrealized loss position when one of the following circumstances exists: • The Company does not expect full recovery of its amortized cost based on the estimate of cash flows expected to be collected; • The Company intends to sell a security; or • It is more likely than not that the Company will be required to sell a security prior to recovery. If the Company intends to sell a fixed maturity available-for-sale security or it is more likely than not the Company will be required to sell the security before recovery of its amortized cost basis and the fair value of the security is below amortized cost, the Company will conclude that an OTTI has occurred and the amortized cost is written down to current fair value, with a corresponding charge to “Net investment gains (losses)” in the accompanying Consolidated Statements of Operations. If the Company does not intend to sell a fixed maturity security or it is more likely than not the Company will not be required to sell a fixed maturity security before recovery of its amortized cost basis and the present value of the cash flows expected to be collected is less than the amortized cost of the security (referred to as the credit loss), an OTTI has occurred and the amortized cost is written down to the estimated recovery value with a corresponding charge to “Net investment gains (losses)” in the accompanying Consolidated Statements of Operations, as this amount is deemed the credit loss portion of the OTTI. The remainder of the decline to fair value is recorded in AOCI as unrealized OTTI on available-for-sale securities, as this amount is considered a non-credit (i.e., recoverable) impairment. When assessing the Company’s intent to sell a fixed maturity security or if it is more likely than not the Company will be required to sell a fixed maturity security before recovery of its cost basis, the Company evaluates facts and circumstances such as, but not limited to, decisions to reposition the Company’s security portfolio, sale of securities to meet cash flow needs and sales of securities to capitalize on favorable pricing and tax planning strategies. In order to determine the amount of the credit loss for a security, the Company calculates the recovery value by performing a discounted cash flow analysis based on the current cash flows and future cash flows the Company expects to recover. The discount rate is the effective interest rate implicit in the underlying security. The effective interest rate is the original purchased yield or the yield at the date the fixed maturity security was previously impaired. When evaluating redeemable preferred stocks for OTTI the Company applies the accounting policy described above for fixed maturity securities. Additionally, the SEC’s staff in the Office of the Chief Accountant issued a letter (SEC OTTI Release) to the Financial Accounting Standards Board (“FASB”) on October 14, 2008, providing clarifying guidance on how to assess impairments of perpetual preferred securities (“PPS”), including perpetual preferred stock. After consultation with and concurrence of the FASB staff, the SEC staff has concluded that it will not object to an issuer treating a PPS similar to a fixed maturity security in an OTTI evaluation (including an anticipated recovery period), provided there has been no evidence of a deterioration in credit of the issuer. Consequently, when such criteria is met we apply the OTTI guidance of fixed maturity securities to perpetual preferred stock. When evaluating mortgage-backed securities and asset-backed securities, the Company considers a number of pool-specific factors as well as market level factors when determining whether or not the impairment on the security is temporary or other-than-temporary. The most important factor is the performance of the underlying collateral in the security and the trends of that performance. The Company uses this information about the collateral to forecast the timing and rate of mortgage loan defaults, including making projections for loans that are already delinquent and for those loans that are currently performing but may become delinquent in the future. Other factors used in this analysis include type of underlying collateral (e.g., prime, Alternative A-paper (“Alt-A”), or subprime), geographic distribution of underlying loans and timing of liquidations by state. Once default rates and timing assumptions are determined, the Company then makes assumptions regarding the severity of a default if it were to occur. Factors that impact the severity assumption include expectations for future home price appreciation or depreciation, loan size, first lien versus second lien, existence of loan level private mortgage insurance, type of occupancy and geographic distribution of loans. Once default and severity assumptions are determined for the security in question, cash flows for the underlying collateral are projected, including expected defaults and prepayments. These cash flows on the collateral are then translated to cash flows on the Company’s tranche based on the cash flow waterfall of the entire capital security structure. If this analysis indicates the entire principal on a particular security will not be returned, the security is reviewed for OTTI by comparing the present value of expected cash flows to amortized cost. To the extent that the security has already been impaired or was purchased at a discount, such that the amortized cost of the security is less than or equal to the present value of cash flows expected to be collected, no impairment is required. The Company also considers the ability of monoline insurers to meet their contractual guarantees on wrapped mortgage-backed securities. Otherwise, if the amortized cost of the security is greater than the present value of the cash flows expected to be collected, then an OTTI is recognized. The Company includes on the face of the Consolidated Statements of Operations the total OTTI recognized in "Net investment gains (losses)", with an offset for the amount of non-credit impairments recognized in AOCI. The Company discloses the amount of OTTI recognized in AOCI and other disclosures related to OTTI in "Note 4. Investments" to the Company’s Consolidated Financial Statements and the Consolidated Statements of Comprehensive Income (Loss).
Mortgage Loans on Real Estate	Mortgage Loans on Real Estate The Company’s mortgage loans on real estate are all commercial mortgage loans, which are reported at amortized cost, less impairment write-downs and allowance for losses. If a mortgage loan is determined to be impaired (i.e., when it is probable that the Company will be unable to collect all amounts due according to the contractual terms of the loan agreement or the loan is modified in a troubled debt restructuring), the carrying value of the mortgage loan is reduced to the lower of either the present value of expected cash flows from the loan, discounted at the loan’s original purchase yield, or fair value of the collateral. For those mortgages that are determined to require foreclosure, the carrying value is reduced to the fair value of the underlying collateral, net of estimated costs to obtain and sell at the point of foreclosure. The carrying value of the impaired loans is reduced by establishing an allowance with the offset recorded in "Net investment gains (losses)" in the Consolidated Statements of Operations. Mortgage loans are evaluated by the Company’s investment professionals, including an appraisal of loan-specific credit quality, property characteristics and market trends. Loan performance is continuously monitored on a loan-specific basis throughout the year. The Company’s review includes submitted appraisals, operating statements, rent revenues and annual inspection reports, among other items. This review evaluates whether the properties are performing at a consistent and acceptable level to secure the debt. Mortgages are rated for the purpose of quantifying the level of risk. Those loans with higher risk are placed on a watch list and are closely monitored for collateral deficiency or other credit events that may lead to a potential loss of principal or interest. The Company defines delinquent mortgage loans consistent with industry practice as 30 days past due. Interest on loans is recognized on an accrual basis at the applicable interest rate on the principal amount outstanding. Loan origination fees and direct costs, as well as premiums and discounts, are amortized as level yield adjustments over the respective loan terms. Unamortized net fees or costs are recognized upon early repayment of the loans. Loan commitment fees are deferred and amortized on an effective yield basis over the term of the loan. We establish mortgage loan valuation allowances both on a loan specific basis for those loans considered impaired where a property specific or market specific risk has been identified that could likely result in a future loss, as well as for pools of loans with similar risk characteristics where a property specific or market specific risk has not been identified, but for which we expect to incur a loss. Accordingly, a valuation allowance is provided to absorb these estimated probable credit losses. As of September 30, 2016 and 2015, the Company did not identify any specific loans that were impaired. The determination of the amount of valuation allowances is based upon our periodic evaluation and assessment of inherent risks associated with our loan portfolios. Such evaluations and assessments are based upon several factors, including our experience for loan losses, defaults and loss severity, and loss expectations for loans with similar risk characteristics. We evaluate and monitor loan-to-value ("LTV") ratios and debt service coverage ("DSC") ratios of our loans as indicators of potential risk of default in establishing our valuation allowance.
Derivative Financial Instruments	Derivative Financial Instruments The Company hedges certain portions of its exposure to product related equity market risk by entering into derivative transactions. All of such derivative instruments are recognized as either assets or liabilities in the accompanying Consolidated Balance Sheets at fair value. The change in fair value is recognized within “Net investment gains (losses)” in the accompanying Consolidated Statements of Operations . The Company purchases financial instruments and issues products that may contain embedded derivative instruments. If it is determined that the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is bifurcated from the host contract for measurement purposes. The embedded derivative is carried at fair value with changes in fair value reported in the accompanying Consolidated Statements of Operations . Reinsurance Related Embedded Derivatives FGL Insurance has a modified coinsurance arrangement with FSRCI, meaning that funds are withheld by FGL Insurance. This arrangement creates an obligation for FGL Insurance to pay FSRCI at a later date, which results in an embedded derivative. This embedded derivative is considered a total return swap with contractual returns that are attributable to the assets and liabilities associated with this reinsurance arrangement. The fair value of the total return swap is based on the change in fair value of the underlying assets held in the funds withheld portfolio. Investment results for the assets that support the coinsurance with funds withheld reinsurance arrangement, including gains and losses from sales, are passed directly to the reinsurer pursuant to contractual terms of the reinsurance arrangement. The reinsurance related embedded derivative is reported in “Other assets”, if in a net gain position, or "Other liabilities", if in a net loss position, on the Consolidated Balance Sheets and the related gains or losses are reported in “Net investment gains” on the Consolidated Statements of Operations.
Limited Partnership Investment	Limited Partnership Investment Our investment in a limited partnership is included in Other invested assets on our Consolidated Balance Sheets. We account for our investments in the limited partnership using the equity method to determine the carrying value. Income from the limited partnership is included in Net investment income in the accompanying Consolidated Statements of Operations. Recognition of income is delayed due to the availability of the related financial statements, which are obtained from the partnership’s general partner generally on a three-month delay. Management also meets quarterly with the general partner to determine whether any credit or other market events have occurred since prior quarter financial statements to ensure any material events are properly included in current quarter valuation and investment income. In addition, the impact of audit adjustments related to completion of calendar-year financial statement audits of the limited partnership are typically received during the third quarter of each fiscal year. Accordingly, our investment income from the limited partnership investment for any fiscal-year period may not include the complete impact of the change in the underlying net assets for the partnership for that fiscal-year period.
Intangible Assets	Intangible Assets The Company’s intangible assets include value of business acquired (“VOBA”), deferred acquisition cost (“DAC”) and deferred sales inducements (“DSI”). VOBA is an intangible asset that reflects the estimated fair value of in-force contracts in a life insurance company acquisition less the amount recorded as insurance contract liabilities. It represents the portion of the purchase price that is allocated to the value of the rights to receive future cash flows from the business in force at the acquisition date. DAC represents costs that are related directly to the successful sale of new or renewal insurance contracts, which may be deferred to the extent recoverable. These costs include incremental direct costs of successful contract acquisition, primarily commissions, as well as certain costs related directly to underwriting, policy issuance and processing. DSI represents up front bonus credits and vesting bonuses to policyholder account values, which are accounted for similarly to DAC and are recorded within the DAC asset balance. The methodology for determining the amortization of DAC and VOBA varies by product type. For all insurance contracts accounted for under long-duration contract deposit accounting, amortization is based on assumptions consistent with those used in the development of the underlying contract adjusted for emerging experience and expected trends. DAC and VOBA amortization are reported within “Amortization of intangibles” in the accompanying Consolidated Statements of Operations. DAC and VOBA for investment-type products and DAC for IUL products are generally amortized over the lives of the policies in relation to the incidence of estimated gross profits (“EGPs”) from investment income, surrender charges and other product fees, policy benefits, maintenance expenses, mortality net of reinsurance ceded and expense margins, and recognized gains (losses) on investments and changes in fair value of the coinsurance embedded derivative. Changes in assumptions can have a significant impact on DAC and VOBA balances and amortization rates. Due to the relative size and sensitivity to minor changes in underlying assumptions of DAC and VOBA balances, the Company performs quarterly and annual analyses of DAC and VOBA for the annuity and IUL businesses. The DAC and VOBA balances are also periodically evaluated for recoverability to ensure that the unamortized portion does not exceed the expected recoverable amounts. At each evaluation date, actual historical gross profits are reflected, and estimated future gross profits and related assumptions are evaluated for continued reasonableness. Any adjustment in estimated future gross profits requires that the amortization rate be revised (“unlocking”) retroactively to the date of the policy or contract issuance. The cumulative unlocking adjustment is recognized as a component of current period amortization. The carrying amounts of DAC and VOBA are adjusted for the effects of realized and unrealized gains and losses on fixed maturity securities classified as available-for-sale and certain derivatives and embedded derivatives. For investment-type products, the DAC and VOBA assets are adjusted for the impact of unrealized gains (losses) on investments as if these gains (losses) had been realized, with corresponding credits or charges included in AOCI. Amortization expense of DAC and VOBA reflects an assumption for an expected level of credit-related investment losses. When actual credit-related investment losses are realized, the Company performs a retrospective unlocking of DAC and VOBA amortization as actual margins vary from expected margins. This unlocking is reflected in the accompanying Consolidated Statements of Operations.
Reinsurance	Reinsurance The Company’s insurance subsidiaries enter into reinsurance agreements with other companies in the normal course of business. The assets, liabilities, premiums and benefits of certain reinsurance contracts are presented on a net basis in the accompanying Consolidated Balance Sheets and Consolidated Statements of Operations , respectively, when there is a right of offset explicit in the reinsurance agreements. All other reinsurance agreements are reported on a gross basis in the Company’s Consolidated Balance Sheets as an asset for amounts recoverable from reinsurers or as a component of other liabilities for amounts, such as premiums, owed to the reinsurers, with the exception of amounts for which the right of offset also exists. Premiums and benefits are reported net of insurance ceded. Front Street Re (Cayman) Ltd (“FSRCI”) Effective December 31, 2012, FGL Insurance entered into a reinsurance treaty with FSRCI, an indirect wholly-owned subsidiary of HRG, FGL’s parent, whereby FGL Insurance ceded 10% of its June 30, 2012 in-force annuity block business not already reinsured on a funds withheld basis. Effective September 17, 2014, FGL Insurance entered into a second reinsurance treaty with FSRCI whereby FGL Insurance ceded 30% of any new business of its multi-year guaranteed annuity block of business ("MYGA") issued effective September 17, 2014 and later on a funds withheld basis. Under the terms of the agreement, no initial ceding commission was paid as all of the underlying business is new business. The September 17, 2014 treaty was subsequently terminated as to new business effective April 30, 2015, but will remain in effect for policies ceded to FSRCI with an effective date between September 17, 2014 and April 30, 2015. Accordingly, policies issued with an effective date of May 1, 2015 and later will not be ceded to FSRCI.
Income Taxes	Income Taxes FGL and certain of its non-life insurance subsidiaries are included in the consolidated U.S. Federal income tax return of HRG. The Company’s life insurance subsidiaries file a consolidated life insurance income tax return. Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company assesses the recoverability of its deferred tax assets in each reporting period under the guidance outlined within Accounting Standards Codification (“ASC”) Topic 740, “Income Taxes”. The guidance requires an assessment of both positive and negative evidence in determining the realizability of deferred tax assets. A valuation allowance is required to reduce the Company’s deferred tax asset to an amount that is more likely than not to be realized. In determining the net deferred tax asset and valuation allowance, management is required to make judgments and estimates related to projections of future profitability. These judgments include the following: the timing and extent of the utilization of net operating loss carry-forwards, the reversals of temporary differences, and tax planning strategies. Because of the change in facts and circumstances described in "Note 11. Income Taxes" to the Company’s Consolidated Financial Statements , during the year ended September 30, 2014 the Company determined that a portion of its existing deferred tax assets that had previously had a valuation allowance placed against them, were now more likely than not recoverable. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company has the ability and intent to recover in a tax-free manner assets (or liabilities) with book/tax basis differences for which no deferred taxes have been provided, in accordance with ASC Topic 740 "Income Taxes". The Company applies the accounting guidance for uncertain tax positions which prescribes a minimum recognition threshold a tax position is required to meet before being recognized in the financial statements. The guidance also provides information on de-recognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. Accrued interest expense and penalties related to uncertain tax positions are recorded in “Income tax expense (benefit)” in the Company’s Consolidated Statements of Operations . The Company had no unrecognized tax benefits related to uncertain tax positions as of September 30, 2016 and 2015 .
Contractholder Funds	Contractholder Funds The liabilities for contractholder funds for deferred annuities, IUL and UL policies consist of contract account balances that accrue to the benefit of the contractholders. The liabilities for FIAs consist of the value of the host contract plus the value of the embedded derivative. The embedded derivative is carried at fair value in “Contractholder funds” in the accompanying Consolidated Balance Sheets with changes in fair value reported in the accompanying Consolidated Statements of Operations. Liabilities for immediate annuities without life contingencies are recorded at the present value of future benefits. Liabilities for the secondary guarantees on UL-type products or Investment-type contracts are calculated by multiplying the benefit ratio by the cumulative assessments recorded from contract inception through the balance sheet date less the cumulative secondary guarantee benefit payments plus interest. If experience or assumption changes result in a new benefit ratio, the reserves are adjusted to reflect the changes in a manner similar to the unlocking of DAC and VOBA. The accounting for secondary guarantee benefits impacts, and is impacted by, EGPs used to calculate amortization of DAC and VOBA.
Future Policy Benefits	Future Policy Benefits The liabilities for future policy benefits and claim reserves for traditional life policies and life contingent pay-out annuity policies are computed using assumptions for investment yields, mortality and withdrawals based principally on generally accepted actuarial methods and assumptions at the time of contract issue. Investment yield assumptions for traditional direct life reserves for all contracts range from 5.8% to 6.2% . The investment yield assumptions for life contingent pay-out annuities range from 0.8% to 6.0% .
Federal Home Loan Bank of Atlanta Agreements	Federal Home Loan Bank of Atlanta Agreements Contractholder funds include funds related to funding agreements that have been issued by the Company to the Federal Home Loan Bank of Atlanta (“FHLB”) as a funding medium for single premium funding agreements.
Commitments and Contingencies	Commitments and Contingencies Contingencies arising from environmental remediation costs, regulatory judgments, claims, assessments, guarantees, litigation, recourse reserves, fines, penalties and other sources are recorded when deemed probable and reasonably estimable.
Reclassifications and Retrospective Adjustments	Reclassifications and Retrospective Adjustments Certain prior year amounts have been reclassified or combined to conform to the current year presentation. These reclassifications and combinations had no effect on previously reported results of operations or operating cash flows.
Adoption of New Accounting Pronouncements	Adoption of New Accounting Pronouncements Improvements to Employee Share-Based Payment Accounting In March 2016, the Financial Accounting Standards Board ("FASB") issued amended guidance (Accounting Standards Update ("ASU") 2016-09, Compensation - Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting) , effective for fiscal years beginning after December 15, 2016 and interim periods within those fiscal years. ASU 2016-09 simplifies certain aspects of accounting for share-based awards issued to employees, including income taxes consequences, cash flow presentations of excess tax benefits and employee withheld taxes paid, and an entity forfeiture policy election. The amendments in this ASU may be early adopted during any interim or annual period. Amendments related to timing of when excess tax benefits are recognized, minimum statutory withholding requirements, and forfeitures should be applied using a modified retrospective transition method by means of a cumulative-effect adjustment to equity as of the beginning of the period in which the guidance is adopted. Amendments related to the presentation of employee taxes paid on the statement of cash flows when an employer withholds shares to meet the minimum statutory withholding requirement should be applied retrospectively. Amendments requiring recognition of excess tax benefits and tax deficiencies in the income statement should be applied prospectively. The amendments related to the presentation of excess tax benefits on the statement of cash flows may be applied using either a prospective transition method or a retrospective transition method. The Company early adopted this guidance effective October 1, 2015. The Company elected to account for forfeitures as they occur and to use a prospective transition method for the presentation of excess tax benefits on the statement of cash flows. The adoption of ASU 2016-09 did not have a material effect on the Company's financial statements and related disclosures. Future Adoption of Accounting Pronouncements Revenue from Contracts with Customers In May 2014, the FASB issued new guidance on Revenue Recognition (ASU 2014-09, Revenue from Contracts with Customers (Topic 606) ), effective for fiscal years beginning after December 15, 2016 and interim periods within those years. In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers (Topic 606) - Deferral of the Effective Date , which defers the effective date of ASU 2014-09 by one year. The FASB also issued the following ASUs which clarify the guidance in ASU 2014-09: • ASU 2016-08 - Revenue from Contracts with Customers (Topic 606) - Principal versus Agent Considerations (Reporting Revenue Gross versus Net) issued in March 2016 • ASU 2016-10 - Revenue from Contracts with Customers (Topic 606) - Identifying Performance Obligations and Licensing issued in April 2016 • ASU 2016-11 - Revenue Recognition (Topic 605) and Derivatives and Hedging (Topic 815) - Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2016 EITF Meeting issued in May 2016 • ASU 2016-12 - Revenue from Contracts with Customers (Topic 606) - Narrow-Scope Improvements and Practical Expedients issued in May 2016 The guidance in ASU 2014-09 and the related ASUs supersedes the revenue recognition requirements in Topic 605, Revenue Recognition , and most industry-specific guidance unless the contracts are within the scope of other standards (for example, financial instruments, insurance contracts or lease contracts). The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance establishes a five-step process to achieve this core principle. These standards may be early adopted. The amendments should be applied using either of two methods: retrospective to each prior reporting period presented with certain practical expedients, or retrospective with the cumulative effect of initial application recognized at the date of initial application subject to certain additional disclosures. The Company will not early adopt these standards. The Company expects that the adoption of these standards will have an insignificant impact on its consolidated financial statements as the Company’s primary sources of revenue, insurance contracts and financial instruments, are excluded from the scope of these standards. Share-Based Payments When a Performance Target is achieved after the Requisite Service Period In June 2014, the FASB issued new guidance on Stock Compensation (ASU 2014-12, Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period ), effective for fiscal years beginning after December 15, 2015 and interim periods within those years. The new guidance will: • require performance targets that affect vesting and that could be achieved after the requisite service period to be treated as performance conditions. • exclude such performance targets from the grant-date fair value calculation of the award • require compensation cost to be recorded when it is probable the performance target will be reached and should represent the compensation cost attributable to period(s) for which the requisite service has already been rendered This standard may be early adopted and the amendments may be applied either prospectively or retrospectively. The Company will not early adopt this standard and has no material impact on its consolidated financial statements. Amendments to the Consolidation Analysis In February 2015, the FASB issued amended consolidation guidance (ASU 2015-02, Amendments to the Consolidation Analysis ), effective for fiscal years beginning after December 15, 2015. The amended guidance changes the consolidation analysis of reporting entities with VIE relationships by: • modifying the criteria used to evaluate whether limited partnerships and similar legal entities are VIEs or voting interest entities and revising the primary beneficiary determination of a VIE • eliminating the specialized consolidation model and guidance for limited partnerships thereby removing the presumption that a general partner should consolidate a limited partnership • reducing the criteria in the variable interest model contained in ASC Topic 810, Consolidation, that is used to evaluate whether the fees paid to a decision maker or service provider represents a variable interest • exempting reporting entities from consolidating money market funds that operate in accordance with Rule 2a-7 of the Investment Company Act of 1940 This standard may be early adopted and the amendments in this Update may be applied with a modified retrospective approach or retrospective approach. The Company will not early adopt this standard and is currently evaluating the impact of this new accounting guidance on its consolidated financial statements. Presentation of Debt Issuance Costs In April 2015, the FASB issued amended guidance (ASU 2015-03, Interest-Imputation of Interest (Subtopic 835-30 ), Simplifying the Presentation of Debt Issuance Costs ), effective for fiscal years beginning after December 15, 2015 and interim periods within those years. The amended guidance will require: • debt issuance costs related to a recognized debt liability to be presented on the balance sheet as a direct deduction from the debt liability, similar to the presentation of debt discounts or premiums • the cost of issuing debt to no longer be recorded as a separate asset, except when incurred before the receipt of the funding from the associated debt liability • debt issuance costs to be presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability, and the costs will be amortized to interest expense using the effective interest method. This standard may be early adopted. The amendments in this Update are required to be applied retrospectively to all prior periods presented in the financial statements. The Company will not early adopt this standard and is has no material impact on its consolidated financial statements. Accounting for Fees Paid in Cloud Computing Arrangements In April 2015, the FASB issued amended guidance (ASU 2015-05, Customer's Accounting for Fees Paid in a Cloud Computing Arrangement ), effective for fiscal years beginning after December 15, 2015 and interim periods within those years. Current GAAP does not include explicit guidance regarding a customer's accounting for fees paid in a cloud computing arrangement, which may include software as a service, platform as a service, infrastructure as a service, and other similar hosting arrangements. The amended guidance addresses whether a cloud computing arrangement includes a software license: • if a cloud computing arrangement includes a software license, the customer should account for the software license element of the arrangement consistent with the acquisition of other software licenses • if a cloud computing arrangement does not include a software license, the customer should account for the arrangement as a service contract This amended standard may be early adopted. The amendments in this Update may be applied retrospectively to all prior periods presented in the financial statements or prospectively to all arrangements entered into or materially modified after the effective date. The Company will not early adopt this standard and is currently evaluating the impact of this new accounting guidance on its consolidated financial statements. Investments That Calculate Net Asset Value per Share In May 2015, the FASB issued amended guidance (ASU 2015-07, Disclosures for Investments in Certain Entities That Calculate Net Asset Value per Share (or Its Equivalent) ), effective for fiscal years beginning after December 15, 2015 and interim periods within those years. Current GAAP requires that investments for which fair value is measured at net asset value (or its equivalent) using the practical expedient in Topic 820, "Fair Value Measurement" be categorized within the fair value hierarchy using criteria that differ from the criteria used to categorize other fair value measurements within the hierarchy. Currently, investments valued using the practical expedient are categorized within the fair value hierarchy on the basis of whether the investment is redeemable with the investee at net asset value on the measurement date, never redeemable with the investee at net asset value, or redeemable with the investee at net asset value at a future date. For investments that are redeemable with the investee at a future date, a reporting entity must take into account the length of time until those investments become redeemable to determine the classification within the fair value hierarchy. There is diversity in practice related to how certain investments measured at net asset value with redemption dates in the future (including periodic redemption dates) are categorized within the fair value hierarchy. Under the amendments in this Update: • investments for which fair value is measured at net asset value per share (or its equivalent) using the practical expedient should not be categorized in the fair value hierarchy. Removing those investments from the fair value hierarchy not only eliminates the diversity in practice resulting from the way in which investments measured at net asset value per share (or its equivalent) with future redemption dates are classified, but also ensures that all investments categorized in the fair value hierarchy are classified using a consistent approach • investments that calculate net asset value per share (or its equivalent), but for which the practical expedient is not applied will continue to be included in the fair value hierarchy The amendments in this Update are required to be applied retrospectively to all prior periods presented in the financial statements. The Company will not early adopt this standard and is currently evaluating the impact of this new accounting guidance on its consolidated financial statements. Amendments to Recognition and Measurement of Financial Assets and Financial Liabilities In January 2016, the FASB issued amended guidance (ASU 2016-01, Financial Instruments- Overall (Subtopic 825-10), Recognition and Measurement of Financial Assets and Financial Liabilities ), effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Notable amendments in this update will: • require all equity securities (other than equity investments accounted for under the equity method of accounting or requiring the consolidation of the investee) to be measured at fair value with changes in fair value recognized through net income. Equity securities may be measured at cost minus impairment that do not have readily determinable fair values • require qualitative assessment for impairment of equity investments without readily determinable fair values at each reporting period and, if the qualitative assessment indicates that impairment exists, to measure the investment at fair value • eliminate the requirement to disclose the methods and significant assumptions used to estimate fair value (which is currently required to be disclosed for financial instruments measured at amortized cost on the balance sheet) The amendments in this ASU should be applied by means of a cumulative-effect adjustment to the balance sheet as of the beginning of the fiscal year of adoption, and the amendments related to equity securities without readily determinable fair values should be applied prospectively to equity investments that exist as of the date of adoption. The Company will not early adopt this standard and is currently evaluating the impact of this new accounting guidance on its consolidated financial statements. Amendments to Lease Accounting In February 2016, the FASB issued amended guidance (ASU 2016-02, Leases (Topic 842) ), effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Notable amendments in this update will: • require entities to recognize the rights and obligations resulting from all leases or lease components of contracts, including operating leases, as lease assets and lease liabilities, with an exception allowed for leases with a term of 12 months or less • create a distinction between finance leases and operating leases, with classification criteria substantially similar to that for distinguishing between capital leases and operating leases under previous guidance • not retain the accounting model for leveraged leases under previous guidance for leases that commence after the effective date of ASU 2016-02 • provide additional guidance on separating the lease components from the nonlease components of a contract • require qualitative disclosures along with specific quantitative disclosures to provide information regarding the amount, timing, and uncertainty of cash flows arising from leases • include modifications to align lessor accounting with the changes to lessee accounting, as well as changes to the requirements of recognizing a transaction as a sale and leaseback transaction, however, these changes will have no impact on the Company's current lease arrangements The amendments in this ASU may be early adopted. The amendments are required to be applied at the beginning of the earliest period presented using a modified retrospective approach (including several optional practical expedients related to leases commenced before the effective date). The Company will not early adopt this standard and is currently evaluating the impact of this new accounting guidance on its consolidated financial statements. New Credit Loss Standard In June 2016, the FASB issued new guidance (ASU 2016-13, Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments) , effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Notable amendments in this update will change the accounting for impairment of most financial assets and certain other instruments in the following ways: • financial assets (or a group of financial assets) measured at amortized cost will be required to be presented at the net amount expected to be collected, with an allowance for credit losses deducted from the amortized cost basis, resulting in a net carrying value that reflects the amount the entity expects to collect on the financial asset at purchase • credit losses relating to available-for-sale fixed maturity securities will be recorded through an allowance for credit losses, rather than reductions in the amortized cost of the securities. The allowance methodology recognizes that value may be realized either through collection of contractual cash flows or through the sale of the security. Therefore, the amount of the allowance for credit losses will be limited to the amount by which fair value is below amortized cost because the classification as available for sale is premised on an investment strategy that recognizes that the investment could be sold at fair value, if cash collection would result in the realization of an amount less than fair value • the income statement will reflect the measurement of expected credit losses for newly recognized financial assets as well as the expected increases or decreases (including the reversal of previously recognized losses) of expected credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount • disclosures will be required to include information around how the credit loss allowance was developed, further details on information currently disclosed about credit quality of financing receivables and net investments in leases, and a rollforward of the allowance for credit losses for available-for-sale fixed maturity securities as well as an aging analysis for securities that are past due The amendments in this ASU may be early adopted during any interim or annual period beginning after December 15, 2018. The Company is currently evaluating the impact of this new accounting guidance on its consolidated financial statements. Statement of Cash Flows Classification of Certain Cash Receipts and Cash Payments In August 2016, the FASB issued new guidance (ASU 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments) , effective for fiscal years beginning after December 15, 2017 and interim periods within those fiscal years. Notable amendments in this update will change the classification of certain cash receipts and cash payments in the Statement of Cash Flows in the following ways: • cash payments for debt prepayment or debt extinguishment costs will be classified as cash outflows for financing activities • the settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing should be classified as follows: the portion of the cash payment attributable to the accreted interest related to the debt discount as cash outflows for operating activities, and the portion of the cash payment attributable to the principal as cash outflows for financing activities • a reporting entity must make an accounting policy election to classify distributions received from equity method investees using either: ◦ the cumulative earnings approach, which considers distributions received as returns on the investment and are classified as cash inflows from operating activities (with an exception when cumulative distributions received less distributions received in prior periods that were classified as returns of investment exceeds cumulative equity in earnings, in which case the current period distribution up to this excess amount will be considered a return of investment and classified as cash inflows from investing activities); or ◦ the nature of the distribution approach, which classifies distributions received based on the nature of the activity or activities of the investee that generated the distribution (would be considered either a return on investment and classified as cash inflows from operating activities or a return of investment and classified as cash inflows from investing activities) • in the absence of specific GAAP guidance, an entity should classify cash receipts and payments that have aspects of more than one class of cash flows by determining and appropriately classifying each separately identifiable source or use within the cash receipts and cash payments on the basis of the underlying cash flows. If cash receipts and payments have aspects of more than one class of cash flows and cannot be separated by source or use, the activity that is likely to be the predominant source or use of cash flows for the item will determine the classification. The amendments in this ASU may be early adopted, including adoption during an interim period. The amendments in the update should be applied using a retrospective transition method to each period presented (except where impracticable to apply retrospectively; those specific amendments would be applied prospectively as of the earliest date practicable). The Company is currently evaluating the impact of this new accounting guidance on its consolidated financial statements. Interests Held through Related Parties That Are under Common Control In October 2016, the FASB issued new guidance (ASU 2016-17, Consolidation (Topic 810), Interests Held through Related Parties That Are under Common Control) , effective for fiscal years beginning after December 15, 2016 and interim periods within those fiscal years. Under this update: • the characteristics of a primary beneficiary do not change, but the way in which their existence is determined does change • in determining whether there exists an obligation to absorb the losses of, or to receive benefits from, a VIE that could potentially be significant to the VIE (the second characteristic of a primary beneficiary), an entity will be required to include all of its direct variable interests in a VIE and, on a proportionate basis (as opposed to in its entirety as under current guidance), its indirect variable interests in a VIE held through related parties (including related parties under common control with the reporting entity) The amendments in this ASU may be early adopted during any interim or annual period, however, if adopted during an interim period other than the first interim period, the entity should reflect the cumulative effect of the accounting change as of the beginning of the fiscal year. The Company is currently evaluating the impact of this new accounting guidance on its consolidated financial statements. Income Taxes - Intra-Entity Transfers of Assets Other Than Inventory In October 2016, the FASB issued new guidance (ASU 2016-16, Income Taxes (Topic 740), Intra-Entity Transfers of Assets Other Than Inventory) , effective for fiscal years beginning after December 15, 2017 including interim periods within those fiscal years. Under this update: • an entity should recognize current and deferred income taxes for an intra-entity transfer of an asset other than inventory at the time of the transfer • the entity will no longer delay recognition of the income tax consequences of these types of intra-entity asset transfers until the asset has been sold to an outside party, as is practiced under current guidance The amendments in this ASU may be early adopted as of the beginning of an annual reporting period for which financial statements have not yet been issued, including interim financial statements. The Company does not have any intra-entity asset transfers, therefore this new accounting guidance will have no impact on its consolidated financial statements.

Basis of Presentation and Nat32

Basis of Presentation and Nature of Business (Tables)	12 Months Ended
	Sep. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Premiums and Annuity Deposits, net of Coinsurance, Not Included as Revenue [Table Text Block]	Premiums and annuity deposits (net of coinsurance), which are not included as revenues (except for traditional premiums) in the accompanying Consolidated Statements of Operations, collected during the years ended September 30, 2016 , 2015 and 2014 , by product type were as follows: Year ended September 30, Product Type 2016 2015 2014 Fixed indexed annuities $ 1,861 $ 2,185 $ 1,451 Fixed rate annuities 539 211 708 Single premium immediate annuities 28 16 10 Life insurance (a) 181 163 143 Total $ 2,609 $ 2,575 $ 2,312 (a) Life insurance includes Universal Life (“UL”) and traditional life insurance products.

Investments (Tables)

Investments (Tables)	12 Months Ended
	Sep. 30, 2016
Investments, Debt and Equity Securities [Abstract]
Consolidated Investments	The Company’s consolidated investments at September 30, 2016 and 2015 are summarized as follows: September 30, 2016 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Carrying Value Available-for sale securities Asset-backed securities $ 2,528 $ 16 $ (45 ) $ 2,499 $ 2,499 Commercial mortgage-backed securities 850 23 (9 ) 864 864 Corporates 10,712 760 (132 ) 11,340 11,340 Equities 640 47 (4 ) 683 683 Hybrids 1,356 77 (47 ) 1,386 1,386 Municipals 1,515 206 (4 ) 1,717 1,717 Residential mortgage-backed securities 1,327 63 (28 ) 1,362 1,362 U.S. Government 233 10 — 243 243 Total available-for-sale securities 19,161 1,202 (269 ) 20,094 20,094 Derivative investments 221 78 (23 ) 276 276 Commercial mortgage loans 595 — — 614 595 Other invested assets 60 — — 58 60 Total investments $ 20,037 $ 1,280 $ (292 ) $ 21,042 $ 21,025 September 30, 2015 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Carrying Value Available-for-sale securities Asset-backed securities $ 2,148 $ 5 $ (47 ) $ 2,106 $ 2,106 Commercial mortgage-backed securities 878 14 (10 ) 882 882 Corporates 9,533 351 (354 ) 9,530 9,530 Equities 597 27 (4 ) 620 620 Hybrids 1,211 45 (42 ) 1,214 1,214 Municipals 1,520 103 (15 ) 1,608 1,608 Residential mortgage-backed securities 2,099 89 (26 ) 2,162 2,162 U.S. Government 233 11 — 244 244 Total available-for-sale securities 18,219 645 (498 ) 18,366 18,366 Derivatives investments 218 13 (149 ) 82 82 Commercial mortgage loans 491 — — 490 491 Other invested assets 164 — (9 ) 153 155 Total investments $ 19,092 $ 658 $ (656 ) $ 19,091 $ 19,094
Amortized Cost and Fair Value of Fixed Maturity Available-for-Sale Securities	The amortized cost and fair value of fixed maturity available-for-sale securities by contractual maturities, as applicable, are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call or pre-pay obligations. September 30, 2016 Amortized Cost Fair Value Corporates, Non-structured Hybrids, Municipal and U.S. Government securities: Due in one year or less $ 261 $ 263 Due after one year through five years 1,863 1,919 Due after five years through ten years 3,233 3,407 Due after ten years 7,710 8,346 Subtotal 13,067 13,935 Other securities which provide for periodic payments: Asset-backed securities 2,528 2,499 Commercial mortgage-backed securities 850 864 Structured hybrids 749 751 Residential mortgage-backed securities 1,327 1,362 Subtotal 5,454 5,476 Total fixed maturity available-for-sale securities $ 18,521 $ 19,411
Fair Value and Gross Unrealized Losses of Available-for-Sale-Securities	The fair value and gross unrealized losses of available-for-sale securities, aggregated by investment category and duration of fair value below amortized cost, were as follows: September 30, 2016 Less than 12 months 12 months or longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Available-for-sale securities Asset-backed securities $ 352 $ (4 ) $ 1,368 $ (41 ) $ 1,720 $ (45 ) Commercial mortgage-backed securities 44 (1 ) 182 (8 ) 226 (9 ) Corporates 413 (9 ) 1,031 (123 ) 1,444 (132 ) Equities 51 (1 ) 75 (3 ) 126 (4 ) Hybrids 41 (2 ) 412 (45 ) 453 (47 ) Municipals 69 (2 ) 38 (2 ) 107 (4 ) Residential mortgage-backed securities 70 (1 ) 544 (27 ) 614 (28 ) Total available-for-sale securities $ 1,040 $ (20 ) $ 3,650 $ (249 ) $ 4,690 $ (269 ) Total number of available-for-sale securities in an unrealized loss position less than twelve months 193 Total number of available-for-sale securities in an unrealized loss position twelve months or longer 543 Total number of available-for-sale securities in an unrealized loss position 736 September 30, 2015 Less than 12 months 12 months or longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Available-for-sale securities Asset-backed securities $ 816 $ (14 ) $ 833 $ (33 ) $ 1,649 $ (47 ) Commercial mortgage-backed securities 262 (8 ) 133 (2 ) 395 (10 ) Corporates 2,342 (201 ) 1,328 (153 ) 3,670 (354 ) Equities 37 — 106 (4 ) 143 (4 ) Hybrids 88 (4 ) 542 (38 ) 630 (42 ) Municipals 220 (6 ) 192 (9 ) 412 (15 ) Residential mortgage-backed securities 423 (10 ) 294 (16 ) 717 (26 ) Total available-for-sale securities $ 4,188 $ (243 ) $ 3,428 $ (255 ) $ 7,616 $ (498 ) Total number of available-for-sale securities in an unrealized loss position less than twelve months 712 Total number of available-for-sale securities in an unrealized loss position twelve months or longer 396 Total number of available-for-sale securities in an unrealized loss position 1,108
Reconciliation of Other-than-Temporary Impairment on Fixed Maturity	The following table provides a reconciliation of the beginning and ending balances of the credit loss portion of OTTI on fixed maturity available-for-sale securities held by the Company for the years ended September 30, 2016 and 2015 , for which a portion of the OTTI was recognized in AOCI: Year ended September 30, 2016 2015 Beginning balance $ 3 $ 3 Increases attributable to credit losses on securities: OTTI was previously recognized — — OTTI was not previously recognized — — Ending balance $ 3 $ 3 A summary of the RSH-related impairments by investment is as follows: Year Ended September 30, 2015 Type Balance Sheet Classification OTTI Losses Collateralized loan obligations ("CLOs") (a) Fixed maturities, available-for-sale $ 25 Preferred equity (a) Equity securities, available-for-sale 21 Participations Other invested assets 35 OTTI, gross of reinsurance $ 81 CLOs (a) Fixed maturities, available-for-sale (1 ) Preferred equity (a) Equity securities, available-for-sale (21 ) OTTI, net of reinsurance $ 59 (a) Preferred equity and a portion of the CLOs are included in the FSRCI funds withheld portfolio, accordingly all income and losses on these assets are ceded to FSRCI. Details underlying write-downs taken as a result of OTTI that were recognized in "Net income" and included in net realized gains on securities were as follows: Year ended September 30, 2016 2015 2014 OTTI recognized in net income: Asset-backed securities $ 12 $ 36 $ — Corporates 6 2 — Related party loans 4 — — Residential mortgage-backed securities — 8 — Other invested assets 22 36 1 Total $ 44 $ 82 $ 1 A summary of the Salus-related impairments by investment is as follows: Year ended September 30, 2016 2015 Type Balance Sheet Classification OTTI Losses CLOs Fixed maturities, available-for-sale $ 12 $ 13 Preferred equity (a) Equity securities, available-for-sale — 9 Participations Other invested assets 24 2 OTTI, gross of reinsurance $ 36 $ 24 CLOs (a) Fixed maturities, available-for-sale (1 ) (1 ) Preferred equity (a) Equity securities, available-for-sale — (9 ) Participations (a) Other invested assets (2 ) (1 ) OTTI, net of reinsurance $ 33 $ 13 (a) Preferred equity and a portion of the CLOs and participations are included in the FSRCI funds withheld portfolio, accordingly all income and losses on these assets are ceded to FSRCI.
Schedule of Accounts, Notes, Loans and Financing Receivable	September 30, 2016 September 30, 2015 Gross balance commercial mortgage loans $ 596 $ 492 Allowance for loan loss (1 ) (1 ) Net balance commercial mortgage loans $ 595 $ 491 The distribution of CMLs, gross of valuation allowances, by property type and geographic region is reflected in the following tables: September 30, 2016 September 30, 2015 Gross Carrying Value % of Total Gross Carrying Value % of Total Property Type: Funeral Home $ 1 — % $ 1 — % Hotel 23 4 % 13 3 % Industrial - General 58 10 % 38 8 % Industrial - Warehouse 64 11 % 76 15 % Multifamily 70 11 % 64 13 % Office 160 27 % 137 28 % Retail 220 37 % 163 33 % Total commercial mortgage loans, gross of valuation allowance $ 596 100 % $ 492 100 % Allowance for loan loss (1 ) (1 ) Total commercial mortgage loans $ 595 $ 491 U.S. Region: East North Central $ 137 23 % $ 121 25 % East South Central 21 4 % 12 2 % Middle Atlantic 97 16 % 87 18 % Mountain 67 12 % 42 9 % New England 14 2 % 9 2 % Pacific 136 23 % 113 23 % South Atlantic 67 11 % 69 13 % West North Central 14 2 % 14 3 % West South Central 43 7 % 25 5 % Total commercial mortgage loans, gross of valuation allowance $ 596 100 % $ 492 100 % Allowance for loan loss (1 ) (1 ) Total commercial mortgage loans $ 595 $ 491
Schedule of Investment in Mortgage Loans by Loan to Value and Debt Service Coverage Ratios	The following table presents the recorded investment in CMLs by LTV and DSC ratio categories and estimated fair value by the indicated loan-to-value ratios at September 30, 2016 and September 30, 2015 : Debt-Service Coverage Ratios Total Amount % of Total Estimated Fair Value % of Total >1.25 1.00 - 1.25 N/A(a) September 30, 2016 LTV Ratios: Less than 50% $ 158 $ 18 $ 1 $ 177 29 % $ 181 29 % 50% to 60% 189 — — 189 32 % 194 32 % 60% to 75% 230 — — 230 39 % 239 39 % Commercial mortgage loans $ 577 $ 18 $ 1 $ 596 100 % $ 614 100 % September 30, 2015 LTV Ratios: Less than 50% $ 115 $ — $ 11 $ 126 25 % $ 125 25 % 50% to 60% 161 20 — 181 37 % 180 37 % 60% to 75% 185 — — 185 38 % 185 38 % Commercial mortgage loans $ 461 $ 20 $ 11 $ 492 100 % $ 490 100 % (a) N/A - Current DSC ratio not available.
Past Due Financing Receivables	The following provides the current and past due composition of our CMLs: September 30, 2016 September 30, 2015 Current to 30 days $ 596 $ 492 Past due — — Total carrying value $ 596 $ 492
Net Investment Income	The major sources of “Net investment income” on the accompanying Consolidated Statements of Operations were as follows: Year ended September 30, 2016 2015 2014 Fixed maturity securities, available-for-sale $ 869 $ 799 $ 723 Equity securities, available-for-sale 32 33 23 Commercial mortgage loans 24 11 3 Related party loans 4 6 7 Invested cash and short-term investments 3 2 — Other investments 9 20 20 Gross investment income 941 871 776 Investment expense (18 ) (20 ) (16 ) Net investment income $ 923 $ 851 $ 760
Net Investment Gains	Details underlying “Net investment gains (losses)” reported on the accompanying Consolidated Statements of Operations were as follows: Year ended September 30, 2016 2015 2014 Net realized gains on fixed maturity available-for-sale securities $ 11 $ 11 $ 104 Realized gains (losses) on equity securities 1 — (1 ) Change in fair value of other derivatives and embedded derivatives — 7 2 Realized losses on other invested assets (26 ) (40 ) (2 ) Net realized (losses) gains on available-for-sale securities (14 ) (22 ) 103 Realized (losses) gains on certain derivative instruments (84 ) 108 209 Unrealized gains (losses) on certain derivative instruments 166 (215 ) 37 Change in fair value of reinsurance related embedded derivative (49 ) 92 (42 ) Realized gains (losses) on hedging derivatives and reinsurance-related embedded derivatives 33 (15 ) 204 Net investment gains (losses) $ 19 $ (37 ) $ 307

Derivative Financial Instrume34

Derivative Financial Instruments (Tables)	12 Months Ended
	Sep. 30, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Fair Value of Outstanding Derivative Contracts in Condensed Consolidated Balance Sheets	The carrying amounts of derivative instruments, including derivative instruments embedded in fixed indexed annuity ("FIA") contracts, is as follows: September 30, 2016 September 30, 2015 Assets: Derivative investments: Call options $ 276 $ 81 Futures contracts — 1 Other invested assets: Other derivatives and embedded derivatives 13 21 Other assets: Reinsurance related embedded derivative 119 168 $ 408 $ 271 Liabilities: Contractholder funds: FIA embedded derivative $ 2,383 $ 2,149 Funds withheld for reinsurance liabilities Call options payable to FSRCI 11 5 Other liabilities: Futures contracts — — $ 2,394 $ 2,154
Schedule of Change in Fair Value of Derivative Instruments	The change in fair value of derivative instruments included in the accompanying Consolidated Statements of Operations is as follows: Year ended September 30, 2016 2015 2014 Revenues: Net investment (losses) gains: Call options $ 74 $ (100 ) $ 220 Futures contracts 8 (7 ) 26 Other derivatives and embedded derivatives — 7 2 Reinsurance related embedded derivative (49 ) 92 (42 ) $ 33 $ (8 ) $ 206 Benefits and other changes in policy reserves: FIA embedded derivatives $ 234 $ 241 $ 363
FGL's Exposure to Credit Loss on Call Options Held	Information regarding the Company’s exposure to credit loss on the call options it holds is presented in the following table: September 30, 2016 September 30, 2015 Counterparty Credit Rating (Fitch/Moody's/S&P) (a) Notional Amount Fair Value Collateral Net Credit Risk Notional Amount Fair Value Collateral Net Credit Risk Merrill Lynch A/*/A $ 2,302 $ 55 $ 10 $ 45 $ 2,233 $ 16 $ — $ 16 Deutsche Bank */Baa3/BBB+ 1,620 46 12 34 2,482 26 — 26 Morgan Stanley */A1/A 2,952 87 58 29 4,086 35 7 28 Barclay's Bank */A2/A- 1,389 39 — 39 392 4 — 4 Canadian Imperial Bank of Commerce AA-/A3/A+ 1,623 49 48 1 — — — — Total $ 9,886 $ 276 $ 128 $ 148 $ 9,193 $ 81 $ 7 $ 74 (a) An * represents credit ratings that were not available.

Fair Value of Financial Instr35

Fair Value of Financial Instruments (Tables)	12 Months Ended
	Sep. 30, 2016
Fair Value Disclosures [Abstract]
Assets and Liabilities Carrying at Fair Value on Recurring Basis	The carrying amounts and estimated fair values of the Company’s financial instruments for which the disclosure of fair values is required, including financial assets and liabilities measured and carried at fair value on a recurring basis, with the exception of investment contracts, related party loans, portions of other invested assets and debt which are disclosed later within this footnote, are summarized according to the hierarchy previously described, as follows: September 30, 2016 Level 1 Level 2 Level 3 Fair Value Carrying Amount Assets Cash and cash equivalents $ 864 $ — $ — $ 864 $ 864 Fixed maturity securities, available-for-sale: Asset-backed securities — 2,327 172 2,499 2,499 Commercial mortgage-backed securities — 785 79 864 864 Corporates — 10,219 1,121 11,340 11,340 Hybrids — 1,386 — 1,386 1,386 Municipals — 1,676 41 1,717 1,717 Residential mortgage-backed securities — 1,362 — 1,362 1,362 U.S. Government 61 182 — 243 243 Equity securities, available-for-sale 22 617 44 683 683 Derivative financial instruments — 276 — 276 276 Reinsurance related embedded derivative, included in other assets — 119 — 119 119 Other invested assets — — 34 34 34 Total financial assets at fair value $ 947 $ 18,949 $ 1,491 $ 21,387 $ 21,387 Liabilities Derivatives: FIA embedded derivatives, included in contractholder funds $ — $ — $ 2,383 $ 2,383 $ 2,383 Call options payable for FSRCI, included in funds withheld for reinsurance liabilities — 11 — 11 11 Total financial liabilities at fair value $ — $ 11 $ 2,383 $ 2,394 $ 2,394 September 30, 2015 Level 1 Level 2 Level 3 Fair Value Carrying Amount Assets Cash and cash equivalents $ 502 $ — $ — $ 502 $ 502 Fixed maturity securities, available-for-sale: Asset-backed securities — 2,068 38 2,106 2,106 Commercial mortgage-backed securities — 738 144 882 882 Corporates — 8,566 964 9,530 9,530 Hybrids — 1,214 — 1,214 1,214 Municipals — 1,569 39 1,608 1,608 Residential mortgage-backed securities — 2,162 — 2,162 2,162 U.S. Government 60 184 — 244 244 Equity securities available-for-sale 26 560 34 620 620 Derivative financial instruments 1 81 — 82 82 Reinsurance related embedded derivative, included in other assets — 168 — 168 168 Other invested assets — 11 129 140 140 Total financial assets at fair value $ 589 $ 17,321 $ 1,348 $ 19,258 $ 19,258 Liabilities Derivatives: FIA embedded derivatives, included in contractholder funds $ — $ — $ 2,149 $ 2,149 $ 2,149 Call options payable for FSRCI, included in funds withheld for reinsurance liabilities — 5 — 5 5 Total financial liabilities at fair value $ — $ 5 $ 2,149 $ 2,154 $ 2,154 The following tables provide the carrying value and estimated fair value of our financial instruments that are carried on the Consolidated Balance Sheet at amounts other than fair value, summarized according to the fair value hierarchy previously described. September 30, 2016 Level 1 Level 2 Level 3 Total Estimated Fair Value Carrying Amount Assets Commercial mortgage loans $ — $ — $ 614 $ 614 $ 595 Policy loans, included in other invested assets — — 13 13 14 Limited partnership investment, included in other invested assets — — 12 12 12 Related party loans — — 71 71 71 Total $ — $ — $ 710 $ 710 $ 692 Liabilities Investment contracts, included in contractholder funds $ — $ — $ 14,884 $ 14,884 $ 16,868 Debt — 300 100 400 400 Total $ — $ 300 $ 14,984 $ 15,284 $ 17,268 September 30, 2015 Level 1 Level 2 Level 3 Total Estimated Fair Value Carrying Amount Assets Commercial mortgage loans $ — $ — $ 490 $ 490 $ 491 Policy loans, included in other invested assets — — 9 9 11 Limited partnership investment, included in other invested assets — — 4 4 4 Related party loans — — 78 78 78 Total $ — $ — $ 581 $ 581 $ 584 Liabilities Investment contracts, included in contractholder funds $ — $ — $ 14,126 $ 14,126 $ 15,621 Debt — 312 — 312 300 Total $ — $ 312 $ 14,126 $ 14,438 $ 15,921
Schedule of Unobservable Inputs Used for Level Three Fair Value Measurements of Financial Instruments on Recurring Basis	Quantitative information regarding significant unobservable inputs used for recurring Level 3 fair value measurements of financial instruments carried at fair value as of September 30, 2016 and 2015 are as follows: Fair Value at Range (Weighted average) September 30, 2016 Valuation Technique Unobservable Input(s) September 30, 2016 Assets Asset-backed securities $ 144 Broker-quoted Offered quotes 97.54% - 101.55% Asset-backed securities 9 Matrix Pricing Quoted prices 98.75% - 98.75% Asset-backed securities (Salus CLO equity tranche) 19 Third-Party Valuation Offered quotes 28.37% - 28.37% Discount rate 15.00% RSH Recovery 5.50% Other loan recoveries 0.00% - 100.00% Commercial mortgage-backed securities 75 Broker-quoted Offered quotes 104.31% - 122.19% Commercial mortgage-backed securities 4 Matrix Pricing Quoted prices 98.41% - 98.41% Corporates 920 Broker-quoted Offered quotes 50.00% - 118.33% Corporates 201 Matrix Pricing Quoted prices 99.00% - 150.23% Municipals 41 Broker-quoted Offered quotes 119.04% Equity securities available-for-sale 41 Net Asset Value Not applicable 100.00% Equity securities available-for-sale (Salus preferred equity) 3 Market-approach Yield 11.00% RSH Recovery 5.50% Discount rate 15.00% Salus CLO Equity 28.37% Other invested assets: Available-for-sale embedded derivative 13 Black-Scholes model Market value of AnchorPath fund 100.00% Loan participations - Other 2 Market Pricing Offered quotes 100.00% Loan participations - JSN Jewellery, Inc. 17 Liquidation value – 52.5% Recovery Estimate Recovery estimate (wind-down costs) 49.93% - 56.67% (52.50%) Loan participation - RadioShack (RSH) Corporation 2 Liquidation value – 5% Recovery Estimate Recovery estimate (wind-down costs) 1.36% - 14.28% Total $ 1,491 Liabilities Derivatives: FIA embedded derivatives, included in contractholder funds $ 2,383 Discounted Cash Flow Market value of option 0.00% - 26.64% SWAP rates 1.18% - 1.46% Mortality multiplier 80.00% - 80.00% Surrender rates 0.50% - 75.00% Non-performance spread 0.25% - 0.25% Future option budget 1.15% - 5.57% (2.91%) Total liabilities at fair value $ 2,383 Fair Value at Range (Weighted average) September 30, 2015 Valuation Technique Unobservable Input(s) September 30, 2015 Assets Asset-backed securities $ 10 Broker-quoted Offered quotes 100.37% - 107.84% Asset-backed securities (Salus CLO equity tranche) 28 Third-Party Valuation Offered quotes 41.80% Discount rate 15.00% Constant default rate 2.00% RSH Recovery 30.00% Other loan recoveries 4.00% - 100.00% Commercial mortgage-backed securities 144 Broker-quoted Offered quotes 99.32% - 119.00% Corporates 898 Broker-quoted Offered quotes 56.75% - 113.83% Corporates 66 Matrix Pricing Quoted prices 104.58% - 142.43% Municipals 39 Broker-quoted Offered quotes 111.47% Equity securities available-for-sale 25 Net Asset Value Not applicable 100.00% Equity securities available-for-sale 6 Matrix Pricing Quoted prices 100.00% Equity securities available-for-sale (Salus preferred equity) 3 Market-approach Yield 11.00% RSH recovery 30.00% Discount rate 15.00% Salus CLO Equity 41.80% Other invested assets: Available-for-sale embedded derivative 10 Black-Scholes model Market value of AnchorPath fund 100.00% Loan participations 104 Market Pricing Offered quotes 100.00% Salus participation - RSH Corporation 15 Liquidation value – 30% Recovery Estimate Recovery estimate (wind-down costs) 30.00% - 34.00% Total $ 1,348 Liabilities Derivatives: FIA embedded derivatives, included in contractholder funds $ 2,149 Discounted Cash Flow Market value of option 0.00% - 33.83% SWAP rates 1.38% - 2.00% Mortality multiplier 80.00% - 80.00% Surrender rates 0.50% - 75.00% Non-performance spread 0.25% - 0.25% Future option budget 1.19% - 5.25% (2.93%) Total liabilities at fair value $ 2,149
Changes in Fair Value of Financial Instruments - Assets	The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the years ended September 30, 2016 , 2015 and 2014 , respectively. This summary excludes any impact of amortization of VOBA and DAC. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology. Year ended September 30, 2016 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 38 $ (12 ) $ 3 $ 141 $ — $ (3 ) $ 5 $ 172 Commercial mortgage-backed securities 144 — 4 — — (3 ) (66 ) 79 Corporates 964 — 32 154 (3 ) (26 ) — 1,121 Hybrids — — — — — — — — Municipals 39 — 2 — — — — 41 Equity securities available-for-sale 34 — (1 ) 17 (6 ) — — 44 Other invested assets: Available-for-sale embedded derivative 10 3 — — — — — 13 Loan participations 119 (21 ) 9 54 — (140 ) — 21 Total assets at Level 3 fair value $ 1,348 $ (30 ) $ 49 $ 366 $ (9 ) $ (172 ) $ (61 ) $ 1,491 Liabilities FIA embedded derivatives, included in contractholder funds $ 2,149 $ 234 $ — $ — $ — $ — $ — $ 2,383 Total liabilities at Level 3 fair value $ 2,149 $ 234 $ — $ — $ — $ — $ — $ 2,383 (a) The net transfers out of Level 3 during the year ended September 30, 2016 were exclusively to Level 2. Year ended September 30, 2015 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 74 $ (37 ) $ 3 $ 73 $ (15 ) $ (31 ) $ (29 ) $ 38 Commercial mortgage-backed securities 83 — (2 ) 63 — — — 144 Corporates 834 4 10 202 (1 ) (61 ) (24 ) 964 Municipals 37 — 2 — — — — 39 Equity securities available-for-sale 40 (30 ) (1 ) 25 — — — 34 Other invested assets: Available-for-sale embedded derivative 11 (1 ) — — — — — 10 Loan participations 213 (39 ) (5 ) 88 — (138 ) — 119 Total assets at Level 3 fair value $ 1,292 $ (103 ) $ 7 $ 451 $ (16 ) $ (230 ) $ (53 ) $ 1,348 Liabilities FIA embedded derivatives, included in contractholder funds $ 1,908 $ 241 $ — $ — $ — $ — $ — $ 2,149 Total liabilities at Level 3 fair value $ 1,908 $ 241 $ — $ — $ — $ — $ — $ 2,149 (a) The net transfers out of Level 3 during the year ended September 30, 2015 were exclusively to Level 2. Year ended September 30, 2014 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Level 3 (a) Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 246 $ — $ (1 ) $ 36 $ — $ — $ (207 ) $ 74 Commercial mortgage-backed securities 6 — — 83 — — (6 ) 83 Corporates 461 — 19 382 (12 ) (2 ) (14 ) 834 Municipals — — 2 35 — — — 37 Equity securities available-for-sale — — 1 39 — — — 40 Other invested assets: Available-for-sale embedded derivative — — — 11 — — — 11 Loan participations 157 — (1 ) 187 — (130 ) — 213 Total assets at Level 3 fair value $ 870 $ — $ 20 $ 773 $ (12 ) $ (132 ) $ (227 ) $ 1,292 Liabilities FIA embedded derivatives, included in contractholder funds $ 1,545 $ 363 $ — $ — $ — $ — $ — $ 1,908 Total liabilities at Level 3 fair value $ 1,545 $ 363 $ — $ — $ — $ — $ — $ 1,908 (a) The net transfers out of Level 3 during the year ended September 30, 2014 were exclusively to Level 2.
Changes in Fair Value of Financial Instruments - Liabilities	The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the years ended September 30, 2016 , 2015 and 2014 , respectively. This summary excludes any impact of amortization of VOBA and DAC. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology. Year ended September 30, 2016 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 38 $ (12 ) $ 3 $ 141 $ — $ (3 ) $ 5 $ 172 Commercial mortgage-backed securities 144 — 4 — — (3 ) (66 ) 79 Corporates 964 — 32 154 (3 ) (26 ) — 1,121 Hybrids — — — — — — — — Municipals 39 — 2 — — — — 41 Equity securities available-for-sale 34 — (1 ) 17 (6 ) — — 44 Other invested assets: Available-for-sale embedded derivative 10 3 — — — — — 13 Loan participations 119 (21 ) 9 54 — (140 ) — 21 Total assets at Level 3 fair value $ 1,348 $ (30 ) $ 49 $ 366 $ (9 ) $ (172 ) $ (61 ) $ 1,491 Liabilities FIA embedded derivatives, included in contractholder funds $ 2,149 $ 234 $ — $ — $ — $ — $ — $ 2,383 Total liabilities at Level 3 fair value $ 2,149 $ 234 $ — $ — $ — $ — $ — $ 2,383 (a) The net transfers out of Level 3 during the year ended September 30, 2016 were exclusively to Level 2. Year ended September 30, 2015 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 74 $ (37 ) $ 3 $ 73 $ (15 ) $ (31 ) $ (29 ) $ 38 Commercial mortgage-backed securities 83 — (2 ) 63 — — — 144 Corporates 834 4 10 202 (1 ) (61 ) (24 ) 964 Municipals 37 — 2 — — — — 39 Equity securities available-for-sale 40 (30 ) (1 ) 25 — — — 34 Other invested assets: Available-for-sale embedded derivative 11 (1 ) — — — — — 10 Loan participations 213 (39 ) (5 ) 88 — (138 ) — 119 Total assets at Level 3 fair value $ 1,292 $ (103 ) $ 7 $ 451 $ (16 ) $ (230 ) $ (53 ) $ 1,348 Liabilities FIA embedded derivatives, included in contractholder funds $ 1,908 $ 241 $ — $ — $ — $ — $ — $ 2,149 Total liabilities at Level 3 fair value $ 1,908 $ 241 $ — $ — $ — $ — $ — $ 2,149 (a) The net transfers out of Level 3 during the year ended September 30, 2015 were exclusively to Level 2. Year ended September 30, 2014 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Level 3 (a) Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 246 $ — $ (1 ) $ 36 $ — $ — $ (207 ) $ 74 Commercial mortgage-backed securities 6 — — 83 — — (6 ) 83 Corporates 461 — 19 382 (12 ) (2 ) (14 ) 834 Municipals — — 2 35 — — — 37 Equity securities available-for-sale — — 1 39 — — — 40 Other invested assets: Available-for-sale embedded derivative — — — 11 — — — 11 Loan participations 157 — (1 ) 187 — (130 ) — 213 Total assets at Level 3 fair value $ 870 $ — $ 20 $ 773 $ (12 ) $ (132 ) $ (227 ) $ 1,292 Liabilities FIA embedded derivatives, included in contractholder funds $ 1,545 $ 363 $ — $ — $ — $ — $ — $ 1,908 Total liabilities at Level 3 fair value $ 1,545 $ 363 $ — $ — $ — $ — $ — $ 1,908 (a) The net transfers out of Level 3 during the year ended September 30, 2014 were exclusively to Level 2.

Intangible Assets (Tables)

Intangible Assets (Tables)	12 Months Ended
	Sep. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Information Regarding VOBA and DAC	Information regarding VOBA and DAC which includes deferred sales inducement, is as follows: VOBA DAC Total Balance at September 30, 2015 $ 187 $ 801 $ 988 Deferrals — 350 350 Adjustments Unlocking 25 2 27 Interest 11 34 45 Amortization (41 ) (85 ) (126 ) Adjustment for unrealized investment gains (163 ) (95 ) (258 ) Balance at September 30, 2016 $ 19 $ 1,007 $ 1,026 Accumulated amortization $ 396 VOBA DAC Total Balance at September 30, 2014 $ 59 $ 456 $ 515 Deferrals — 317 317 Adjustments Unlocking 19 4 23 Interest 12 22 34 Amortization (68 ) (53 ) (121 ) Adjustment for unrealized investment losses 165 55 220 Balance at September 30, 2015 $ 187 $ 801 $ 988 Accumulated amortization $ 391 VOBA DAC Total Balance at September 30, 2013 $ 192 $ 331 $ 523 Deferrals — 238 238 Adjustments Unlocking 22 3 25 Interest 15 14 29 Amortization (87 ) (56 ) (143 ) Adjustment for unrealized investment gains (83 ) (74 ) (157 ) Balance at September 30, 2014 $ 59 $ 456 $ 515 Accumulated amortization $ 354
Estimated Amortization Expense for VOBA and DAC in Future Fiscal Periods	Estimated amortization expense for VOBA in future fiscal periods is as follows: Estimated Amortization Expense Fiscal Year VOBA 2017 $ 27 2018 25 2019 22 2020 18 2021 15 Thereafter 74

Debt (Tables)

Debt (Tables)	12 Months Ended
	Sep. 30, 2016
Debt Disclosure [Abstract]
Schedule of Debt	The Company's outstanding debt as of September 30, 2016 and 2015 is as follows: September 30, 2016 September 30, 2015 Debt $ 300 $ 300 Revolving credit facility 100 — The interest expense and amortization of debt issuance costs of the Company's debt for the years ended September 30, 2016 , 2015 and 2014 , respectively, were as follows: Year ended September 30, 2016 2015 2014 Interest Expense Amortization Interest Expense Amortization Interest Expense Amortization Debt $ 19 $ 2 $ 19 $ 4 $ 19 $ 4 Revolving credit facility — 1 — 1 — —

Equity (Tables)

Equity (Tables)	12 Months Ended
	Sep. 30, 2016
Equity [Abstract]
Dividends Declared	The Company declared and paid the following cash dividends during the years ended September 30, 2016 , 2015 , and 2014: Date Declared Date Paid Date Shareholders of record Shareholders of record (in thousands) Cash Dividend declared (per share) Total cash paid November 18, 2014 December 15, 2014 December 1, 2014 58,279 $0.065 $4 February 10, 2015 March 9, 2015 February 23, 2015 57,975 $0.065 $4 May 1, 2015 June 1, 2015 May 18, 2015 57,932 $0.065 $4 July 31, 2015 August 31, 2015 August 17, 2015 57,976 $0.065 $4 November 12, 2015 December 14, 2015 November 30, 2015 58,144 $0.065 $4 February 2, 2016 March 7, 2016 February 22, 2016 58,210 $0.065 $4 April 28, 2016 May 30, 2016 May 16, 2016 58,211 $0.065 $4 August 1, 2016 September 6, 2016 August 22, 2016 58,211 $0.065 $4

Stock Compensation (Tables)

Stock Compensation (Tables)	12 Months Ended
	Sep. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan	The Company recognized total stock compensation expense related to the FGL Plans and FGLH Plans as follows: Year ended September 30, 2016 2015 2014 FGL Plans Stock options $ — $ 1 $ — Restricted shares 2 6 1 Performance restricted stock units 10 3 1 Unrestricted shares — — 1 12 10 3 FGLH Plans Stock Incentive Plan - stock options — 1 6 2011 DEP — — 1 Amended and Restated Stock Incentive Plan - stock options 1 5 5 Amended and Restated Stock Incentive Plan - restricted stock units — 2 2 2012 DEP — 1 — 1 9 14 Total stock compensation expense 13 19 17 Related tax benefit 5 7 6 Net stock compensation expense $ 8 $ 12 $ 11
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan, Unrecognized	Total compensation expense related to the FGL Plans and FGLH Plans not yet recognized as of September 30, 2016 and the weighted-average period over which this expense will be recognized are as follows: Unrecognized Compensation Weighted Average Recognition FGL Plans Stock options $ — 1 Restricted shares 2 1 Total unrecognized stock compensation expense $ 2 1
Summary of Stock Options Outstanding and Related Activity	A summary of FGLH's outstanding stock options as of September 30, 2016 and related activity during the year then ended is as follows (share amount in thousands): FGLH Stock Option Awards Options Weighted Average Exercise Price Stock options outstanding at September 30, 2015 87 $ 45.04 Granted — — Exercised (4 ) 48.71 Forfeited or expired (1 ) 49.45 Stock options outstanding at September 30, 2016 82 44.82 Vested and exercisable at September 30, 2016 82 44.82 A summary of FGL’s outstanding stock options as of September 30, 2016 , and related activity during the period, is as follows (share amount in thousands): Stock Option Awards Options Weighted Average Exercise Price Stock options outstanding at September 30, 2015 317 $ 21.60 Granted 119 25.75 Exercised (77 ) 24.31 Forfeited or expired (13 ) 22.12 Stock options outstanding at September 30, 2016 346 22.40 Vested and exercisable at September 30, 2016 114 19.52
Assumptions Used in Determination of Grant Date Fair Values Using Black-Scholes Option Pricing Model	The following assumptions were used in the determination of the grant date fair values using the Black-Scholes option pricing model and based on the value of FGL's common stock: 2016 2015 2014 Weighted average fair value per options granted $1.01 $4.96 $3.76 Risk-free interest rate 0.42% 1.41%-1.50% 1.40% - 1.41% Assumed dividend yield 1.14% 1.18%-1.19% 1.30%-1.50% Expected option term 0.5 years 4.5 years 4.5 years Volatility 14.55% 25.00% 25.00% The following assumptions were used in the determination of the grant date fair values using the Black-Scholes option pricing model for the former Chief Executive Officer's modified stock options and based on the value of FGL's common stock: Weighted average fair value per option modified $2.53 Risk-free interest rate 0.20% Assumed dividend yield 1.18% Expected option term 0.75 years Volatility 25.00% At September 30, 2016 , the liability for vested stock options was based on the fair values of the outstanding options. The following assumptions were used in the determination of these fair values using the Black-Scholes option pricing model and based on the value of FGLH's common stock: 2016 2015 Weighted average stock option fair value $78.62 $74.99 FGLH common stock fair value $123.76 $122.02 FGL common stock value $23.19 $24.54 Risk-free interest rate 0.26% 0.48%-0.74% Assumed dividend yield 1.12% 1.16% Expected option term 0.25 years 1.50 - 2.25 years Volatility 15.0% 25.0%
Schedule of Nonvested Performance-based Units Activity	A summary of nonvested PRSUs outstanding as of September 30, 2016 , and related activity during the year then ended, is as follows (share amount in thousands): Performance Restricted Stock Units (PRSUs) Shares Weighted Average Grant PRSUs outstanding at September 30, 2015 515 $ 17.69 Granted 63 17.82 Vested (578 ) 17.71 Forfeited or expired — — PRSUs outstanding at September 30, 2016 — —
Summary of Restricted Stock and Restricted Stock Units Outstanding and Related Activity	A summary of FGLH's nonvested restricted stock units as of September 30, 2016 and related activity during the year then ended is as follows (share amount in thousands): Restricted Stock Awards Shares Weighted Average Grant Date Fair Value (a) Restricted shares outstanding at September 30, 2015 11 $ 49.57 Granted — — Vested (11 ) 49.57 Forfeited or expired — 49.45 Restricted shares outstanding at September 30, 2016 — — (a) Fair value is based on the value of FGLH’s common stock, not the value of the Company’s common stock. A summary of FGL’s nonvested restricted shares outstanding as of September 30, 2016 , and related activity during the year then ended, is as follows (share amount in thousands): Restricted Stock Awards Shares Weighted Average Grant Date Fair Value Restricted shares outstanding at September 30, 2015 246 $ 21.92 Granted 26 25.75 Vested (100 ) 21.32 Forfeited or expired (18 ) 22.46 Restricted shares outstanding at September 30, 2016 154 22.91

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Sep. 30, 2016
Income Tax Disclosure [Abstract]
Schedule of Income before Income Tax, Domestic and Foreign	Income tax (expense) benefit was calculated based upon the following components of income before income taxes: Year ended September 30, 2016 2015 2014 Pretax income (loss): United States $ 153 $ 182 $ 189 Outside the United States — — — Total pretax income $ 153 $ 182 $ 189
Schedule of Components of Income Tax Expense (Benefit)	The components of income tax (expense) benefit were as follows: Year ended September 30, 2016 2015 2014 Current: Federal $ (5 ) $ (14 ) $ (51 ) State — — — Total current $ (5 ) $ (14 ) $ (51 ) Deferred: Federal $ (51 ) $ (50 ) $ 25 State — — — Total deferred $ (51 ) $ (50 ) $ 25 Income tax (expense)/benefit $ (56 ) $ (64 ) $ (26 )
Schedule of Effective Income Tax Rate Reconciliation	The difference between income taxes expected at the U.S. Federal statutory income tax rate of 35% and reported income tax (expense) benefit is summarized as follows: Year ended September 30, 2016 2015 2014 Expected income tax (expense)/benefit at Federal statutory rate $ (54 ) $ (64 ) $ (66 ) Valuation allowance for deferred tax assets 69 (1 ) 40 Amortization of low income housing tax credits (2 ) (1 ) — Benefit on LIHTC under proportional amortization method 3 1 — Write off of expired capital loss carryforward (73 ) — — Other 1 1 — Reported income tax (expense)/benefit $ (56 ) $ (64 ) $ (26 ) Effective tax rate 37 % 35 % 14 %
Schedule of Deferred Tax Assets and Liabilities	The following table is a summary of the components of deferred income tax assets and liabilities: Year ended September 30, 2016 2015 Deferred tax assets: Net operating loss, credit and capital loss carryforwards $ 93 $ 169 Insurance reserves and claim related adjustments 511 424 Investments — 24 Other 44 32 Valuation allowance (51 ) (120 ) Total deferred tax assets $ 597 $ 529 Deferred tax liabilities: Value of business acquired $ (7 ) $ (65 ) Investments (312 ) — Deferred acquisition costs (277 ) (209 ) Other (11 ) (27 ) Total deferred tax liabilities $ (607 ) $ (301 ) Net deferred tax assets and (liabilities) $ (10 ) $ 228

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Sep. 30, 2016
Commitments and Contingencies Disclosure [Abstract]
Summary of Unfunded Commitments	A summary of unfunded commitments by invested asset class are included below: Asset Type September 30, 2016 Other invested assets $ 55 Fixed maturity securities, available-for-sale 16 Other assets 32 Total $ 103
Schedule of Minimum Rental Commitments	As of September 30, 2016 , the minimum rental commitments under the non-cancelable leases are as follows: Fiscal Year Amount 2017 $ 2 2018 2 2019 2 2020 2 2021 1 Thereafter — Total $ 9

Reinsurance (Tables)

Reinsurance (Tables)	12 Months Ended
	Sep. 30, 2016
Reinsurance Disclosures [Abstract]
Effect of Reinsurance on Premiums Earned, Benefits Incurred and Reserve Changes	The effect of reinsurance on premiums earned, benefits incurred and reserve changes (net benefits incurred) for the years ended September 30, 2016 , 2015 and 2014 were as follows: Year ended September 30, 2016 2015 2014 Net Premiums Earned Net Benefits Incurred Net Premiums Earned Net Benefits Incurred Net Premiums Earned Net Benefits Incurred Direct $ 261 $ 1,069 $ 260 $ 833 $ 267 $ 1,103 Assumed 1 1 — — 36 28 Ceded (192 ) (279 ) (202 ) (255 ) (247 ) (343 ) Net $ 70 $ 791 $ 58 $ 578 $ 56 $ 788

Related Party Transactions (Tab

Related Party Transactions (Tables)	12 Months Ended
	Sep. 30, 2016
Related Party Transactions [Abstract]
Schedule of Related Party Transactions	The Company’s related party investments as of September 30, 2016 and 2015 , and related net investment income for the years ended September 30, 2016 , 2015 , and 2014 are summarized as follows: September 30, 2016 Type Balance Sheet Classification Asset carrying value Accrued Investment Income Total carrying value Salus CLOs Fixed maturities, available for sale $ 19 $ — $ 19 Fortress Investment Group CLOs Fixed maturities, available for sale 225 2 227 Salus preferred equity (a) Equity securities, available for sale 3 — 3 Salus participations (b) Other invested assets 21 — 21 HGI energy loan (c) Related party loans 71 — 71 (a) Salus preferred equity is included in the FSRCI funds withheld portfolio, accordingly all income on this asset is ceded to FSRCI. (b) Includes loan participations with 4 different borrowers with an average loan fair value of $5 as of September 30, 2016 . (c) The total HGI energy loan is included in the FSRCI funds withheld portfolio, accordingly the income related to this portion is ceded to FSRCI. September 30, 2015 Type Balance Sheet Classification Asset carrying value Accrued Investment Income Total carrying value Salus CLOs Fixed maturities, available for sale $ 245 $ — $ 245 Fortress Investment Group CLOs Fixed maturities, available for sale 181 2 183 Salus preferred equity (a) Equity securities, available for sale 3 — 3 Salus participations (b) Other invested assets 110 1 111 EIC participations Other invested assets 9 — 9 Foreign exchange derivatives and embedded derivatives Other invested assets 11 — 11 HGI energy loan (c) Related party loans 70 1 71 Salus 2012 participations Related party loans 4 — 4 Salus promissory note Related party loans 3 — 3 (a) Salus preferred equity is included in the FSRCI funds withheld portfolio, accordingly all income on this asset is ceded to FSRCI. (b) Includes loan participations with 17 different borrowers with an average loan fair value of $6 as of September 30, 2015 (c) $20 of the total HGI energy loan is included in the FSRCI funds withheld portfolio, accordingly the income related to this portion is ceded to FSRCI. Year ended September 30, 2016 2015 2014 Type Investment Income Classification Net investment income Net investment income Net investment income Salus CLOs Fixed maturities $ 9 $ 11 $ 13 Fortress Investment Group CLOs Fixed maturities 11 8 2 Leucadia National Corporation Fixed maturities — — 1 Jefferies Group Inc. Fixed maturities — — 1 Salus preferred equity Equity securities — — 2 Salus participations Other invested assets 4 15 19 EIC participations Other invested assets 1 — — HGI energy loan Related party loans 4 5 6 Salus 2012 participations Related party loans — — 1 Salus promissory note Related party loans — 1 1 Salus revolver Related party loans — — 1 Below are the ceded operating results to FSRCI for the year ended September 30, 2016 , 2015 and 2014 : Revenues: Year ended September 30, 2016 Year ended September 30, 2015 Year ended September 30, 2014 Premiums $ 3 $ 1 $ 1 Net investment income 61 63 64 Net investment gains (losses) (8 ) (30 ) 25 Insurance and investment product fees 3 4 5 Total revenues 59 38 95 Benefits and expenses: Benefits and other changes in policy reserves (47 ) (42 ) (60 ) Acquisition & operating expenses, net of deferrals (4 ) (4 ) (6 ) Total benefits and expenses (51 ) (46 ) (66 ) Operating income (loss) $ 8 $ (8 ) $ 29

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
	Sep. 30, 2016
Earnings Per Share [Abstract]
Summary of Basic and Diluted EPS	The following table sets forth the computation of basic and diluted earnings per share (share amounts in thousands): Year ended September 30, 2016 2015 2014 Net income attributable to common shares - basic $ 97 $ 118 $ 163 Weighted-average common shares outstanding - basic 58,275 58,118 55,970 Dilutive effect of unvested restricted stock and unvested performance restricted stock 271 208 31 Dilutive effect of stock options 32 35 10 Weighted-average shares outstanding - diluted 58,578 58,361 56,011 Net income per common share: Basic $ 1.67 $ 2.03 $ 2.91 Diluted $ 1.66 $ 2.02 $ 2.90

Insurance Subsidiary Financia45

Insurance Subsidiary Financial Information and Regulatory Matters (Tables)	12 Months Ended
	Sep. 30, 2016
Insurance [Abstract]
Statutory Accounting Practices Disclosure	The Company’s principal insurance subsidiaries’ statutory financial statements are based on a December 31 year end. Statutory net income and statutory capital and surplus of the Company’s wholly owned insurance subsidiaries were as follows: Subsidiary (state of domicile)(a) FGL Insurance (IA)(b) FGL NY Insurance (NY) Statutory Net Income (loss): Year ended December 31, 2015 $ (53 ) $ (1 ) Year ended December 31, 2014 105 2 Year ended December 31, 2013 118 1 Statutory Capital and Surplus: December 31, 2015 $ 1,239 $ 59 December 31, 2014 1,212 61 (a) FGL NY Insurance is a subsidiary of FGL Insurance, and the columns should not be added together. (b) FGL Insurance Company re-domesticated to Iowa effective November 1, 2013. Prior to November 1, 2013, the Company was domiciled in the state of Maryland.

Other Liabilities (Tables)

Other Liabilities (Tables)	12 Months Ended
	Sep. 30, 2016
Other Liabilities Disclosure [Abstract]
Schedule Other Liabilities	Other liabilities consisted of the following: Year ended September 30, 2016 2015 Amounts payable for investment purchases $ 106 $ 125 Retained asset account 221 213 Option collateral liabilities 118 7 Remittances and items not allocated 77 42 Amounts payable to reinsurers 36 17 Accrued expenses 60 43 Deferred reinsurance revenue 25 27 Other 103 89 Total $ 746 $ 563

Quarterly Results (Unaudited) (

Quarterly Results (Unaudited) (Tables)	12 Months Ended
	Sep. 30, 2016
Quarterly Financial Information Disclosure [Abstract]
Schedule of Quarterly Financial Information	Unaudited quarterly results of operations are summarized below. Quarter Ended September 30, 2016 June 30, 2016 March 31, 2016 December 31, 2015 (Dollars in millions, except per share data) Premiums $ 18 $ 21 $ 16 $ 15 Net investment income 238 236 227 222 Net realized gains (losses) 26 (28 ) (42 ) 63 Insurance and investment product fees and other 34 32 32 29 Total revenue 316 261 233 329 Total expenses 262 240 212 250 Net income 30 10 9 48 Net income per common share - basic 0.52 0.16 0.16 0.82 Net income per common share - diluted 0.52 0.16 0.16 0.82 Quarter Ended September 30, 2015 June 30, 2015 March 31, 2015 December 31, 2014 (Dollars in millions, except per share data) Premiums $ 15 $ 17 $ 15 $ 11 Net investment income 223 212 208 208 Net realized (losses) gains (112 ) 74 (58 ) 59 Insurance and investment product fees and other 24 23 22 20 Total revenue 150 326 187 298 Total expenses 101 192 193 269 Net income (loss) 30 86 (12 ) 14 Net income (loss) per common share - basic 0.52 1.48 (0.21 ) 0.24 Net income (loss) per common share - diluted 0.51 1.48 (0.21 ) 0.24

Basis of Presentation and Nat48

Basis of Presentation and Nature of Business - Narrative (Details) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Sep. 30, 2016segmentshares	Nov. 08, 2015USD ($)$ / sharesshares
Effects of Reinsurance [Line Items]
Shareholders' disclosure, common stock (in shares) | shares	47,000	47,000
Shareholders' disclosure, ownership percentage	80.00%	81.00%
Reporting segments | segment	1
Anbang Insurance Group Co., Ltd.
Effects of Reinsurance [Line Items]
Termination fee payable for termination of merger agreement | $		$ 51
FGL | Anbang Insurance Group Co., Ltd.
Effects of Reinsurance [Line Items]
Acquisition share price (in USD per share) | $ / shares		$ 26.80

Basis of Presentation and Nat49

Basis of Presentation and Nature of Business - Schedule of Premiums and Annuity Deposits, net of Coinsurance, Not Included in Revenue (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Premiums and annuity deposits, net of coinsurance, not included as revenue, excluding traditional premiums	$ 2,609	$ 2,575	$ 2,312
Fixed indexed annuities
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Premiums and annuity deposits, net of coinsurance, not included as revenue, excluding traditional premiums	1,861	2,185	1,451
Fixed rate annuities
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Premiums and annuity deposits, net of coinsurance, not included as revenue, excluding traditional premiums	539	211	708
Single premium immediate annuities
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Premiums and annuity deposits, net of coinsurance, not included as revenue, excluding traditional premiums	28	16	10
Traditional life insurance premiums
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Premiums and annuity deposits, net of coinsurance, not included as revenue, excluding traditional premiums	$ 181	$ 163	$ 143

Significant Accounting Polici50

Significant Accounting Policies and Practices (Details) - USD ($)	Sep. 17, 2014	Dec. 31, 2012	Sep. 30, 2016	Jun. 28, 2016	Sep. 30, 2015
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Cash and cash equivalents			$ 465,000,000		$ 0
Unrecognized tax benefits			0		0
FHLB advances, short-term				$ 157,000,000
FHLB advances, short-term, interest rate				0.73%
Reserves for funding agreements			584,000,000		482,000,000
FHLB collateral pledged			$ 649,000,000		$ 524,000,000
Fixed indexed annuities | Minimum
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Interest crediting rates associated with subsidiaries			0.00%
Fixed indexed annuities | Maximum
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Interest crediting rates associated with subsidiaries			6.00%
Indexed Universal Life | Minimum
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Interest crediting rates associated with subsidiaries			0.00%
Indexed Universal Life | Maximum
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Interest crediting rates associated with subsidiaries			4.50%
Traditional life insurance premiums | Minimum
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Estimated investment yield			5.80%
Traditional life insurance premiums | Maximum
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Estimated investment yield			6.20%
Life Contingent Payout Annuity | Minimum
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Estimated investment yield			0.80%
Life Contingent Payout Annuity | Maximum
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Estimated investment yield			6.00%
Fgl Reinsurance Agreement With Fsr [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Reinsurance arrangement in percentage	30.00%	10.00%

Significant Risks and Uncerta51

Significant Risks and Uncertainties - Narrative (Details) $ in Millions	12 Months Ended
	Sep. 30, 2016USD ($)insurers	Sep. 30, 2015USD ($)insurers	Sep. 30, 2014USD ($)
Concentration Risk [Line Items]
Change in DAC and VOBA amortization	$ 20	$ 55	$ (2)
Increase/(decrease) in liability for annuity contracts	$ 22	18	$ (4)
FGL's investment securities in the banking industry		$ 170
Exposure of FGL's invested assets		1.00%
Number of issuers in investment | insurers	0	1
Wilton Reassurance Company
Concentration Risk [Line Items]
Net amount recoverable	$ 1,523
Front Street RE (Cayman) Ltd.
Concentration Risk [Line Items]
Net amount recoverable	1,120
All Financial Instruments
Concentration Risk [Line Items]
FGL's investment securities in the banking industry	$ 2,448	$ 1,979
Exposure of FGL's invested assets	12.00%	10.00%
Number of issuers in investment | insurers	97
Percentage of total holdings in industry	34.00%
Single Issuer
Concentration Risk [Line Items]
FGL's investment securities in the banking industry	$ 171	$ 0
Exposure of FGL's invested assets	1.00%	1.00%
Banking Industry | All Financial Instruments
Concentration Risk [Line Items]
Investment securities held by subsidiaries subject to specialized industry accounting principles, amortized cost	$ 2,352	$ 1,962

Investments - Available-for-Sa

Investments - Available-for-Sale Securities Table (Details) - USD ($) $ in Millions	Sep. 30, 2016	Sep. 30, 2015
Available-for-sale Securities, Fair Value to Amortized Cost Basis [Abstract]
Investment, Cost or Amortized Cost	$ 19,161	$ 18,219
Gross Unrealized Gains	1,202	645
Gross Unrealized Losses	(269)	(498)
Fair Value	20,094	18,366
Carrying Value	20,094	18,366
Investments, Derivatives, Fair Value to Amortized Cost Basis [Abstract]
Derivatives, Amortized Cost	221	218
Derivatives, Gross Unrealized Gain	78	13
Derivatives, Gross Unrealized Loss	(23)	(149)
Derivative Investments, Fair Value	276	82
Derivative investments, Carrying Value	276	82
Other Investments, Fair Value to Amortized Cost Basis [Abstract]
Commercial Mortgage Loans, Amortized Cost	595	491
Commercial Mortgage Loans, Gross Unrealized Gain	0	0
Commercial Mortgage Loans, Gross Unrealized Loss	0	0
Commercial Mortgage Loans, Fair Value	614	490
Commercial Mortgage Loans, Carrying Value	595	491
Investments, Cost or Amortized Cost	20,037	19,092
Investments, Gross Unrealized Gain	1,280	658
Investments, Gross Unrealized Loss	(292)	(656)
Investments, Fair Value Disclosure	21,042	19,091
Investments	21,025	19,094
Asset-backed securities
Available-for-sale Securities, Fair Value to Amortized Cost Basis [Abstract]
Investment, Cost or Amortized Cost	2,528	2,148
Gross Unrealized Gains	16	5
Gross Unrealized Losses	(45)	(47)
Fair Value	2,499	2,106
Carrying Value	2,499	2,106
Commercial mortgage-backed securities
Available-for-sale Securities, Fair Value to Amortized Cost Basis [Abstract]
Investment, Cost or Amortized Cost	850	878
Gross Unrealized Gains	23	14
Gross Unrealized Losses	(9)	(10)
Fair Value	864	882
Carrying Value	864	882
Corporates
Available-for-sale Securities, Fair Value to Amortized Cost Basis [Abstract]
Investment, Cost or Amortized Cost	10,712	9,533
Gross Unrealized Gains	760	351
Gross Unrealized Losses	(132)	(354)
Fair Value	11,340	9,530
Carrying Value	11,340	9,530
Equity securities, available-for-sale
Available-for-sale Securities, Fair Value to Amortized Cost Basis [Abstract]
Investment, Cost or Amortized Cost	640	597
Gross Unrealized Gains	47	27
Gross Unrealized Losses	(4)	(4)
Fair Value	683	620
Carrying Value	683	620
Hybrids
Available-for-sale Securities, Fair Value to Amortized Cost Basis [Abstract]
Investment, Cost or Amortized Cost	1,356	1,211
Gross Unrealized Gains	77	45
Gross Unrealized Losses	(47)	(42)
Fair Value	1,386	1,214
Carrying Value	1,386	1,214
Municipals
Available-for-sale Securities, Fair Value to Amortized Cost Basis [Abstract]
Investment, Cost or Amortized Cost	1,515	1,520
Gross Unrealized Gains	206	103
Gross Unrealized Losses	(4)	(15)
Fair Value	1,717	1,608
Carrying Value	1,717	1,608
Residential mortgage-backed securities
Available-for-sale Securities, Fair Value to Amortized Cost Basis [Abstract]
Investment, Cost or Amortized Cost	1,327	2,099
Gross Unrealized Gains	63	89
Gross Unrealized Losses	(28)	(26)
Fair Value	1,362	2,162
Carrying Value	1,362	2,162
U.S. Government
Available-for-sale Securities, Fair Value to Amortized Cost Basis [Abstract]
Investment, Cost or Amortized Cost	233	233
Gross Unrealized Gains	10	11
Gross Unrealized Losses	0	0
Fair Value	243	244
Carrying Value	243	244
Other invested assets
Available-for-sale Securities, Fair Value to Amortized Cost Basis [Abstract]
Investment, Cost or Amortized Cost	60	164
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	(9)
Fair Value	58	153
Carrying Value	$ 60	$ 155

Investments - Amortized Cost a

Investments - Amortized Cost and Fair Value of Fixed Maturity Available-for-Sale Securities (Details) - USD ($) $ in Millions	Sep. 30, 2016	Sep. 30, 2015
Schedule of Available-for-sale Securities [Line Items]
Due in one year or less, Amortized Cost	$ 261
Due after one year through five years, Amortized Cost	1,863
Due after five years through ten years, Amortized Cost	3,233
Due after ten years, Amortized Cost	7,710
Subtotal, Amortized Cost	13,067
Other securities which provide for periodic payments, Amortized Cost	5,454
Total fixed maturity available-for-sale securities, Amortized Cost	18,521	$ 17,622
Due in one year or less, Fair Value	263
Due after one year through five years, Fair Value	1,919
Due after five years through ten years, Fair Value	3,407
Due after ten years, Fair Value	8,346
Subtotal, Fair Value	13,935
Other securities which provide for periodic payments, Fair Value	5,476
Total fixed maturity available-for-sale securities, Fair Value	19,411
Asset-backed securities
Schedule of Available-for-sale Securities [Line Items]
Other securities which provide for periodic payments, Amortized Cost	2,528
Other securities which provide for periodic payments, Fair Value	2,499
Commercial mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Other securities which provide for periodic payments, Amortized Cost	850
Other securities which provide for periodic payments, Fair Value	864
Structured hybrids
Schedule of Available-for-sale Securities [Line Items]
Other securities which provide for periodic payments, Amortized Cost	749
Other securities which provide for periodic payments, Fair Value	751
Residential mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Other securities which provide for periodic payments, Amortized Cost	1,327
Other securities which provide for periodic payments, Fair Value	$ 1,362

Investments - Fair Value and G

Investments - Fair Value and Gross Unrealized Losses of Available-for-Sale Securities (Details) $ in Millions	Sep. 30, 2016USD ($)Security	Sep. 30, 2015USD ($)Security
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	$ 1,040	$ 4,188
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(20)	(243)
Available-for-sale securities, Fair Value, 12 months or longer	3,650	3,428
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(249)	(255)
Available-for-sale securities, Fair Value, Total	4,690	7,616
Available-for-sale Securities, Gross Unrealized Losses, Total	$ (269)	$ (498)
Total number of available-for-sale securities in an unrealized loss position less than twelve months | Security	193	712
Total number of available-for-sale securities in an unrealized loss position twelve months or longer | Security	543	396
Total number of available-for-sale securities in an unrealized loss position | Security	736	1,108
Asset-backed securities
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	$ 352	$ 816
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(4)	(14)
Available-for-sale securities, Fair Value, 12 months or longer	1,368	833
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(41)	(33)
Available-for-sale securities, Fair Value, Total	1,720	1,649
Available-for-sale Securities, Gross Unrealized Losses, Total	(45)	(47)
Commercial mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	44	262
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(1)	(8)
Available-for-sale securities, Fair Value, 12 months or longer	182	133
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(8)	(2)
Available-for-sale securities, Fair Value, Total	226	395
Available-for-sale Securities, Gross Unrealized Losses, Total	(9)	(10)
Corporates
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	413	2,342
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(9)	(201)
Available-for-sale securities, Fair Value, 12 months or longer	1,031	1,328
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(123)	(153)
Available-for-sale securities, Fair Value, Total	1,444	3,670
Available-for-sale Securities, Gross Unrealized Losses, Total	(132)	(354)
Equity securities, available-for-sale
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	51	37
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(1)
Available-for-sale securities, Fair Value, 12 months or longer	75	106
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(3)	(4)
Available-for-sale securities, Fair Value, Total	126	143
Available-for-sale Securities, Gross Unrealized Losses, Total	(4)	(4)
Hybrids
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	41	88
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(2)	(4)
Available-for-sale securities, Fair Value, 12 months or longer	412	542
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(45)	(38)
Available-for-sale securities, Fair Value, Total	453	630
Available-for-sale Securities, Gross Unrealized Losses, Total	(47)	(42)
Municipals
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	69	220
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(2)	(6)
Available-for-sale securities, Fair Value, 12 months or longer	38	192
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(2)	(9)
Available-for-sale securities, Fair Value, Total	107	412
Available-for-sale Securities, Gross Unrealized Losses, Total	(4)	(15)
Residential mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	70	423
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(1)	(10)
Available-for-sale securities, Fair Value, 12 months or longer	544	294
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(27)	(16)
Available-for-sale securities, Fair Value, Total	614	717
Available-for-sale Securities, Gross Unrealized Losses, Total	$ (28)	$ (26)

Investments - Reconciliation o

Investments - Reconciliation of Other than Temporary Impairment on Fixed Maturity (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Other than Temporary Impairment, Credit Losses Recognized in Earnings [Roll Forward]
Balance at the beginning of the period	$ 3	$ 3
Increases attributable to credit losses on securities:
OTTI was previously recognized	0	0
OTTI was not previously recognized	0	0
Balance at the end of the period	$ 3	$ 3

Investments - Other-than-Tempo

Investments - Other-than-Temporary Impairments (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Schedule of Investments [Line Items]
Total other-than-temporary impairments		$ 44	$ 82	$ 1
OTTI, gross of reinsurance		45	82	1
Asset-backed securities
Schedule of Investments [Line Items]
Total other-than-temporary impairments		12	36	0
Corporates
Schedule of Investments [Line Items]
Total other-than-temporary impairments		6	2	0
Related party loans
Schedule of Investments [Line Items]
Total other-than-temporary impairments		4	0	0
OTTI, gross of reinsurance		4
Residential mortgage-backed securities
Schedule of Investments [Line Items]
Total other-than-temporary impairments		0	8	0
Other invested assets
Schedule of Investments [Line Items]
Total other-than-temporary impairments		22	36	$ 1
Front Street RE (Cayman) Ltd.
Schedule of Investments [Line Items]
OTTI, gross of reinsurance		81
OTTI, net of reinsurance	$ 59	59
Salus Capital Partners L L C
Schedule of Investments [Line Items]
OTTI, gross of reinsurance		36	24
OTTI, net of reinsurance		33	13
Fixed maturity securities, available-for-sale | Front Street RE (Cayman) Ltd. | Collateralized Loan Obligations
Schedule of Investments [Line Items]
OTTI, gross of reinsurance		25
OTTI, reinsurance		(1)
Fixed maturity securities, available-for-sale | Salus Capital Partners L L C | Collateralized Loan Obligations
Schedule of Investments [Line Items]
OTTI, gross of reinsurance		12	13
OTTI, reinsurance		(1)	(1)
Equity Available For Sale Securities | Front Street RE (Cayman) Ltd. | Preferred Equity
Schedule of Investments [Line Items]
OTTI, gross of reinsurance		21
OTTI, reinsurance		(21)
Equity Available For Sale Securities | Salus Capital Partners L L C | Preferred Equity
Schedule of Investments [Line Items]
OTTI, gross of reinsurance		0	9
OTTI, reinsurance		0	(9)
Other invested assets
Schedule of Investments [Line Items]
OTTI, gross of reinsurance		22	36
Other invested assets | Front Street RE (Cayman) Ltd. | Participations
Schedule of Investments [Line Items]
OTTI, gross of reinsurance		35
Other invested assets | Salus Capital Partners L L C | Participations
Schedule of Investments [Line Items]
OTTI, gross of reinsurance		24	2
OTTI, reinsurance		$ (2)	$ (1)

Investments - Schedule of Comm

Investments - Schedule of Commercial Mortgage Loan Investment (Details) - USD ($) $ in Millions	Sep. 30, 2016	Sep. 30, 2015
Schedule of Investments [Line Items]
Commercial mortgage loans, current and past due	$ 0	$ 0
Commercial mortgage loans	$ 596	$ 492
Commercial mortgage loans, % of total	100.00%	100.00%
Allowance for loan loss	$ (1)	$ (1)
Total commercial mortgage loans	595	491
East North Central
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 137	$ 121
Commercial mortgage loans, % of total	23.00%	25.00%
East South Central
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 21	$ 12
Commercial mortgage loans, % of total	4.00%	2.00%
Middle Atlantic
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 97	$ 87
Commercial mortgage loans, % of total	16.00%	18.00%
Mountain
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 67	$ 42
Commercial mortgage loans, % of total	12.00%	9.00%
New England
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 14	$ 9
Commercial mortgage loans, % of total	2.00%	2.00%
Pacific
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 136	$ 113
Commercial mortgage loans, % of total	23.00%	23.00%
South Atlantic
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 67	$ 69
Commercial mortgage loans, % of total	11.00%	13.00%
West North Central
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 14	$ 14
Commercial mortgage loans, % of total	2.00%	3.00%
West South Central
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 43	$ 25
Commercial mortgage loans, % of total	7.00%	5.00%
Funeral Home
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 1	$ 1
Commercial mortgage loans, % of total	0.00%	0.00%
Hotel
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 23	$ 13
Commercial mortgage loans, % of total	4.00%	3.00%
Industrial - General
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 58	$ 38
Commercial mortgage loans, % of total	10.00%	8.00%
Industrial - Warehouse
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 64	$ 76
Commercial mortgage loans, % of total	11.00%	15.00%
Multifamily
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 70	$ 64
Commercial mortgage loans, % of total	11.00%	13.00%
Office
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 160	$ 137
Commercial mortgage loans, % of total	27.00%	28.00%
Retail
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 220	$ 163
Commercial mortgage loans, % of total	37.00%	33.00%
1 to 29 Days Past Due
Schedule of Investments [Line Items]
Commercial mortgage loans, current and past due	$ 596	$ 492
LTV Less Than 50 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 177	$ 126
Commercial mortgage loans, % of total	29.00%	25.00%
LTV 50 to 60 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 189	$ 181
Commercial mortgage loans, % of total	32.00%	37.00%
LTV 60 to 75 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 230	$ 185
Commercial mortgage loans, % of total	39.00%	38.00%
Greater than 1.25
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 577	$ 461
Greater than 1.25 | LTV Less Than 50 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	158	115
Greater than 1.25 | LTV 50 to 60 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	189	161
Greater than 1.25 | LTV 60 to 75 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	230	185
Greater than 1.00 but less than 1.25
Schedule of Investments [Line Items]
Commercial mortgage loans	18	20
Greater than 1.00 but less than 1.25 | LTV Less Than 50 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	18	0
Greater than 1.00 but less than 1.25 | LTV 50 to 60 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	0	20
Greater than 1.00 but less than 1.25 | LTV 60 to 75 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	0	0
Ratio Not Available
Schedule of Investments [Line Items]
Commercial mortgage loans	1	11
Ratio Not Available | LTV Less Than 50 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	1	11
Ratio Not Available | LTV 50 to 60 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	0	0
Ratio Not Available | LTV 60 to 75 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	0	0
Fair Value
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 614	$ 490
Commercial mortgage loans, % of total	100.00%	100.00%
Fair Value | LTV Less Than 50 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 181	$ 125
Commercial mortgage loans, % of total	29.00%	25.00%
Fair Value | LTV 50 to 60 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 194	$ 180
Commercial mortgage loans, % of total	32.00%	37.00%
Fair Value | LTV 60 to 75 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 239	$ 185
Commercial mortgage loans, % of total	39.00%	38.00%

Investments - Net Investment I

Investments - Net Investment Income (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Schedule of Investments [Line Items]
Gross investment income	$ 941	$ 871	$ 776
Investment expense	(18)	(20)	(16)
Net investment income	923	851	760
Fixed maturity securities, available-for-sale
Schedule of Investments [Line Items]
Gross investment income	869	799	723
Equity securities, available-for-sale
Schedule of Investments [Line Items]
Gross investment income	32	33	23
Commercial mortgage loans
Schedule of Investments [Line Items]
Gross investment income	24	11	3
Related party loans
Schedule of Investments [Line Items]
Gross investment income	4	6	7
Invested cash and short-term investments
Schedule of Investments [Line Items]
Gross investment income	3	2	0
Other investments
Schedule of Investments [Line Items]
Gross investment income	$ 9	$ 20	$ 20

Investments - Net Investment G

Investments - Net Investment Gains (Losses) (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Investments, Debt and Equity Securities [Abstract]
Net realized gains on fixed maturity available-for-sale securities									$ 11	$ 11	$ 104
Realized gains on equity securities									1	0	(1)
Change in fair value of other derivatives and embedded derivatives									0	7	2
Realized losses on other invested assets									(26)	(40)	(2)
Net realized gains on securities									(14)	(22)	103
Realized gains (losses) on certain derivative instruments									(84)	108	209
Unrealized gains (losses) on certain derivative instruments									166	(215)	37
Change in fair value of reinsurance related embedded derivative									(49)	92	(42)
Realized gains (losses) on hedging derivatives and reinsurance-related embedded derivatives									33	(15)	204
Net investment gains (losses)	$ 26	$ (28)	$ (42)	$ 63	$ (112)	$ 74	$ (58)	$ 59	$ 19	$ (37)	$ 307

Investments - Narrative (Detai

Investments - Narrative (Details) $ in Millions	1 Months Ended	3 Months Ended			12 Months Ended
	Jun. 30, 2016USD ($)	Mar. 31, 2017USD ($)	Jun. 30, 2016USD ($)	Mar. 31, 2015USD ($)	Sep. 30, 2016USD ($)loan	Sep. 30, 2015USD ($)loan	Sep. 30, 2014USD ($)	Jun. 30, 2015USD ($)
Schedule of Available-for-sale Securities [Line Items]
Non-income producing investment fair value					$ 2	$ 0
FHLB collateral pledged					649	524
Available for sale depressed securities fair value disclosure					$ 183	$ 302
Percentage of available for sale depressed securities above amortized cost					20.00%	20.00%
Percentage of available for sale depressed securities in relation to carrying value of investments					1.00%	2.00%
Other than temporary impairment credit losses recognized in earnings, including credit impairments					$ (40)	$ (74)	$ (1)
Other than temporary impairment credit losses recognized in earnings, reductions, change in status					(4)	(8)	0
Other than temporary impairment, non-credit losses recognized in OCI					1
Amortized cost					19,161	18,219
Fair Value					20,094	18,366
Realized gains on other invested assets					(26)	(40)	(2)
Total financial assets at fair value					$ 1,491	$ 1,348
Number of delinquent CMLs | loan					0	0
Impaired loans, number | loan					0	0
Litigation settlement amount	$ (2)		$ 18
Forecast
Schedule of Available-for-sale Securities [Line Items]
Litigation settlement amount		$ (2)
Residential mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Unrealized gain related to non-credit portion of OTTI included in AOCI					$ 1	$ 1
Unrealized losses related to non-credit portion of OTTI included in AOCI					3	2
Asset Backed Securities and Corporate Securities
Schedule of Available-for-sale Securities [Line Items]
Amortized cost					418	488	2
Fair Value					374	406	1
Residential mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Amortized cost					1,327	2,099
Fair Value					1,362	2,162
Available-for-sale Securities
Schedule of Available-for-sale Securities [Line Items]
Assets held by insurance regulators					18,075	16,012
Proceeds from available-for-sale investments, sold, matured or repaid:					$ 2,264	$ 4,947	5,084
Commercial mortgage loans
Schedule of Available-for-sale Securities [Line Items]
Investments, costs or amortized, percentage of total investments					3.00%	3.00%
Ratio of performing loans to all loans					100.00%	100.00%
Loan to value, threshold					75.00%	75.00%
Front Street RE (Cayman) Ltd.
Schedule of Available-for-sale Securities [Line Items]
Recognized credit-related impairment losses, net of reinsurance				$ 59	$ 59
Salus Capital Partners L L C
Schedule of Available-for-sale Securities [Line Items]
Recognized credit-related impairment losses, net of reinsurance					33	$ 13
Commitment to Invest
Variable Interest Entity [Line Items]
Unfunded investment commitment					$ 103
Commitment to Invest | Boardwalk, L.P.
Variable Interest Entity [Line Items]
Other commitment period					3 years
Other Investments					$ 12
Unfunded investment commitment					35
Commitment to Invest | Crescent Capital BDC Inc.
Variable Interest Entity [Line Items]
Other Investments					42
Unfunded investment commitment								$ 75
Total fixed maturities | Available-for-sale Securities
Schedule of Available-for-sale Securities [Line Items]
Proceeds from available-for-sale investments, sold, matured or repaid:					1,318	3,200	2,775
Gain on sale of investments					40	104	113
Loss on sale of investments					(23)	(44)	$ (13)
Salus Capital Partners L L C | Variable Interest Entity, Not Primary Beneficiary
Variable Interest Entity [Line Items]
Maximum loss exposure					22	$ 251
RadioShack (RSH) Corporation
Schedule of Available-for-sale Securities [Line Items]
Proceeds from liquidation					$ 23
Recovery of par value					45.00%
Estimated recovery value percentage				30.00%
Realized gains on other invested assets					$ 8
Total financial assets at fair value					$ 2

Derivative Financial Instrume61

Derivative Financial Instruments - Fair Value of Derivative Instruments (Details) - USD ($) $ in Millions	Sep. 30, 2016	Sep. 30, 2015
Derivative [Line Items]
Total asset derivatives	$ 408	$ 271
Total liability derivatives	2,394	2,154
Call options | Derivative investments
Derivative [Line Items]
Total asset derivatives	276	81
Call options | Funds withheld for reinsurance liabilities
Derivative [Line Items]
Total liability derivatives	11	5
Futures contracts | Derivative investments
Derivative [Line Items]
Total asset derivatives	0	1
Futures contracts | Other liabilities
Derivative [Line Items]
Total liability derivatives	0	0
Other derivatives and embedded derivatives | Other invested assets
Derivative [Line Items]
Total asset derivatives	13	21
Reinsurance related embedded derivative | Other assets
Derivative [Line Items]
Total asset derivatives	119	168
FIA embedded derivative | Contractholder funds
Derivative [Line Items]
Total liability derivatives	$ 2,383	$ 2,149

Derivative Financial Instrume62

Derivative Financial Instruments - Schedule of Change in Fair Value of Derivative Instruments (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivative	$ (49)	$ 92	$ (42)
Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivative	33	(8)	206
Call options | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivative	74	(100)	220
Futures contracts | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivative	8	(7)	26
Other derivatives and embedded derivatives | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivative	0	7	2
Reinsurance related embedded derivative | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivative	(49)	92	(42)
FIA embedded derivative
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivative	$ 234	$ 241	$ 363

Derivative Financial Instrume63

Derivative Financial Instruments - FGL's Exposure to Credit Loss on Call Options Held (Detail) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Derivatives, Fair Value [Line Items]
Fair Value	$ 408	$ 271
Merrill Lynch
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	A/*/A
Deutsche Bank
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	*/Baa3/BBB+
Morgan Stanley
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	*/A1/A
Barclay's Bank
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	*/A2/A-
Canadian Imperial Bank of Commerce
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	AA-/A3/A+
Not Designated as Hedging Instrument | Call options | Canadian Imperial Bank of Commerce
Derivatives, Fair Value [Line Items]
Notional Amount	$ 1,623	0
Fair Value	49	0
Collateral	48	0
Net Credit Risk	1	0
Derivatives For Trading And Investment | Not Designated as Hedging Instrument | Call options
Derivatives, Fair Value [Line Items]
Notional Amount	9,886	9,193
Fair Value	276	81
Collateral	128	7
Net Credit Risk	148	74
Derivatives For Trading And Investment | Not Designated as Hedging Instrument | Call options | Merrill Lynch
Derivatives, Fair Value [Line Items]
Notional Amount	2,302	2,233
Fair Value	55	16
Collateral	10	0
Net Credit Risk	45	16
Derivatives For Trading And Investment | Not Designated as Hedging Instrument | Call options | Deutsche Bank
Derivatives, Fair Value [Line Items]
Notional Amount	1,620	2,482
Fair Value	46	26
Collateral	12	0
Net Credit Risk	34	26
Derivatives For Trading And Investment | Not Designated as Hedging Instrument | Call options | Morgan Stanley
Derivatives, Fair Value [Line Items]
Notional Amount	2,952	4,086
Fair Value	87	35
Collateral	58	7
Net Credit Risk	29	28
Derivatives For Trading And Investment | Not Designated as Hedging Instrument | Call options | Barclay's Bank
Derivatives, Fair Value [Line Items]
Notional Amount	1,389	392
Fair Value	39	4
Collateral	0	0
Net Credit Risk	$ 39	$ 4

Derivative Financial Instrume64

Derivative Financial Instruments - Narrative (Details) $ in Millions	12 Months Ended			24 Months Ended
	Sep. 30, 2016USD ($)loancontract	Sep. 30, 2015USD ($)loancontract	Sep. 30, 2014USD ($)	Sep. 30, 2016USD ($)loancontract	Aug. 31, 2016contract	Jun. 16, 2014USD ($)	Sep. 30, 2013USD ($)
Derivative [Line Items]
Fair value of assets	$ 1,491	$ 1,348	$ 1,292	$ 1,491			$ 870
Number of participating loans denominated in CAD | loan	1	3		4
Number of participating loans denominated in CAD, settled | loan	3
Participating loans denominated in CAD, reimbursement provision included, number of loans | loan	2
Realized gain (loss)	$ (49)	$ 92	(42)
Participating loans denominated in CAD, reimbursement provision excluded, number of loans | loan	2
Participating loans denominated in CAD, reimbursement provision excluded, number of loans repaid | loan	1
Other derivatives and embedded derivatives
Derivative [Line Items]
Term of contract, term one	1 year
Term of contract, term two	2 years
Term of contract, term three	3 years
Term of contract, term four	5 years
CAD Currency Forward
Derivative [Line Items]
Realized gain (loss)	$ 0
Number of instruments held | contract	1			1	2
Futures contracts
Derivative [Line Items]
Number of instruments held | contract	559	738		559
Collateral held	$ 3	$ 3		$ 3
Other liabilities | Not Designated as Hedging Instrument | Call options
Derivative [Line Items]
Collateral posted	118	7		118
Derivatives For Trading And Investment | Not Designated as Hedging Instrument | Call options
Derivative [Line Items]
Derivative notional amount	9,886	9,193		9,886
Collateral posted	128	7		128
Maximum amount of loss due to credit risk	148	74		148
Cash and Cash Equivalents | Not Designated as Hedging Instrument | Call options
Derivative [Line Items]
Collateral posted	118	7		118
Other invested assets
Derivative [Line Items]
Fair value of assets	26			26
Available-for-sale embedded derivative
Derivative [Line Items]
Fair value of assets	13	10	11	$ 13
Net investment (losses) gains
Derivative [Line Items]
Realized gain (loss)	33	(8)	206
Net investment (losses) gains | Other derivatives and embedded derivatives
Derivative [Line Items]
Realized gain (loss)	0	7	2
Net investment (losses) gains | Foreign exchange embedded derivative
Derivative [Line Items]
Realized gain (loss)	(1)	(1)	2
Net investment (losses) gains | Call options
Derivative [Line Items]
Realized gain (loss)	74	(100)	220
Net investment (losses) gains | Futures contracts
Derivative [Line Items]
Realized gain (loss)	8	(7)	$ 26
Net investment (losses) gains | Other invested assets | Other derivatives and embedded derivatives
Derivative [Line Items]
Realized gain (loss)	0	1
Salus Participations
Derivative [Line Items]
Realized gain (loss)	0	10
Salus Participations | Net investment (losses) gains
Derivative [Line Items]
Realized gain (loss)	$ (2)	$ 10
Other Investments Asset | Other invested assets
Derivative [Line Items]
Fixed maturities securities, available-for-sale, at fair value						$ 35
Other Investments Asset | Other invested assets | Other derivatives and embedded derivatives
Derivative [Line Items]
Derivative notional amount						$ 11

Fair Value of Financial Instr65

Fair Value of Financial Instruments - Assets and Liabilities Carrying at Fair Value Measured on a Recurring Basis (Details) - USD ($) $ in Millions	Sep. 30, 2016	Sep. 30, 2015
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	$ 20,094	$ 18,366
Derivative investments	276	82
Total financial assets at fair value	1,491	1,348
Commercial mortgage loans	614	490
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	864	502
Equity securities, available-for-sale	22	26
Derivative investments	0	1
Other invested assets	0	0
Total financial assets at fair value	947	589
Total financial liabilities at fair value	0	0
Commercial mortgage loans	0	0
Policy loans, included in other invested assets	0	0
Limited partnership investment, included in other invested assets	0	0
Related party loans	0	0
Total assets carried on balance sheet at amounts other than fair value	0	0
Investment contracts, included in contractholder funds	0	0
Debt	0	0
Total liabilities carried on balance sheet at amounts other than fair value	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0	0
Equity securities, available-for-sale	617	560
Derivative investments	276	81
Other invested assets	0	11
Total financial assets at fair value	18,949	17,321
Total financial liabilities at fair value	11	5
Commercial mortgage loans	0	0
Policy loans, included in other invested assets	0	0
Limited partnership investment, included in other invested assets	0	0
Related party loans	0	0
Total assets carried on balance sheet at amounts other than fair value	0	0
Investment contracts, included in contractholder funds	0	0
Debt	300	312
Total liabilities carried on balance sheet at amounts other than fair value	300	312
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0	0
Equity securities, available-for-sale	44	34
Derivative investments	0	0
Other invested assets	34	129
Total financial assets at fair value	1,491	1,348
Total financial liabilities at fair value	2,383	2,149
Commercial mortgage loans	614	490
Policy loans, included in other invested assets	13	9
Limited partnership investment, included in other invested assets	12	4
Related party loans	71	78
Total assets carried on balance sheet at amounts other than fair value	710	581
Investment contracts, included in contractholder funds	14,884	14,126
Debt	100	0
Total liabilities carried on balance sheet at amounts other than fair value	14,984	14,126
Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	864	502
Equity securities, available-for-sale	683	620
Derivative investments	276	82
Other invested assets	34	140
Total financial assets at fair value	21,387	19,258
Total financial liabilities at fair value	2,394	2,154
Commercial mortgage loans	614	490
Policy loans, included in other invested assets	13	9
Limited partnership investment, included in other invested assets	12	4
Related party loans	71	78
Total assets carried on balance sheet at amounts other than fair value	710	581
Investment contracts, included in contractholder funds	14,884	14,126
Debt	400	312
Total liabilities carried on balance sheet at amounts other than fair value	15,284	14,438
Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	864	502
Equity securities, available-for-sale	683	620
Derivative investments	276	82
Other invested assets	34	140
Total financial assets at fair value	21,387	19,258
Total financial liabilities at fair value	2,394	2,154
Commercial mortgage loans	595	491
Policy loans, included in other invested assets	14	11
Limited partnership investment, included in other invested assets	12	4
Related party loans	71	78
Total assets carried on balance sheet at amounts other than fair value	692	584
Investment contracts, included in contractholder funds	16,868	15,621
Debt	400	300
Total liabilities carried on balance sheet at amounts other than fair value	17,268	15,921
Reinsurance related embedded derivative | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative investments	0	0
Reinsurance related embedded derivative | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative investments	119	168
Reinsurance related embedded derivative | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative investments	0	0
Reinsurance related embedded derivative | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative investments	119	168
Reinsurance related embedded derivative | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative investments	119	168
Fixed indexed annuities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
FIA embedded derivatives, included in contractholder funds	0	0
Fixed indexed annuities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
FIA embedded derivatives, included in contractholder funds	0	0
Fixed indexed annuities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
FIA embedded derivatives, included in contractholder funds	2,383	2,149
Fixed indexed annuities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
FIA embedded derivatives, included in contractholder funds	2,383	2,149
Fixed indexed annuities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
FIA embedded derivatives, included in contractholder funds	2,383	2,149
Call options | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Call options payable for FSRCI, included in funds withheld for reinsurance liabilities	0	0
Call options | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Call options payable for FSRCI, included in funds withheld for reinsurance liabilities	11	5
Call options | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Call options payable for FSRCI, included in funds withheld for reinsurance liabilities	0	0
Call options | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Call options payable for FSRCI, included in funds withheld for reinsurance liabilities	11	5
Call options | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Call options payable for FSRCI, included in funds withheld for reinsurance liabilities	11	5
Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,499	2,106
Asset-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Asset-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,327	2,068
Asset-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	172	38
Asset-backed securities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,499	2,106
Asset-backed securities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,499	2,106
Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	864	882
Commercial mortgage-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Commercial mortgage-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	785	738
Commercial mortgage-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	79	144
Commercial mortgage-backed securities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	864	882
Commercial mortgage-backed securities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	864	882
Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	11,340	9,530
Corporates | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Corporates | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	10,219	8,566
Corporates | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,121	964
Corporates | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	11,340	9,530
Corporates | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	11,340	9,530
Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,386	1,214
Hybrids | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Hybrids | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,386	1,214
Hybrids | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Hybrids | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,386	1,214
Hybrids | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,386	1,214
States, municipalities and political subdivisions | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
States, municipalities and political subdivisions | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,676	1,569
States, municipalities and political subdivisions | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	41	39
States, municipalities and political subdivisions | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,717	1,608
States, municipalities and political subdivisions | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,717	1,608
Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,362	2,162
Residential mortgage-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Residential mortgage-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,362	2,162
Residential mortgage-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Residential mortgage-backed securities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,362	2,162
Residential mortgage-backed securities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,362	2,162
U.S. Government
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	243	244
U.S. Government | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	61	60
U.S. Government | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	182	184
U.S. Government | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
U.S. Government | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	243	244
U.S. Government | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	$ 243	$ 244

Fair Value of Financial Instr66

Fair Value of Financial Instruments - Schedule of Unobservable Inputs Used for Level Three Fair Value Measurements of Financial Instruments on Recurring Basis (Detail) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 1,491	$ 1,348
Liabilities, fair value	2,383	2,149
Market Approach | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 144	$ 10
Valuation Technique	Broker-quoted	Broker-quoted
Fair value inputs, quoted prices		41.80%
Market Approach | Commercial mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 75	$ 144
Valuation Technique	Broker-quoted	Broker-quoted
Market Approach | Corporates
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 920	$ 898
Valuation Technique	Broker-quoted	Broker-quoted
Market Approach | Municipals
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 41	$ 39
Valuation Technique	Broker-quoted	Broker-quoted
Fair value inputs, quoted prices	119.04%	111.47%
Market Approach | Equity securities, available-for-sale
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 41	$ 25
Valuation Technique	Net Asset Value	Net Asset Value
Fair value inputs, quoted prices		100.00%
Fair value inputs, matrix pricing	100.00%	100.00%
Market Approach | Other invested assets
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 2	$ 15
Valuation Technique	Liquidation value – 5% Recovery Estimate	Liquidation value – 30% Recovery Estimate
Income Approach Valuation Technique | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 9
Valuation Technique	Matrix Pricing
Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 4
Valuation Technique	Matrix Pricing
Income Approach Valuation Technique | Corporates
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 201	$ 66
Valuation Technique	Matrix Pricing	Matrix Pricing
Income Approach Valuation Technique | Equity securities, available-for-sale
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value		$ 6
Valuation Technique		Matrix Pricing
Income Approach Valuation Technique | Other invested assets
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 13	$ 10
Valuation Technique	Black-Scholes model	Black-Scholes model
Fair value inputs, black scholes model	100.00%	100.00%
Fixed indexed annuities | Income Approach Valuation Technique
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Liabilities, fair value	$ 2,383	$ 2,149
Valuation Technique	Discounted Cash Flow	Discounted Cash Flow
Minimum | Market Approach | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	97.54%	100.37%
Minimum | Market Approach | Commercial mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	104.31%	99.32%
Minimum | Market Approach | Corporates
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	50.00%	56.75%
Minimum | Market Approach | Other invested assets
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, sales agreement	1.36%	30.00%
Minimum | Income Approach Valuation Technique | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, matrix pricing	98.75%
Minimum | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, matrix pricing	98.41%
Minimum | Income Approach Valuation Technique | Corporates
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, matrix pricing	99.00%	104.58%
Minimum | Fixed indexed annuities | Income Approach Valuation Technique
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, market value of option	0.00%	0.00%
Fair value inputs, swap rates	1.18%	1.38%
Fair value inputs, mortality multiplier	80.00%	80.00%
Fair value inputs, surrender rates	0.50%	0.50%
Fair value inputs, non performance spread	0.25%	0.25%
Fair value inputs, future option budget	1.15%	1.19%
Maximum | Market Approach | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	101.55%	107.84%
Maximum | Market Approach | Commercial mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	122.19%	119.00%
Maximum | Market Approach | Corporates
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	118.33%	113.83%
Maximum | Market Approach | Other invested assets
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, sales agreement	14.28%	34.00%
Maximum | Income Approach Valuation Technique | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, matrix pricing	98.75%
Maximum | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, matrix pricing	98.41%
Maximum | Income Approach Valuation Technique | Corporates
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, matrix pricing	150.23%	142.43%
Maximum | Fixed indexed annuities | Income Approach Valuation Technique
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, market value of option	26.64%	33.83%
Fair value inputs, swap rates	1.46%	2.00%
Fair value inputs, mortality multiplier	80.00%	80.00%
Fair value inputs, surrender rates	75.00%	75.00%
Fair value inputs, non performance spread	0.25%	0.25%
Fair value inputs, future option budget	5.57%	5.25%
Weighted Average | Market Approach | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	99.66%	102.42%
Weighted Average | Market Approach | Commercial mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	114.10%	110.95%
Weighted Average | Market Approach | Corporates
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	103.37%	100.69%
Weighted Average | Income Approach Valuation Technique | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, matrix pricing	98.75%
Weighted Average | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, matrix pricing	98.41%
Weighted Average | Income Approach Valuation Technique | Corporates
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, matrix pricing	107.65%	110.03%
Weighted Average | Fixed indexed annuities | Income Approach Valuation Technique
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, market value of option	2.55%	1.01%
Fair value inputs, swap rates	1.31%	1.69%
Fair value inputs, mortality multiplier	80.00%	80.00%
Fair value inputs, surrender rates	9.59%	10.13%
Fair value inputs, non performance spread	0.25%	0.25%
Fair value inputs, future option budget	2.91%	2.93%
Insurance Subsidiary | Market Approach | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 19	$ 28
Valuation Technique	Third-Party Valuation	Third-Party Valuation
Fair value inputs, discount rate	15.00%	15.00%
Fair value inputs, probability of default		2.00%
Estimated recovery value percentage	5.50%	30.00%
Insurance Subsidiary | Market Approach | Equity securities, available-for-sale
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 3	$ 3
Valuation Technique	Market-approach	Market-approach
Insurance Subsidiary | Market Approach | Other invested assets
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 2	$ 104
Valuation Technique	Market Pricing	Market Pricing
Fair value inputs, quoted prices		100.00%
Insurance Subsidiary | Income Approach Valuation Technique | Equity securities, available-for-sale
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, discount rate	15.00%	15.00%
Fair value inputs, collateralized loan obligation equity percentage	28.37%	41.80%
Estimated recovery value percentage	5.50%	30.00%
Fair value inputs, yield	11.00%	11.00%
Insurance Subsidiary | Income Approach Valuation Technique | Other invested assets
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	100.00%
Insurance Subsidiary | Minimum | Market Approach | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	28.37%
Fair value inputs, other loan recoveries	0.00%	4.00%
Insurance Subsidiary | Maximum | Market Approach | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	28.37%
Fair value inputs, other loan recoveries	100.00%	100.00%
Insurance Subsidiary | Weighted Average | Market Approach | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	28.37%
Loan Participation - JSN Jewelry, Inc. | Market Approach | Other invested assets
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 17
Valuation Technique	Liquidation value – 52.5% Recovery Estimate
Loan Participation - JSN Jewelry, Inc. | Minimum | Market Approach | Other invested assets
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Estimated recovery value percentage	49.93%
Loan Participation - JSN Jewelry, Inc. | Maximum | Market Approach | Other invested assets
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Estimated recovery value percentage	56.67%
Loan Participation - JSN Jewelry, Inc. | Weighted Average | Market Approach | Other invested assets
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Estimated recovery value percentage	52.50%

Fair Value of Financial Instr67

Fair Value of Financial Instruments - Changes to Fair Value of Financial Instruments Level 3 (Detail) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	$ 1,348	$ 1,292	$ 870
Assets, Total Gains (Losses) Included in Earnings	(30)	(103)	0
Assets, Total Gains (Losses) Included in AOCI	49	7	20
Assets, Purchases	366	451	773
Assets, Sales	(9)	(16)	(12)
Assets, Settlements	(172)	(230)	(132)
Assets, Net transfer In (Out) of Level 3	(61)	(53)	(227)
Balance at End of Period	1,491	1,348	1,292
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	2,149	1,908	1,545
Liabilities, Total Gains (Losses) Included in Earnings	234	241	363
Liabilities, Total Gains (Losses) Included in AOCI	0	0	0
Liabilities, Purchases	0	0	0
Liabilities, Sales	0	0	0
Liabilities, Settlements	0	0	0
Liabilities, Net transfer In (Out) of Level 3	0	0	0
Balance at End of Period	2,383	2,149	1,908
FIA embedded derivatives, included in contractholder funds
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	2,149	1,908	1,545
Liabilities, Total Gains (Losses) Included in Earnings	234	241	363
Liabilities, Total Gains (Losses) Included in AOCI	0	0	0
Liabilities, Purchases	0	0	0
Liabilities, Sales	0	0	0
Liabilities, Settlements	0	0	0
Liabilities, Net transfer In (Out) of Level 3	0	0	0
Balance at End of Period	2,383	2,149	1,908
Asset-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	38	74	246
Assets, Total Gains (Losses) Included in Earnings	(12)	(37)	0
Assets, Total Gains (Losses) Included in AOCI	3	3	(1)
Assets, Purchases	141	73	36
Assets, Sales	0	(15)	0
Assets, Settlements	(3)	(31)	0
Assets, Net transfer In (Out) of Level 3	5	(29)	(207)
Balance at End of Period	172	38	74
Commercial mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	144	83	6
Assets, Total Gains (Losses) Included in Earnings	0	0	0
Assets, Total Gains (Losses) Included in AOCI	4	(2)	0
Assets, Purchases	0	63	83
Assets, Sales	0	0	0
Assets, Settlements	(3)	0	0
Assets, Net transfer In (Out) of Level 3	(66)	0	(6)
Balance at End of Period	79	144	83
Corporates
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	964	834	461
Assets, Total Gains (Losses) Included in Earnings	0	4	0
Assets, Total Gains (Losses) Included in AOCI	32	10	19
Assets, Purchases	154	202	382
Assets, Sales	(3)	(1)	(12)
Assets, Settlements	(26)	(61)	(2)
Assets, Net transfer In (Out) of Level 3	0	(24)	(14)
Balance at End of Period	1,121	964	834
Hybrids
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	0
Assets, Total Gains (Losses) Included in Earnings	0
Assets, Total Gains (Losses) Included in AOCI	0
Assets, Purchases	0
Assets, Sales	0
Assets, Settlements	0
Assets, Net transfer In (Out) of Level 3	0
Balance at End of Period	0	0
Municipals
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	39	37	0
Assets, Total Gains (Losses) Included in Earnings	0	0	0
Assets, Total Gains (Losses) Included in AOCI	2	2	2
Assets, Purchases	0	0	35
Assets, Sales	0	0	0
Assets, Settlements	0	0	0
Assets, Net transfer In (Out) of Level 3	0	0	0
Balance at End of Period	41	39	37
Equity securities, available-for-sale
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	34	40	0
Assets, Total Gains (Losses) Included in Earnings	0	(30)	0
Assets, Total Gains (Losses) Included in AOCI	(1)	(1)	1
Assets, Purchases	17	25	39
Assets, Sales	(6)	0	0
Assets, Settlements	0	0	0
Assets, Net transfer In (Out) of Level 3	0	0	0
Balance at End of Period	44	34	40
Available-for-sale embedded derivative
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	10	11
Assets, Total Gains (Losses) Included in Earnings	3	(1)
Assets, Total Gains (Losses) Included in AOCI	0	0
Assets, Purchases	0	0
Assets, Sales	0	0
Assets, Settlements	0	0
Assets, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	13	10	11
Other invested assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		11	0
Assets, Total Gains (Losses) Included in Earnings			0
Assets, Total Gains (Losses) Included in AOCI			0
Assets, Purchases			11
Assets, Sales			0
Assets, Settlements			0
Assets, Net transfer In (Out) of Level 3			0
Balance at End of Period			11
Loan participations
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	119	213	157
Assets, Total Gains (Losses) Included in Earnings	(21)	(39)	0
Assets, Total Gains (Losses) Included in AOCI	9	(5)	(1)
Assets, Purchases	54	88	187
Assets, Sales	0	0	0
Assets, Settlements	(140)	(138)	(130)
Assets, Net transfer In (Out) of Level 3	0	0	0
Balance at End of Period	$ 21	$ 119	$ 213

Fair Value of Financial Instr68

Fair Value of Financial Instruments - Narrative (Detail)	12 Months Ended
	Sep. 30, 2016USD ($)$ / Contract	Sep. 30, 2015USD ($)	Sep. 30, 2014USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Transfers between Level 1 and Level 2	$ 0	$ 0	$ 0
Net transfers out of Level 3	159,000,000
Net transfers into Level 3	97,000,000
Assets, net transfer in (out) of Level 3	(61,000,000)	(53,000,000)	(227,000,000)
Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3	$ 5,000,000	$ (29,000,000)	(207,000,000)
Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3			$ 0
Market Approach | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term maturity of loans (less than)	1 year
Income Approach Valuation Technique | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, strike price | $ / Contract	0

Intangible Assets - Summary of

Intangible Assets - Summary of Changes in Carrying Amounts of Intangible Assets Including DAC, VOBA , and DSI (Detail) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
VOBA
VOBA at beginning of period	$ 187	$ 59	$ 192
Deferrals	0	0	0
Unlocking	25	19	22
Interest	11	12	15
Amortization	(41)	(68)	(87)
Adjustment for unrealized investment gains	(163)		(83)
Adjustment for unrealized investment losses		(165)
VOBA at end of period	19	187	59
DAC
DAC at beginning of period	801	456	331
Deferrals	350	317	238
Unlocking	2	4	3
Interest	34	22	14
Amortization	(85)	(53)	(56)
Adjustment for unrealized investment gains (losses)	(95)	55	(74)
DAC at end of period	1,007	801	456
Total
Total VOBA and DAC at beginning of period	988	515	523
Deferrals	350	317	238
Unlocking	27	23	25
Interest	45	34	29
Amortization	126	121	143
Adjustment for unrealized investment gains (losses)	(258)	220	(157)
Total VOBA and DAC at end of period	1,026	988	515
Accumulated amortization	$ 396	$ 391	$ 354

Intangible Assets - Estimated A

Intangible Assets - Estimated Amortization Expense for VOBA in Future Fiscal Periods (Detail) $ in Millions	12 Months Ended
	Sep. 30, 2016USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2,017	$ 27
2,018	25
2,019	22
2,020	18
2,021	15
Thereafter	$ 74

Intangible Assets - Narrative (

Intangible Assets - Narrative (Detail) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
VOBA
Finite-Lived Intangible Assets [Line Items]
Cumulative adjustments for net unrealized investment gains	$ (162)
Cumulative adjustments for net unrealized investment loss		$ (1)
DAC
Finite-Lived Intangible Assets [Line Items]
Cumulative adjustments for net unrealized investment gains	(96)
Cumulative adjustments for net unrealized investment loss		(1)
Deferred sales inducements, net of shadow adjustments	$ 86	$ 59
Minimum
Finite-Lived Intangible Assets [Line Items]
Interest accrual rate utilized to calculation the accretion of interest	4.00%
Maximum
Finite-Lived Intangible Assets [Line Items]
Interest accrual rate utilized to calculation the accretion of interest	5.00%
Weighted Average | VOBA
Finite-Lived Intangible Assets [Line Items]
Weighted average amortization period	5 years 2 months 12 days

Debt - Narrative (Detail)

Debt - Narrative (Detail) - USD ($)	Sep. 30, 2016	Aug. 26, 2014	Mar. 31, 2013	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Line of Credit Facility [Line Items]
Debt issuance costs		$ 4,000,000		$ 0	$ 0	$ 4,000,000
Debt Instrument [Line Items]
Debt	$ 300,000,000			$ 300,000,000	$ 300,000,000
6.375% Senior Notes, Due April 1, 2021 | Senior Notes
Debt Instrument [Line Items]
Debt			$ 300,000,000
Long-term debt, interest rate			6.375%
6.375% Senior Notes, Due April 1, 2021 | Senior Notes | Other assets
Debt Instrument [Line Items]
Debt issue costs			$ 10,000,000
Revolving Credit Facility
Line of Credit Facility [Line Items]
Line of credit expiration period		3 years
Maximum borrowing capacity		$ 150,000,000
Amount drawn	$ 100,000,000
Interest rate if revolver drawn	5.50%			5.50%	5.25%

Debt - Schedule of Debt (Detail

Debt - Schedule of Debt (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Debt Instrument [Line Items]
Debt	$ 300	$ 300
Revolving credit facility	100	0
Interest expense excluding amortization	19	19	$ 19
Amortization of debt issuance costs	2	4	4
Revolving Credit Facility
Debt Instrument [Line Items]
Revolving credit facility	100	0
Interest expense excluding amortization	0	0	0
Amortization of debt issuance costs	$ 1	$ 1	$ 0

Equity - Narrative (Details)

Equity - Narrative (Details) $ / shares in Units, $ in Millions	Nov. 10, 2016$ / shares	Aug. 01, 2016$ / shares	Apr. 28, 2016$ / shares	Feb. 02, 2016$ / shares	Nov. 12, 2015$ / shares	Jul. 31, 2015$ / shares	May 01, 2015$ / shares	Feb. 10, 2015$ / shares	Nov. 18, 2014$ / shares	Nov. 26, 2013$ / sharesshares	Jun. 30, 2015USD ($)shares	Sep. 30, 2016USD ($)$ / sharesshares	Sep. 30, 2015USD ($)$ / sharesshares	Sep. 30, 2016USD ($)$ / sharesshares	Nov. 08, 2015shares	Sep. 02, 2014shares	Nov. 25, 2013shares
Class of Stock [Line Items]
Common stock, par value (in dollars per share) | $ / shares										$ 0.01		$ 0.01	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)										500,000,000		500,000,000	500,000,000	500,000,000			100,000
Common stock split ratio										4,700
Shares outstanding (in shares)										47,000,000
Preferred Stock, shares authorized (in shares)												50,000,000	50,000,000	50,000,000
Preferred Stock, shares outstanding (in shares)												0	0	0
Shares repurchased (in shares)											512,000
Value of stock repurchased | $												$ 1	$ 11
Shareholders' disclosure, common stock (in shares)												47,000,000		47,000,000	47,000,000
Shareholders' disclosure, ownership percentage												80.00%		80.00%	81.00%
Cash dividend per common share (in dollars per share) | $ / shares		$ 0.065	$ 0.065	$ 0.065	$ 0.065	$ 0.065	$ 0.065	$ 0.065	$ 0.065
September 2014 Repurchase Plan
Class of Stock [Line Items]
Authorized repurchase amount (up to)																500,000
Shares repurchased (in shares)											500,000
Stock Compensation Plan
Class of Stock [Line Items]
Shares repurchased (in shares)											12,000	25,000
Value of stock repurchased | $												$ 1
Treasury Stock
Class of Stock [Line Items]
Shares repurchased (in shares)														537,000
Value of stock repurchased | $											$ 11	1	$ 11	$ 12
Subsequent Event
Class of Stock [Line Items]
Cash dividend per common share (in dollars per share) | $ / shares	$ 0.065
Subsidiaries
Class of Stock [Line Items]
Restricted net assets for consolidated subsidiaries | $												$ 1,789		$ 1,789
Restricted net assets for consolidated subsidiaries, percentage of stockholder's equity												94.00%		94.00%

Equity - Schedule of Dividends

Equity - Schedule of Dividends (Details) - USD ($) $ / shares in Units, $ in Millions	Sep. 06, 2016	Aug. 01, 2016	May 30, 2016	Apr. 28, 2016	Mar. 07, 2016	Feb. 02, 2016	Dec. 14, 2015	Nov. 12, 2015	Aug. 31, 2015	Jul. 31, 2015	Jun. 01, 2015	May 01, 2015	Mar. 09, 2015	Feb. 10, 2015	Dec. 15, 2014	Nov. 18, 2014	Sep. 30, 2016	Aug. 22, 2016	May 16, 2016	Feb. 22, 2016	Nov. 30, 2015	Sep. 30, 2015	Aug. 17, 2015	May 18, 2015	Feb. 23, 2015	Dec. 01, 2014
Equity [Abstract]
Common stock, shares outstanding (in shares)																	58,956,127	58,211,000	58,211,000	58,210,000	58,144,000	58,870,823	57,976,000	57,932,000	57,975,000	58,279,000
Cash dividend per common share (in dollars per share)		$ 0.065		$ 0.065		$ 0.065		$ 0.065		$ 0.065		$ 0.065		$ 0.065		$ 0.065
Total cash paid	$ 4		$ 4		$ 4		$ 4		$ 4		$ 4		$ 4		$ 4

Stock Compensation - Schedule o

Stock Compensation - Schedule of Stock Based Compensation Costs (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	$ 13	$ 19	$ 17
Related tax benefit	5	7	6
Net stock compensation expense	8	12	11
FGL Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	12	10	3
FGL Plan | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	0	1	0
FGL Plan | Restricted shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	2	6	1
FGL Plan | Performance restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	10	3	1
FGL Plan | Unrestricted shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	0	0	1
FGLH Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	1	9	14
2011 Stock Incentive Plan | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	0	1	6
2011 Dividend Equivalent Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	0	0	1
2011 Stock Incentive Plan, Amended and Restated | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	1	5	5
2011 Stock Incentive Plan, Amended and Restated | Restricted shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	0	2	2
2012 Dividend Equivalent Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	$ 0	$ 1	$ 0

Stock Compensation - Summary of

Stock Compensation - Summary of Unrecognized Stock Compensation Expense (Details) $ in Millions	12 Months Ended
	Sep. 30, 2016USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 2
Weighted Average Recognition Period in Years	1 year
FGL Plan | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 0
Weighted Average Recognition Period in Years	1 year
FGL Plan | Restricted shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 2
Weighted Average Recognition Period in Years	1 year

Stock Compensation - Summary 78

Stock Compensation - Summary of Stock Options Outstanding and Related Activity (Details) - $ / shares	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
FGL Plan
Options (in shares):
Stock options outstanding at beginning of period (in shares)	317,000
Granted (in shares)	119,000
Exercised (in shares)	(77,000)
Forfeited or expired (in shares)	(13,000)
Stock options outstanding at end (in shares)	346,000	317,000
Vested and exercisable at end of period (in shares)	114,000
Weighted Average Exercise Price (in dollars per share):
Stock options outstanding at beginning of period (USD per share)	$ 21.60
Granted (USD per share)	25.75
Exercised (USD per share)	24.31
Forfeited or expired (USD per share)	22.12
Stock options outstanding at end of period (USD per share)	22.40	$ 21.60
Vested and exercisable at end of period (USD per share)	$ 19.52
FGLH Plan
Options (in shares):
Stock options outstanding at beginning of period (in shares)	87,000
Granted (in shares)	0	0	0
Exercised (in shares)	(4,000)
Forfeited or expired (in shares)	(1,000)
Stock options outstanding at end (in shares)	82,000	87,000
Vested and exercisable at end of period (in shares)	82,000
Weighted Average Exercise Price (in dollars per share):
Stock options outstanding at beginning of period (USD per share)	$ 45.04
Granted (USD per share)	0
Exercised (USD per share)	48.71
Forfeited or expired (USD per share)	49.45
Stock options outstanding at end of period (USD per share)	44.82	$ 45.04
Vested and exercisable at end of period (USD per share)	$ 44.82

Stock Compensation - Assumption

Stock Compensation - Assumptions Used in Determination of Grant Date Fair Values Using Black-Scholes Option Pricing Model (Details) - $ / shares	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
FGL Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (USD per share)	$ 1.01	$ 4.96	$ 3.76
Risk-free interest rate	0.42%
Assumed dividend yield	1.14%
Expected option term	6 months	4 years 6 months	4 years 6 months
Volatility	14.55%	25.00%	25.00%
FGLH Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (USD per share)	$ 78.62	$ 74.99
Assumed dividend yield	1.12%	1.16%
Volatility	15.00%	25.00%
Minimum | FGL Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate		1.41%	1.40%
Assumed dividend yield		1.18%	1.30%
Minimum | FGLH Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate		0.48%
Expected option term		1 year 6 months
Maximum | FGL Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate		1.50%	1.41%
Assumed dividend yield		1.19%	1.50%
Maximum | FGLH Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	0.26%	0.74%
Expected option term	3 months	2 years 3 months
CEO | FGL Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (USD per share)	$ 2.53
Risk-free interest rate	0.20%
Assumed dividend yield	1.18%
Expected option term	9 months
Volatility	25.00%
FHLG
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share price (USD per share)	$ 23.19	$ 24.54
FGL
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share price (USD per share)	$ 123.76	$ 122.02

Stock Compensation - Summary 80

Stock Compensation - Summary of Restricted Stock and Restricted Stock Units Outstanding and Related Activity (Details) - $ / shares shares in Thousands	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
FGL Plan | Restricted shares
Shares:
Restricted shares outstanding at beginning of period (in shares)	246
Granted (in shares)	26
Vested (in shares)	(100)
Forfeited or expired (in shares)	(18)
Restricted shares outstanding at end of period (in shares)	154	246
Weighted Average Grant Date Fair Value (in dollars per share):
Average grant date fair value outstanding at beginning of period (USD per share)	$ 21.92
Average grant date fair value, Granted (USD per share)	25.75
Average grant date fair value, Exercised (USD per share)	21.32
Average grant date fair value, Forfeited or Expired (USD per share)	22.46
Average grant date fair value outstanding at end of period (USD per share)	$ 22.91	$ 21.92
FGL Plan | Performance restricted stock units
Shares:
Restricted shares outstanding at beginning of period (in shares)	515
Granted (in shares)	63
Vested (in shares)	(578)
Forfeited or expired (in shares)	0
Restricted shares outstanding at end of period (in shares)	0	515
Weighted Average Grant Date Fair Value (in dollars per share):
Average grant date fair value outstanding at beginning of period (USD per share)	$ 17.69
Average grant date fair value, Granted (USD per share)	17.82
Average grant date fair value, Exercised (USD per share)	17.71
Average grant date fair value, Forfeited or Expired (USD per share)	0
Average grant date fair value outstanding at end of period (USD per share)	$ 0	$ 17.69
FGLH Plan | Restricted shares
Shares:
Restricted shares outstanding at beginning of period (in shares)	11
Granted (in shares)	0	0	0
Vested (in shares)	(11)
Forfeited or expired (in shares)	0
Restricted shares outstanding at end of period (in shares)	0	11
Weighted Average Grant Date Fair Value (in dollars per share):
Average grant date fair value outstanding at beginning of period (USD per share)	$ 49.57
Average grant date fair value, Granted (USD per share)	0	$ 0	$ 0
Average grant date fair value, Exercised (USD per share)	49.57
Average grant date fair value, Forfeited or Expired (USD per share)	49.45
Average grant date fair value outstanding at end of period (USD per share)	$ 0	$ 49.57

Stock Compensation - Narrative

Stock Compensation - Narrative (Details) - USD ($)	Mar. 18, 2015	Sep. 30, 2016	Mar. 31, 2015	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014	Nov. 19, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized for grant (in shares)		1,159,000		1,159,000			2,838,000
Related tax benefit				$ 5,000,000	$ 7,000,000	$ 6,000,000
FGL Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted (in shares)				119,000
FGL Plan | Stock Option Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding, intrinsic value		$ 1,000,000		$ 1,000,000
Options exercisable, intrinsic value		0		0
Aggregate intrinsic value of options		1,000,000		$ 1,000,000
Weighted average contractual term, outstanding				5 years
Weighted average contractual term, exercisable				4 years
Weighted average contractual term, vested and expected to vest				5 years
Options exercised, intrinsic value				$ 0	1,000,000	0
Cash received from options				2,000,000	2,000,000	0
Related tax benefit				$ 0	0	0
FGL Plan | Restricted shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock unit grants (in shares)				26,000
Vested (in shares)				100,000
Option fair value at grant date				$ 1,000,000	7,000,000	3,000,000
Average grant date fair value, Granted (USD per share)				$ 25.75
FGL Plan | Performance restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Accelerated compensation cost		3,000,000
Restricted stock unit grants (in shares)				63,000
Vested (in shares)				578,000
Share-based liability		14,000,000		$ 14,000,000
Average grant date fair value, Granted (USD per share)				$ 17.82
FGL Plan | Unrestricted shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Option fair value at grant date					$ 0	$ 1,000,000
FGLH Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted (in shares)				0	0	0
Award vesting period				3 years
Expiration period				7 years
FGLH Plan | Stock Option Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding, intrinsic value		6,000,000		$ 6,000,000
Options exercisable, intrinsic value		6,000,000		6,000,000
Aggregate intrinsic value of options		$ 6,000,000		$ 6,000,000
Weighted average contractual term, exercisable				3 years
Weighted average contractual term, vested and expected to vest				3 years
Options exercised, intrinsic value				$ 0	$ 9,000,000	$ 6,000,000
Options outstanding, weighted average remaining term				3 years
FGLH Plan | Restricted shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period				3 years
Restricted stock unit grants (in shares)				0	0	0
Vested (in shares)				11,000
Average grant date fair value, Granted (USD per share)				$ 0	$ 0	$ 0
Cash paid for units in lieu of shares				$ 2,000,000	$ 2,000,000	$ 2,000,000
FGLH Plan | Dividend Equivalent Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cash paid for units in lieu of shares				$ 1,000,000	$ 1,000,000	$ 3,000,000
Directors, Officers, and Other Key Employees | FGL Plan | Stock Option Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted (in shares)				119,000	206,000	249,000
Award vesting period				3 years
Fair value at grant date				$ 0	$ 1,000,000	$ 1,000,000
Directors, Officers, and Other Key Employees | FGL Plan | Restricted shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period				3 years	1 year	2 years
Restricted stock unit grants (in shares)				26,000	173,000	171,000
CEO | FGL Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Accelerated compensation cost			$ 2,000,000
CEO | FGL Plan | Performance restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Forfeiture of awards, percent						66.70%
Officer | FGL Plan | Restricted shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock unit grants (in shares)					12,000	8,000
Officer | FGL Plan | Performance restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value at grant date				$ 1,000,000	$ 0	$ 1,000,000
Restricted stock unit grants (in shares)					32,000	541,000
Option fair value at grant date					$ 1,000,000	$ 9,000,000
Share price (USD per share)		$ 23.19		$ 23.19
Director | FGL Plan | Restricted shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock unit grants (in shares)					140,000
Option fair value at grant date	$ 3,000,000
Director | FGL Plan | Unrestricted shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock unit grants (in shares)					9,000	58,000
Chief Financial Officer | FGL Plan | Performance restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested (in shares)				63,000	14,000	44,000
Minimum | Officer | FGL Plan | Performance restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage				0.00%
Maximum | Officer | FGL Plan | Performance restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage				200.00%
Annual Performance Result | Officer | FGL Plan | Performance restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage					50.00%	33.333%
1st anniversary | FGL Plan | Restricted shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage					20.00%
2nd anniversary | FGL Plan | Restricted shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage					50.00%
3rd anniversary | FGL Plan | Restricted shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage					30.00%

Income Taxes - Schedule of Inco

Income Taxes - Schedule of Income Before Income Tax (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Income Tax Disclosure [Abstract]
United States	$ 153	$ 182	$ 189
Outside the United States	0	0	0
Income before income taxes	$ 153	$ 182	$ 189

Income Taxes - Components of In

Income Taxes - Components of Income Tax Expense (Benefit) (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Current:
Federal	$ (5)	$ (14)	$ (51)
State	0	0	0
Total current	(5)	(14)	(51)
Deferred:
Federal	(51)	(50)	25
State	0	0	0
Total deferred	(51)	(50)	25
Income tax (expense)/benefit	$ (56)	$ (64)	$ (26)

Income Taxes - Reconciliation o

Income Taxes - Reconciliation of Effective Income Tax (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Income Tax Disclosure [Abstract]
Expected income tax (expense)/benefit at Federal statutory rate	$ (54)	$ (64)	$ (66)
Valuation allowance for deferred tax assets	69	(1)	40
Amortization of low income housing tax credits	(2)	(1)	0
Benefit on LIHTC under proportional amortization method	3	1	0
Write off of expired capital loss carryforward	(73)	0	0
Other	1	1	0
Income tax (expense)/benefit	$ (56)	$ (64)	$ (26)
Effective tax rate	37.00%	35.00%	14.00%

Income Taxes - Schedule of Defe

Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Millions	Sep. 30, 2016	Sep. 30, 2015
Deferred tax assets:
Net operating loss, credit and capital loss carryforwards	$ 93	$ 169
Insurance reserves and claim related adjustments	511	424
Investments	0	24
Other	44	32
Valuation allowance	(51)	(120)
Total deferred tax assets	597	529
Deferred tax liabilities:
Value of business acquired	(7)	(65)
Investments	(312)	0
Deferred acquisition costs	(277)	(209)
Other	(11)	(27)
Total deferred tax liabilities	(607)	(301)
Net deferred tax assets and (liabilities)	(10)	0
Net deferred tax assets and (liabilities)	$ 0	$ 228

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Detail) - USD ($)	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014	Sep. 27, 2013
Tax Credit Carryforward [Line Items]
Federal tax rates	35.00%	35.00%	35.00%
Effective tax rate	37.00%	35.00%	14.00%
Write off of expired capital loss carryforward	$ 73,000,000	$ 0	$ 0
Valuation allowance increase (decrease)	(69,000,000)	1,000,000	(40,000,000)
OCI, deferred tax expense	188,000,000
OCI, deferred tax expense, valuation allowance release	1,000,000
Valuation allowance	51,000,000	120,000,000
Allowable net operating losses, capital losses, and tax credits acquired during business combination	5,000,000
NOL carryforwards	92,000,000	92,000,000
Tax liability	2,000,000	1,000,000
Unrecognized tax benefits	0	0
Capital Loss Carryforward
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	6,000,000	217,000,000		$ 350,000,000
Investment Tax Credit Carryforward
Tax Credit Carryforward [Line Items]
Tax credit carryforwards				54,000,000
Low Income Housing Tax Credit Carryforward
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	52,000,000	54,000,000
Alternative Minimum Tax Credit Carryforward
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	6,000,000	6,000,000		$ 6,000,000
Life Company Capital Loss Carryforwards
Tax Credit Carryforward [Line Items]
Valuation allowance increase (decrease)	(74,000,000)	(4,000,000)	(43,000,000)
Valuation allowance	0	74,000,000
Non-Life Company Capital Loss Carryforwards
Tax Credit Carryforward [Line Items]
Valuation allowance increase (decrease)	5,000,000	5,000,000	$ 3,000,000
Valuation allowance	$ 51,000,000	$ 46,000,000

Commitments and Contingencies -

Commitments and Contingencies - Schedule of Investment Commitments (Details) - Commitment to Invest $ in Millions	Sep. 30, 2016USD ($)
Other Commitments [Line Items]
Unfunded investment commitment	$ 103
Other invested assets
Other Commitments [Line Items]
Unfunded investment commitment	55
Fixed maturity securities, available-for-sale
Other Commitments [Line Items]
Unfunded investment commitment	16
Other assets
Other Commitments [Line Items]
Unfunded investment commitment	$ 32

Commitments and Contingencies88

Commitments and Contingencies - Schedule of Minimum Rental Commitments (Details) $ in Millions	Sep. 30, 2016USD ($)
Commitments and Contingencies Disclosure [Abstract]
2,017	$ 2
2,018	2
2,019	2
2,020	2
2,021	1
Thereafter	0
Total	$ 9

Commitments and Contingencies89

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions	Aug. 10, 2015	Jan. 07, 2015	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014	Jun. 30, 2015
Loss Contingencies [Line Items]
Rent expense			$ 2	$ 2	$ 2
Accrued amount of guaranty fund assessments			3
Estimated future premium tax deductions			3
Eddie L. Cressy v. Fidelity Guaranty [sic] Life Insurance Company, et. al.
Loss Contingencies [Line Items]
Settlement costs	$ 1		3
Estimate of possible loss			9
Unpaid portion of estimate (less than)			1
Legal fees incurred and paid			6
Amount received to settle outstanding claim						$ 4
Dale R. Ludwick, on behalf of Herself and All Others Similarly Situated v. Harbinger Group Inc., Fidelity & Guaranty Life Insurance Company, Raven Reinsurance Company, and Front Street Re (Cayman) Ltd
Loss Contingencies [Line Items]
Unpaid portion of estimate (less than)			$ 2
Damages sought (at least)		$ 0

Reinsurance - Effect of Reinsur

Reinsurance - Effect of Reinsurance on Premiums Earned, Benefits Incurred and Reserve Changes (Detail) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Premiums and other considerations:
Direct	$ 452	$ 416	$ 406
Assumed	1	0	36
Ceded	(259)	(271)	(320)
Net	194	145	122
Benefits and Other Changes in Insurance Policy Reserves:
Net	791	578	788
Traditional life insurance premiums
Premiums and other considerations:
Direct	261	260	267
Assumed	1	0	36
Ceded	(192)	(202)	(247)
Net	70	58	56
Benefits and Other Changes in Insurance Policy Reserves:
Direct	1,069	833	1,103
Assumed	1	0	28
Ceded	(279)	(255)	(343)
Net	$ 791	$ 578	$ 788

Reinsurance - Narrative (Detail

Reinsurance - Narrative (Details)	Oct. 01, 2012USD ($)	Sep. 30, 2016USD ($)policy	Sep. 30, 2015USD ($)	Sep. 30, 2014USD ($)	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Sep. 30, 2012USD ($)
Ceded Credit Risk [Line Items]
Ceded		$ 259,000,000	$ 271,000,000	$ 320,000,000
Number of policies reinsured by foreign company not engaged in insurance | policy		0
Pretax gain on reinsurance transactions deferred		$ 10,000,000	11,000,000				$ 18,000,000
Statutory capital and surplus					$ 210,000,000	$ 187,000,000
Nomura | Letter of Credit
Ceded Credit Risk [Line Items]
Maximum borrowing capacity	$ 295,000,000	201,000,000
Upfront structuring fee	3,000,000
Quarterly reduction in borrowing capacity	$ 6,000,000
Raven Re
Ceded Credit Risk [Line Items]
Statutory capital and surplus					$ 28,000,000
Life and Annuity Insurance Product Line
Ceded Credit Risk [Line Items]
Reinsurance, write off		0	$ 0	$ 0
Ceded		$ 0

Related Party Transactions - Su

Related Party Transactions - Summary of Affiliated Entity Operations (Details) - Front Street RE (Cayman) Ltd. - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Revenues:
Premiums	$ 3	$ 1	$ 1
Net investment income	61	63	64
Net investment gains (losses)	(8)	(30)	25
Insurance and investment product fees	3	4	5
Total revenues	59	38	95
Benefits and expenses:
Benefits and other changes in policy reserves	(47)	(42)	(60)
Acquisition & operating expenses, net of deferrals	(4)	(4)	(6)
Total benefits and expenses	(51)	(46)	(66)
Operating income (loss)	$ 8	$ (8)	$ 29

Related Party Transactions - Re

Related Party Transactions - Related Party Investments (Details) $ in Millions	12 Months Ended
	Sep. 30, 2016USD ($)borrower	Sep. 30, 2015USD ($)borrower	Sep. 30, 2014USD ($)
Salus participations
Related Party Transaction [Line Items]
Number of borrowers in loan participation | borrower	4	17
Average loan fair value	$ 5	$ 6
Fixed maturity securities, available-for-sale | Salus CLOs
Related Party Transaction [Line Items]
Asset carrying value	19	245
Accrued Investment Income	0	0
Total carrying value	19	245
Net investment income	9	11	$ 13
Fixed maturity securities, available-for-sale | Fortress Investment Group CLOs
Related Party Transaction [Line Items]
Asset carrying value	225	181
Accrued Investment Income	2	2
Total carrying value	227	183
Net investment income	11	8	2
Fixed maturity securities, available-for-sale | Leucadia National Corporation
Related Party Transaction [Line Items]
Net investment income	0	0	1
Fixed maturity securities, available-for-sale | Jefferies Group Inc.
Related Party Transaction [Line Items]
Net investment income	0	0	1
Equity securities, available-for-sale | Salus preferred equity
Related Party Transaction [Line Items]
Asset carrying value	3	3
Accrued Investment Income	0	0
Total carrying value	3	3
Net investment income	0	0	2
Other invested assets
Related Party Transaction [Line Items]
Asset carrying value		11
Accrued Investment Income		0
Total carrying value		11
Other invested assets | Salus participations
Related Party Transaction [Line Items]
Asset carrying value	21	110
Accrued Investment Income	0	1
Total carrying value	21	111
Net investment income	4	15	19
Other invested assets | EIC participations
Related Party Transaction [Line Items]
Asset carrying value		9
Accrued Investment Income		0
Total carrying value		9
Net investment income	1	0	0
Related party investment | HGI energy loan
Related Party Transaction [Line Items]
Asset carrying value	71	70
Accrued Investment Income	0	1
Total carrying value	71	71
Net investment income	4	5	6
Related party investment | Salus 2012 participations
Related Party Transaction [Line Items]
Asset carrying value		4
Accrued Investment Income		0
Total carrying value		4
Net investment income	0	0	1
Related party investment | Salus promissory note
Related Party Transaction [Line Items]
Asset carrying value		3
Accrued Investment Income		0
Total carrying value		3
Net investment income	0	1	1
Related party investment | Salus revolver
Related Party Transaction [Line Items]
Net investment income	$ 0	0	$ 1
Front Street RE (Cayman) Ltd. | HGI energy loan
Related Party Transaction [Line Items]
Asset carrying value		$ 20

Related Party Transactions - Na

Related Party Transactions - Narrative (Details)	1 Months Ended			3 Months Ended	12 Months Ended
	Aug. 31, 2016USD ($)	Jun. 30, 2016USD ($)	Jan. 31, 2014USD ($)	Jun. 30, 2016USD ($)	Sep. 30, 2016USD ($)loan	Sep. 30, 2015USD ($)	Sep. 30, 2014USD ($)	Sep. 30, 2013USD ($)	Mar. 31, 2016loan	Oct. 31, 2015
Related Party Transaction [Line Items]
Reinsurance recoverable					$ 3,464,000,000	$ 3,579,000,000
Funds withheld for reinsurance liabilities					1,172,000,000	1,267,000,000
Net realized gains on fixed maturity available-for-sale securities					11,000,000	11,000,000	$ 104,000,000
Litigation settlement amount		$ 2,000,000		$ (18,000,000)
Realized losses on other invested assets					(26,000,000)	(40,000,000)	(2,000,000)
Realized impairment losses					(45,000,000)	(82,000,000)	(1,000,000)
OTTI recognized in earnings					44,000,000	82,000,000	1,000,000
Other invested assets
Related Party Transaction [Line Items]
Realized impairment losses					(22,000,000)	(36,000,000)
Available-for-sale Securities
Related Party Transaction [Line Items]
Realized impairment losses					(11,000,000)	(46,000,000)
Front Street RE (Cayman) Ltd.
Related Party Transaction [Line Items]
Reinsurance recoverable					1,120,000,000	1,227,000,000
Funds withheld for reinsurance liabilities					1,172,000,000	1,258,000,000
Expenses from transactions with related party					51,000,000	46,000,000	66,000,000
Realized impairment losses					$ (81,000,000)
HRG
Related Party Transaction [Line Items]
Fees reimbursed by entity, percentage of shares sold by affiliated entity triggering prorated reimbursement										50.00%
Leucadia National Corporation
Related Party Transaction [Line Items]
Net realized gains on fixed maturity available-for-sale securities							2,000,000
Jefferies Group Inc.
Related Party Transaction [Line Items]
Net realized gains on fixed maturity available-for-sale securities							6,000,000
Frederick's of Hollywood
Related Party Transaction [Line Items]
Net realized gains on fixed maturity available-for-sale securities							0
Salus preferred equity
Related Party Transaction [Line Items]
Preferred stock dividend rate			10.00%
Total par value			$ 30,000,000
Salus Loan Participation, Collateralized Loan Obligation Subordinated Debt | Affiliated Entity
Related Party Transaction [Line Items]
CLO debt						16,000,000
Loan participation value						14,000,000
Related party promissory note						20,000,000
Related party debt, current						10,000,000
FGL Loan Participation, Collateralized Loan Obligation Subordinated Debt and Salus Promissory Note | Affiliated Entity
Related Party Transaction [Line Items]
Number of CLO's | loan					2				4
CLO debt					$ 25,000,000	27,000,000
Loan participation value						29,000,000
Related party promissory note						3,000,000
Commercial Real Estate Acquisition | Affiliated Entity
Related Party Transaction [Line Items]
Expenses from transactions with related party	$ 15,000,000
Salus Participations
Related Party Transaction [Line Items]
Realized impairment losses						(35,000,000)
Management Fees | Affiliated Entity | Salus
Related Party Transaction [Line Items]
Expenses from transactions with related party					0	1,000,000	0
Management Fees | Affiliated Entity | CorAmerica Capital, LLC
Related Party Transaction [Line Items]
Expenses from transactions with related party					3,000,000	1,000,000	0
Management Fees | Affiliated Entity | Energy & Infrastructure Capital, LLC
Related Party Transaction [Line Items]
Expenses from transactions with related party					0	0	0
Asset Sale and Recapitalization | Front Street RE (Cayman) Ltd.
Related Party Transaction [Line Items]
Notes payable, change in status, impairment loss								$ 2,000,000
Exchange of notes for cash					46,000,000
Asset Sale and Recapitalization | Affiliated Entity | HGI Energy Holdings, LLC
Related Party Transaction [Line Items]
Notes payable, change in status, impairment loss					6,000,000
Contribution | Affiliated Entity | HGI Energy Holdings, LLC
Related Party Transaction [Line Items]
Reinvestment amount					110,000,000
Purchase | Affiliated Entity | HGI Energy Holdings, LLC
Related Party Transaction [Line Items]
Reinvestment amount					110,000,000
Other derivatives and embedded derivatives | Other invested assets | Net investment (losses) gains
Related Party Transaction [Line Items]
Loss on derivative					(5,000,000)	(4,000,000)	(1,000,000)
Currency Forward | Other invested assets | Net investment (losses) gains
Related Party Transaction [Line Items]
Loss on derivative						(2,000,000)
Gain on derivative						9,000,000	2,000,000
RadioShack (RSH) Corporation
Related Party Transaction [Line Items]
Proceeds from liquidation					23,000,000
Realized losses on other invested assets					8,000,000
Related party loans
Related Party Transaction [Line Items]
Realized impairment losses					(4,000,000)
OTTI recognized in earnings					4,000,000	0	0
Other invested assets
Related Party Transaction [Line Items]
OTTI recognized in earnings					22,000,000	$ 36,000,000	$ 1,000,000
Carrying Value | Asset Sale and Recapitalization | Front Street RE (Cayman) Ltd.
Related Party Transaction [Line Items]
Notes payable, par value								28,000,000
Carrying Value | Asset Sale and Recapitalization | Affiliated Entity | HGI Energy Holdings, LLC
Related Party Transaction [Line Items]
Notes payable, par value					72,000,000			78,000,000
Fair Value | Asset Sale and Recapitalization | Front Street RE (Cayman) Ltd.
Related Party Transaction [Line Items]
Notes payable, par value	$ 71,000,000							26,000,000
Fair Value | Asset Sale and Recapitalization | Affiliated Entity | HGI Energy Holdings, LLC
Related Party Transaction [Line Items]
Notes payable, par value					$ 72,000,000			$ 72,000,000

Earnings Per Share - Summary of

Earnings Per Share - Summary of Basic and Diluted EPS (Detail) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended								12 Months Ended
	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Earnings Per Share [Abstract]
Net income attributable to common shares - basic	$ 30	$ 10	$ 9	$ 48	$ 30	$ 86	$ (12)	$ 14	$ 97	$ 118	$ 163
Weighted-average common shares outstanding - basic (in shares)									58,275,013	58,117,884	55,969,912
Dilutive effect of unvested restricted stock and unvested performance restricted stock (in shares)									271,000	208,000	31,000
Dilutive effect of stock options (in shares)									32,000	35,000	10,000
Weighted-average shares outstanding - diluted (in shares)									58,578,163	58,360,841	56,011,436
Net income per common share:
Basic (in USD per share)	$ 0.52	$ 0.16	$ 0.16	$ 0.82	$ 0.52	$ 1.48	$ (0.21)	$ 0.24	$ 1.67	$ 2.03	$ 2.91
Diluted (in USD per share)	$ 0.52	$ 0.16	$ 0.16	$ 0.82	$ 0.51	$ 1.48	$ (0.21)	$ 0.24	$ 1.66	$ 2.02	$ 2.90
Stock Option Awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of EPS, less than, amount (shares)									19,000	17,000	1,000

Insurance Subsidiary Financia96

Insurance Subsidiary Financial Information and Regulatory Matters - Statutory Income and Net Capital (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Statutory Accounting Practices [Line Items]
Statutory capital and surplus	$ 210	$ 187
IOWA
Statutory Accounting Practices [Line Items]
Statutory net income	(53)	105	$ 118
Statutory capital and surplus	1,239	1,212
NEW YORK
Statutory Accounting Practices [Line Items]
Statutory net income	(1)	2	$ 1
Statutory capital and surplus	$ 59	$ 61

Insurance Subsidiary Financia97

Insurance Subsidiary Financial Information and Regulatory Matters - Narrative (Details) - USD ($)	Sep. 30, 2016	Dec. 31, 2015	Dec. 31, 2014	Apr. 06, 2011
Statutory Accounting Practices [Line Items]
Statutory account practices, amount available for dividend payments	$ 124,000,000
Increase (decrease) in statutory capital surplus		$ 47,000,000	$ (5,000,000)
Unassigned surplus balance				$ 806,000,000
Unassigned surplus				$ 0
Change in statutory capital surplus		220,000,000	245,000,000
Non-permitted statutory accounting practices		(14,000,000)	(75,000,000)
Statutory capital and surplus		210,000,000	187,000,000
IOWA
Statutory Accounting Practices [Line Items]
Change in statutory capital surplus		4,000,000	17,000,000
Statutory capital and surplus		$ 1,239,000,000	$ 1,212,000,000

Other Liabilities - Schedule of

Other Liabilities - Schedule of Other Liabilities (Details) - USD ($) $ in Millions	Sep. 30, 2016	Sep. 30, 2015
Other Liabilities Disclosure [Abstract]
Amounts payable for investment purchases	$ 106	$ 125
Retained asset account	221	213
Option collateral liabilities	118	7
Remittances and items not allocated	77	42
Amounts payable to reinsurers	36	17
Accrued expenses	60	43
Deferred reinsurance revenue	25	27
Other	103	89
Total	$ 746	$ 563

Employee Benefit Plans - Narrat

Employee Benefit Plans - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Compensation and Retirement Disclosure [Abstract]
Percent of employer matching	5.00%
Employer discretionary contribution	$ 2	$ 2	$ 1

Quarterly Results (Unaudited) -

Quarterly Results (Unaudited) - Schedule of Quarterly Financial Information (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended								12 Months Ended
	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Quarterly Financial Information Disclosure [Abstract]
Premiums	$ 18	$ 21	$ 16	$ 15	$ 15	$ 17	$ 15	$ 11	$ 70	$ 58	$ 56
Net investment income	238	236	227	222	223	212	208	208	923	851	760
Net investment gains (losses)	26	(28)	(42)	63	(112)	74	(58)	59	19	(37)	307
Insurance and investment product fees and other	34	32	32	29	24	23	22	20	127	89	68
Total revenues	316	261	233	329	150	326	187	298	1,139	961	1,191
Total operating expenses	262	240	212	250	101	192	193	269	964	755	979
Net income	$ 30	$ 10	$ 9	$ 48	$ 30	$ 86	$ (12)	$ 14	$ 97	$ 118	$ 163
Net income (loss) per common share - basic (in USD per share)	$ 0.52	$ 0.16	$ 0.16	$ 0.82	$ 0.52	$ 1.48	$ (0.21)	$ 0.24	$ 1.67	$ 2.03	$ 2.91
Net income (loss) per common share - diluted (in USD per share)	$ 0.52	$ 0.16	$ 0.16	$ 0.82	$ 0.51	$ 1.48	$ (0.21)	$ 0.24	$ 1.66	$ 2.02	$ 2.90

Schedule I - Summary of Inve101

Schedule I - Summary of Investments (Details) $ in Millions	Sep. 30, 2016USD ($)
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized Cost	$ 20,037
Fair Value	21,042
Amount at which shown on the balance sheet	21,025
United States Government and government agencies and authorities
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized Cost	345
Fair Value	358
Amount at which shown on the balance sheet	358
States, municipalities and political subdivisions
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized Cost	1,515
Fair Value	1,717
Amount at which shown on the balance sheet	1,717
Foreign governments
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized Cost	5
Fair Value	5
Amount at which shown on the balance sheet	5
Public utilities
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized Cost	1,811
Fair Value	1,881
Amount at which shown on the balance sheet	1,881
All other corporate bonds
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized Cost	14,623
Fair Value	15,215
Amount at which shown on the balance sheet	15,215
Redeemable preferred stock
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized Cost	222
Fair Value	235
Amount at which shown on the balance sheet	235
Total fixed maturities
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized Cost	18,521
Fair Value	19,411
Amount at which shown on the balance sheet	19,411
Public utilities
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized Cost	0
Fair Value	0
Amount at which shown on the balance sheet	0
Banks, trust, and insurance companies
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized Cost	104
Fair Value	103
Amount at which shown on the balance sheet	103
Industrial, miscellaneous and all other
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized Cost	4
Fair Value	3
Amount at which shown on the balance sheet	3
Nonredeemable preferred stock
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized Cost	532
Fair Value	577
Amount at which shown on the balance sheet	577
Total equity securities
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized Cost	640
Fair Value	683
Amount at which shown on the balance sheet	683
Derivative investments
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized Cost	221
Fair Value	276
Amount at which shown on the balance sheet	276
Commercial mortgage loans
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized Cost	595
Fair Value	614
Amount at which shown on the balance sheet	595
Other long-term investments
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized Cost	60
Fair Value	58
Amount at which shown on the balance sheet	$ 60

Schedule II - Condensed Fina102

Schedule II - Condensed Financial Information - Condensed Balance Sheets (Details) - USD ($) $ in Millions	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Condensed Balance Sheet Statements, Captions [Line Items]
Cash and cash equivalents	$ 864	$ 502	$ 576	$ 1,204
Other assets	371	265
Total assets	27,035	24,925
Total liabilities	25,101	23,423
Preferred stock	0	0
Common stock	1	1
Additional paid-in capital	714	714
Retained earnings	792	710
Accumulated other comprehensive income	439	88
Treasury stock	(12)	(11)
Total shareholders' equity	1,934	1,502
Total liabilities and shareholders' equity	27,035	24,925
Parent Company
Condensed Balance Sheet Statements, Captions [Line Items]
Investments in consolidated subsidiaries	1,913	1,464
Fixed maturity securities, available for sale	5	7
Equity securities, available-for-sale, at fair value	12	17
Cash and cash equivalents	2	13	$ 66	$ 0
Other assets	2	1
Total assets	1,934	1,502
Total liabilities	0	0
Preferred stock	0	0
Common stock	1	1
Additional paid-in capital	714	714
Retained earnings	792	710
Accumulated other comprehensive income	439	88
Treasury stock	(12)	(11)
Total shareholders' equity	1,934	1,502
Total liabilities and shareholders' equity	$ 1,934	$ 1,502

Schedule II - Condensed Fina103

Schedule II - Condensed Financial Information - Condensed Statement of Operations (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Condensed Income Statements, Captions [Line Items]
Revenues	$ 316	$ 261	$ 233	$ 329	$ 150	$ 326	$ 187	$ 298	$ 1,139	$ 961	$ 1,191
General and administrative expenses									119	113	102
Total operating expenses	262	240	212	250	101	192	193	269	964	755	979
Operating income									175	206	212
Income before income taxes									153	182	189
Income tax expense									56	64	26
Net income	$ 30	$ 10	$ 9	$ 48	$ 30	$ 86	$ (12)	$ 14	97	118	163
Parent Company
Condensed Income Statements, Captions [Line Items]
Revenues									(2)	(9)	2
Gross Profit									(2)	(9)	2
General and administrative expenses									3	6	6
Total operating expenses									3	6	6
Operating income									(5)	(15)	(4)
Equity in net income of subsidiaries									103	133	167
Income before income taxes									98	118	163
Income tax expense									1	0	0
Net income									$ 97	$ 118	$ 163

Schedule II - Condensed Fina104

Schedule II - Condensed Financial Information - Condensed Statement of Cash Flow (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net income	$ 30	$ 10	$ 9	$ 48	$ 30	$ 86	$ (12)	$ 14	$ 97	$ 118	$ 163
Adjustments to reconcile net income to net cash provided by operating activities:
Realized capital and other gains on investments									(19)	37	(307)
Stock based compensation									8	7	8
Other assets and other liabilities									16	(36)	11
Net cash provided by operating activities									365	35	174
Cash flows from investing activities:
Net cash (used in) investing activities									(1,186)	(1,024)	(1,659)
Cash flows from financing activities:
Proceeds from issuance of common stock, net of transaction fees									0	0	176
Dividends paid									(15)	(15)	(55)
Treasury stock									(1)	(11)	0
Net cash provided by financing activities									1,183	915	857
Change in cash & cash equivalents									362	(74)	(628)
Cash & cash equivalents, beginning of period				502				576	502	576	1,204
Cash & cash equivalents, end of period	864				502				864	502	576
Parent Company
Cash flows from operating activities:
Net income									97	118	163
Adjustments to reconcile net income to net cash provided by operating activities:
Realized capital and other gains on investments									2	9	(1)
Equity in net income of subsidiaries									(103)	(133)	(167)
Stock based compensation									(2)	10	3
Other assets and other liabilities									2	2	(2)
Net cash provided by operating activities									(4)	6	(4)
Cash flows from investing activities:
Net cash (used in) investing activities									5	15	(49)
Cash flows from financing activities:
Proceeds from issuance of common stock, net of transaction fees									2	2	173
Dividends paid									(15)	(15)	(54)
Treasury stock									(1)	(11)	0
Distribution to FGLH and subsidiaries									2	(50)	0
Net cash provided by financing activities									(12)	(74)	119
Change in cash & cash equivalents									(11)	(53)	66
Cash & cash equivalents, beginning of period				$ 13				$ 66	13	66	0
Cash & cash equivalents, end of period	$ 2				$ 13				2	13	66
Equity securities, available-for-sale | Parent Company
Cash flows from investing activities:
Proceeds from available-for-sale investments, sold, matured or repaid:									5	30	125
Cost of available-for-sale investments:									$ 0	$ (15)	$ (174)

Schedule III - Supplementary105

Schedule III - Supplementary Insurance Information (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Supplementary Insurance Information [Abstract]
Deferred acquisition costs	$ 1,007	$ 801	$ 456
Future policy benefits, losses, claims and loss expenses	3,467	3,468	3,504
Other policy claims and benefits payable	55	55	58
Premium revenue	70	58	56
Net investment income	923	851	760
Benefits, claims, losses and settlement expenses	(791)	(578)	(788)
Amortization of deferred acquisition costs	(49)	(27)	(39)
Other operating expenses	$ (119)	$ (113)	$ (102)

Schedule IV - Reinsurance (Deta

Schedule IV - Reinsurance (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Life insurance in force
Gross Amount	$ 3,081	$ 2,933	$ 2,786
Ceded to other companies	(2,024)	(2,010)	(2,014)
Assumed from other companies	0	0	16
Net Amount	$ 1,057	$ 923	$ 788
Percentage of amount assumed of net	0.00%	0.00%	2.00%
Premiums and other considerations:
Direct	$ 452	$ 416	$ 406
Ceded to other companies	(259)	(271)	(320)
Assumed from other companies	1	0	36
Net	$ 194	$ 145	$ 122
Premiums, Percentage Assumed to Net	1.00%	0.00%	30.00%
Traditional life insurance premiums
Premiums and other considerations:
Direct	$ 261	$ 260	$ 267
Ceded to other companies	(192)	(202)	(247)
Assumed from other companies	1	0	36
Net	$ 70	$ 58	$ 56
Premiums, Percentage Assumed to Net	1.00%	0.00%	65.00%
Annuity product charges
Premiums and other considerations:
Direct	$ 191	$ 156	$ 139
Ceded to other companies	(67)	(69)	(73)
Assumed from other companies	0	0	0
Net	$ 124	$ 87	$ 66
Premiums, Percentage Assumed to Net	0.00%	0.00%	0.00%